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QUILL ON SCALPEL
This section provides a medium through which Canadian surgeons can declare themselves, briefly 
and informally, on the day-to-day affairs of surgery.
Colorectal Cancer
Carcinoma of the colon and rectum 
is the commonest killing cancer that 
afflicts Canadians. No doubt this was 
a major reason why the Canadian On­
cology Society presented a symposium 
on the subject at its first annual meet­
ing. Although, among surgeons, only 
those dealing with the gastrointestinal 
tract will encounter colorectal cancer 
professionally, a disease so common 
will unfortunately be experienced per­
sonally by many of us. Moreover, each 
of the six presentations which are pre­
sented in this issue contains prin­
ciples about neoplastic disorders that 
all surgeons can be reminded of with 
benefit. The paper by Morson (page 
206) provides glimpses of the very 
nature of neoplastic transformation.
Miller (page 209) reminds us that 
there are causes, albeit poorly under­
stood, of cancer. Gold’s paper (page 
212) updates the still disappointingly 
limited contributions of immunology 
to cancer control. The papers of 
Localio (page 214), Rider (page 215) 
and Klaassen (page 218) should re­
mind us that neoplasia requires a flex­
ible use of all treatment modalities. 
Until the rates of control reach more 
acceptable levels, there must be a will­
ingness to use any or all of our tools 
in innovative ways and in proper 
prospective randomized trials so that 
therapy can be based as much as possi­
ble on fact and as little as possible on 
hope or belief.
To many, colorectal cancer is a
mundane subject because of its com­
monality. Considering the enormity of 
the morbidity and mortality that it 
produces, current information about it 
must be kept before those physicians 
and surgeons treating bowel tumours, 
so that Canadians are not subjected 
to obsolete or unnecessary manage­
ment. Until our control over this 
disease is considerably improved, the 
continuing education of surgeons must 
regularly include a review of colorectal 
cancer.
J.E. D e v it t , m d , m  sc ,
FRCS(EDIN), FRCS[CJ 
Associate dean,
Continuing medical education,
University of Ottawa,
Ottawa, Ont.
Colorectal Cancer: Its Pathology and Immunology Revisited
The fortunes of carcinoembryonic anti­
gen (CEA) have been fluctuating since 
its discovery in 1965 by Gold and 
Freedman. In this issue (page 212) Gold 
lucidly summarizes the clinical uses of 
the test today, after its role has been 
modified as a result of numerous stu­
dies. Its original promise as a specific 
serologic test for large-bowel cancer 
has not been fulfilled, although it is 
useful in well-defined clinical situations. 
In patients suspected to have cancer of 
the large bowel or pancreas the test may 
be of value if used in conjunction with
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clinical and other laboratory findings. 
But Gold emphasizes that it is not use­
ful as a screening test. Extensive and 
advanced carcinomas of the large bowel 
produce high concentrations of circulat­
ing CEA, so the assay is of great prog­
nostic value; low concentrations indi­
cate a good possibility of cure following 
tumour resection whereas persistent 
high concentrations indicate a poor 
prognosis. The assay for CEA is of 
greatest value in detecting tumour re­
currence as indicated by an elevation of 
CEA concentration following an initial
fall after tumour resection. The signifi­
cant role played by CEA in clinical 
practice is now well established, but the 
most important aspect of the pioneer 
work of Gold and his colleagues in 
Montreal is that it has excited and en­
couraged other investigators to search 
for more specific immunologic markers 
in large-bowel cancer and other malig­
nant conditions.
Dr. Basil Morson presents (page 206) 
a succinct account of the state of the 
art concerning some aspects of the 
pathology of colorectal cancer. He
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restates well-established facts (many 
of which have come from his 
own laboratory) and adds personal 
views reached as a result of extensive 
experience in this field. As he admits, 
some of these opinions result from 
anecdotal experiences; for instance, the 
natural history of many lesions is made 
clear only if the lesions are untreated. 
Thus, it must be a rare experience to 
detect, follow and leave untreated (be­
cause of patient refusal) benign epithe­
lial colonic lesions and watch their 
gradual transformation into cancer. 
This type of observation means that at 
least some adenomas become malignant 
but gives no clue as to how often this 
occurs. Nevertheless, that it does occur 
establishes a vitally important fact and 
many would agree with Morson that 
the epithelial polyp is the most common 
immediate predisposing condition to 
rectocolic carcinoma. It is generally 
agreed that certain polyps with specific 
features are more likely to become 
malignant. The histologic type of the 
polyp is important. Villous lesions al­
though far less common than tubular 
adenomas have a higher potential for 
malignant change. Larger polyps are 
more likely to become malignant than 
smaller ones and polyps that show 
epithelial dysplasia are more likely to
behave in a malignant fashion. The 
propensity of the villous adenoma to 
malignant change may in fact be only 
a reflection of this epithelial atypia 
which is more common in these lesions. 
Epithelial dysplasia, however, is not an 
absolute determinant of ultimate inva­
sive transformation, for it appears that 
regression of atypia can occur in much 
the same way as it happens in carcino­
ma in situ of the cervix. Such regres­
sion, however, must be exceptionally 
rare.
Despite advances in diagnostic tech­
niques the cure rate for colorectal car­
cinoma has not changed substantially 
in the past 10 years. Even now, at the 
time of surgery the tumour will have 
spread beyond the reach of resection in 
about 25% of patients and we are at an 
impasse. If, as Morson suggests (and 
his viewpoint is by no means unanim­
ous), the transformation from benign to 
malignant epithelial lesions is common 
and if most carcinomas arise from 
benign polyps with a long latent 
period in which there is an “in-situ” 
phase, then the position is somewhat 
analogous to the carcinoma in situ- 
invasive squamous cell carcinoma of 
the uterine cervix. If we also accept the 
old surgical aphorism that about 70% 
of all large-bowel carcinomas are with­
in the reach of the proctosigmoidoscope, 
then perhaps it is time to consider the 
feasibility of a program designed to de­
tect these lesions in symptomless pa­
tients, in much the same way as was 
done in British Columbia with “Pap” 
smears of the cervix. Obviously an ap­
propriate community and a selected age 
group would have to be studied. Patient 
cooperation would probably be a serious 
problem and the cost might be too great 
for the federal taste, but such a pro­
gram could provide answers to many 
of the questions regarding the life his­
tory of the polyp. At the same time a 
marked reduction in the incidence of 
large-bowel cancer might follow. Proc- 
tosigmoidoscopic examinations are 
now being done by individual phy­
sicians in the course of routine phys­
ical examinations, but the results are too 
few and are not systematically collected, 
preventing a knowledge of the overall 
outcome because the data derived from 
such studies are not collated or con­
trolled.
F.M. Cole, mb, b ch, frcp[c]
Chief of service,
Anatomic pathology,
McMaster University Medical Centre, 
Hamilton, Ont.
Upper Gastrointestinal Hemorrhage
Upper gastrointestinal hemorrhage, one 
of the commonest causes of emergency 
admission to hospital, is associated with 
a mortality of 5% to 30% depending 
on the extent and site of bleeding. In 
over 50% of cases the hemorrhage is 
from a duodenal ulcer. Acute gastric 
erosions, due to the ingestion of ul­
cerogenic drugs such as alcohol and 
acetylsalicylic acid, have now become 
the second commonest cause of bleed­
ing. Other common causes include 
chronic gastric ulcer and esophageal 
varices. In the early 1960s management 
of patients with upper gastrointestinal 
bleeding consisted of, correcting hypo­
volemic shock, gastric lavage with 
cold saline and, when the patient was 
stable, roentgenography of the upper 
gastrointestinal tract. This approach,
however, was associated with a high 
mortality.1 Although rigid instruments 
were available for endoscopy, the asso­
ciated morbidity and mortality pro­
hibited their widespread use in identi­
fying the source of bleeding.
With the introduction and increasing 
use of fiberoptic endoscopes, it became 
apparent that endoscopy was more 
accurate than roentgenography in dem­
onstrating the source of upper gastro­
intestinal bleeding2"1 and that an ag­
gressive approach—early endoscopy, 
establishing a diagnosis before surgery 
and early surgery for appropriate le­
sions-—would decrease the mortality.5
Once the source of bleeding is estab­
lished, what is the correct surgical 
approach? Addressing themselves to 
this problem, Dufour and Rheault in
this issue of the journal (page 261) 
studied 68 patients with severe upper 
gastrointestinal bleeding who had emer­
gency surgery. Their overall mortality 
of 29.5%, although high, is comparable 
to that of other studies.6'7 Bleeding 
gastric ulcers led to a higher mortality 
than duodenal ulcers, because bleeding 
gastric ulcers generally occur in older 
patients and are associated with a high 
rate of rebleeding. The authors have 
also shown that vagotomy and gastrec­
tomy will result in a significantly lower 
mortality than other surgical proce­
dures. It is not clear from their article 
what type of surgery should be per­
formed for individual lesions.
For bleeding duodenal ulcers, sub­
total gastrectomy was for a long time 
favoured by many surgeons. Since
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emergency gastrectomy can result in a 
30% mortality,8 surgeons have tried 
other procedures in which the mortality 
and rate of rebleeding are low. An 
approach to management has evolved 
that provides maximal reduction of 
acid secretion and “tailors” the opera­
tion to the age and condition of the 
patient. In reasonably healthy patients 
under 60 years of age vagotomy and 
antrectomy, with oversewing of the 
ulcer, result in mortality of less than 
5% .7 In older, ill patients vagotomy 
and pyloroplasty, with oversewing of 
the ulcer, lead to a much lower mor­
tality than gastrectomy.9,10
With respect to the bleeding gastric 
ulcer, gastrectomy in younger patients 
will successfully arrest the hemorrhage 
and has an acceptable operative mor­
tality. In the elderly patient conserva­
tive surgery, comprising vagotomy, py­
loroplasty and oversewing of the ulcer, 
will give the best results.7'11,12
Bleeding acute gastric erosions due 
to the ingestion of alcohol or acetylsali- 
cylic acid can be successfully managed 
by conservative means.13 Septic induced 
erosions are associated with a high mor­
tality, whether management is surgical 
or conservative, but prophylactic ant­
acid therapy and control of infection 
(early drainage of an intra-abdominal 
abscess or removal of an infected cen­
tral venous catheter) will reduce the
In this issue (page 241) Johnston de­
scribes the clinical picture of annular 
pancreas in neonates and adults, and 
correlates the clinical differences be­
tween these two groups of patients with 
anatomical differences in the encircling 
pancreas. Although clinical differences 
between adults and children have been 
noted before1 this is the first suggestion 
that anatomical differences between the 
clinical types of annular pancreas exist. 
Basically Johnston contends that the 
patient who presents with the clinical 
picture of duodenal obstruction (usual­
ly a neonate but not always, as illus­
trated by his cases 2 and 5) has a ring 
of pancreatic tissue lying on the duo­
denal wall, but separable from the duo­
denum. This type of annular pancreas 
is drained by a main duct. The patient
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number of such erosions. If bleeding 
persists then vagotomy and subtotal 
gastrectomy will stop the hemorrhage.
The reports that aggressive manage­
ment and selective surgery result in 
low mortality and morbidity are en­
couraging. What is needed are well- 
designed randomized studies comparing 
different forms of therapy in patients 
under and over 60 years of age. Ethical 
controlled studies would allow us to 
formulate a sound approach to the 
management of patients with upper 
gastrointestinal hemorrhage.
H.S. H im a l , m d , fr c s[c]
Associate professor,
Department of surgery,
Royal Victoria Hospital,
Montreal, PQ
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Annular Pancreas
who has a duodenal ulcer proximal to 
an annular pancreas has pancreatic tis­
sue buried in the duodenal wall, and 
this tissue is drained by many small 
ducts opening into the duodenum. An 
excellent example of this type of an­
nular pancreas is the well-documented 
case reported by Strully, Schwartz and 
Nagaraj.2
From a practical standpoint the ob­
servations made by Johnston are un­
likely to affect the treatment of an­
nular pancreas, since some form of 
bypass is indicated in both types in 
preference to a direct attack on the 
ring of pancreatic tissue.3,4 However, 
the observations may stimulate addi­
tions to our knowledge of the embry­
ology of the pancreas and the entity 
called annular pancreas.
THE CANADIAN JOURNAL OF SURGERY
O.G. T h u r st o n , m d , fr c s[c] 
Department of surgery, 
University of Alberta Hospital, 
Edmonton, Alta.
References
1. T homford NR, K night PR, P ace WG, 
et al: Annular pancreas in the adult: 
selection of operation. Ann Surg 176; 
159, 1972
2. Strully LV, Schwartz DN, N agaraj 
GS: Pancreatoduodenectomy in annular 
pancreas for relief of duodenal obstruc­
tion. Am J Dig Dis 20: 671, 1975
3. M errill JR, R affensperger JG:
Pediatric annular pancreas: twenty
years’ experience. J Pediatr Surg 11: 
921, 1976
4. M endelson G, K otzmann RR, M c- 
Lellan  RM, et al: Annular pancreas 
in an adult. Aust NZ J Surg 42: 278, 
1973
193
To lower 
blood pressure 
during 
anesthesia
reduces excessive' 
blood loss
Precautions
(sodium nitroprusside)
tor controlled hypotension during anesthesia 
Rx Summary
‘Nipride’ is only to be used as an infusion with sterile 5% dextrose 
in water without preservatives. Not for direct injection.
Indications
'Nipride' is indicated for producing controlled hypotension during 
anesthesia to reduce bleeding in surgical procedures where deemed 
appropriate. Benefit-risk ratio should be carefully considered on an 
individual basis.
Contraindications
Adequate facilities, equipment and personnel should be available 
for frequent and vigilant monitoring of blood pressure. When the infu­
sion is slowed or stopped, blood pressure usually begins to rise imme­
diately and returns to pretreatment levels within one to ten minutes.
It should be used with caution and initially in low doses in elderly 
patients, since they may be more sensitive to the hypotensive effects 
of the drug.
If, in the clinical situation, stress induced by pain or manipulation 
is reduced or eliminated during ‘Nipride’ infusion, the patient could 
experience a greater than expected reduction in blood pressure 
unless the rate of infusion is adjusted downward as required.
'Nipride' tends to deteriorate in the presence of light. Therefore, the 
infusion bottle should be wrapped with aluminum foil or other opaque 
material. Solutions of 'Nipride' should not be kept or used longer 
than four hours. 'Nipride' in aqueous solution yields the nitroprusside 
ion, which reacts with even minute quantities of a wide variety of 
organic and inorganic substances to form usually highly coloured 
reaction products (blue, green or dark red). If this occurs, the infusion 
should be replaced as quickly as possible.
In the treatment of compensatory hypertension, e.g. arteriovenous 
shunt or coarctation of the aorta. It is also contraindicated in physically 
poor-risk patients (A.S.A. Risk 5), in patients with uncorrected anemia 
or hypovolemia or in those with known inadequate cerebral circulation. 
In patients with liver disease, severe renal disease, Leber’s optic 
atrophy and disease states associated with vitamin Bi2 deficiency.
Warnings
N^ipride' is only to be used as an infusion with sterile 5% dextrose 
in water without preservatives. Not for direct injection. Infusion rates 
greater than 8 ng/kg/minute are virtually never required. If at this 
rate an adequate reduction in blood pressure is not obtained within 
10 minutes, administration of ‘Nipride’ should be stopped.
Fatalities due to cyanide poisoning have occurred following sodium 
nitroprusside administration. One factor is common to all known 
cases, namely that large amounts of nitroprusside were infused at 
high rates. Since detoxification relies upon enzymatic action, the 
rare possibility of deficient or atypical enzymes occurring in humans 
should always be considered. Patients most apt to run into difficul­
ties are those who are resistant to the hypotensive effect or those 
in whom maintenance at the selected blood pressure level is difficult 
or impossible.
Constant attention to the patient’s dose-response characteristics 
is mandatory. If infusion rates are in excess of 8 ug/kg/minute deter­
mine the nature of the response (effective constant response at 
higher dose; tachyphylactic; resistant - none or less than expected). 
As soon as either tachyphylaxis or resistance is determined the infu­
sion of ‘Nipride’ should be discontinued immediately. In abnormal 
responders it has been noted that metabolic acidosis may occur 
at higher doses.
Caution should be exercised in using ‘Nipride’ in patients with hypo­
thyroidism or severe renal impairment.
Blood levels of thiocyanate should be determined if treatment is to 
be extended especially in patients with severe renal dysfunction.
As long as blood thiocyanate levels do not exceed 10 mg/100 ml, it is 
probably safe to continue with the infusion. Peritoneal dialysis can 
be helpful if too high levels of thiocyanate are found.
Hypertensive patients are more sensitive to the intravenous effect 
of sodium nitroprusside than are normotensive subjects. Patients 
receiving concomitant antihypertensive medications (especially 
hydralazine or hexamethonium) are more sensitive to the hypotensive 
effect of sodium nitroprusside and the dosage of ‘Nipride’ should 
be adjusted downward accordingly.
The following Warnings apply to the use of 'Nipride' for controlled 
hypotension during anesthesia:
1. Extreme caution should be exercised in patients who are especially 
poor surgical risks (A.S.A. class 4 and 4E).
2. Tolerance to blood loss, anemia and hypovolemia may be dimin­
ished. If possible, preexisting anemia and hypovolemia should be 
corrected prior to employing controlled hypotension.
3. Hypotensive anesthetic techniques may alter pulmonary ventilation 
perfusion ratio. Patients intolerant of additional dead air space
at ordinary oxygen partial pressure may benefit from higher oxygen 
partial pressure.
4. Resistance and tachyphylaxis occur more frequently in normoten­
sive patients infused with sodium nitroprusside. Induction of delib­
erate hypotension in healthy young individuals may prove to be 
more difficult than in other segments of the population.
5. Upon discontinuance of the sodium nitroprusside infusion for the 
purpose of controlled hypotension during anesthesia a rebound 
hypertension has been observed on rare occasions.
Usage in pregnancy
The safety of ’Nipride’ in women who are or who may become preg­
nant has not been established; hence, it should be given only when 
the potential benefits have been weighed against possible hazard 
to mother and fetus.
Usage in children
The safety of ‘Nipride’ in children has not been established. Clinical 
experience is limited.
Adverse reactions
Nausea, retching, emesis, diaphoresis, apprehension, headache, 
restlessness, agitation, muscle twitching, retrosternal discomfort and 
chest pain, palpitations, dizziness, faintness, weakness, rash, abdo­
minal pain, confusion and somnolence have been noted with too 
rapid reduction in blood pressure. These symptoms rapidly disap­
peared with slowing of the rate of infusion or temporary discontinua­
tion of infusion and did not reappear with continued slower rate 
of administration.
Irritation of the injection site may occur. Methemoglobinemia and 
one case of hypothyroidism following prolonged therapy have been 
reported.
Dosage and administration (for controlled hypotension)
Use of ‘Nipride’ in anesthetized normotensive patients undergoing 
deliberate hypotensive surgery must be restricted to carefully 
selected cases. There is a possibility of an abnormal response 
occurring in normotensive patients. In this event, the infusion of 
‘Nipride’ should be discontinued immediately. (See Warnings).
The contents of a 50 mg ‘Nipride’ vial should be dissolved in 3 ml 
of sterile dextrose in water without preservatives. No other diluent 
should be used. Depending on the desired concentration, all of the 
prepared stock solution should be diluted in 500 or 1000 ml of 5 per­
cent sterile dextrose in water and promptly wrapped in aluminum 
foil or other opaque material. Both stock solution and infusion solu­
tion should be freshly prepared and any unused portion discarded. 
The freshly prepared solution for infusion has a very faint brownish 
tint. If it is highly coloured, it should be discarde ' (See Precautions). 
The solution should not be kept or used longer than four hours from 
initial reconstitution. The infusion fluid used for the administration 
of 'Nipride' should not be employed as a vehicle for simultaneous 
administration of any other drug.
Nipride' dosage varies considerably from patient to patient, hence 
the need for individual titration. The infusion should be started at 
the lower dosage range, 0.5 jug/kg/minute and increased by 
0.2 fig/kg/minute every 5 minutes until the desired reduction in 
blood pressure is obtained. The blood pressure usually starts to drop 
immediately or at least within a few minutes. Continuous monitoring 
of the blood pressure is necessary. Blood pressure should not be 
allowed to drop at too rapid a rate and systolic pressure should not 
be lowered below 60 mm Hg.
Infusion rates greater than 8 jug/kg/minute should rarely be used.
The maximum recommended dose is 800 ^g/minute.
'Nipride' should be administered by an infusion pump, micro-drip 
regulator or any similar device that will allow precise measurement 
of the flow rate. Avoid extravasation. The rate should be adjusted 
to maintain the desired hypotensive effect, as determined by frequent 
blood pressure determinations.
For the use of ‘Nipride’ in the treatment of hypertensive crises please 
refer to the Product Monograph.
Supply
‘Nipride’ is supplied in 5 ml amber-coloured vials containing the 
equivalent of 50 mg sodium nitroprusside for dilution with 5 percent 
sterile dextrose in water (available in packages of 10).
Product Monograph available on request. ™
O
CO
*  Reg. Trade Mark for sodium nitroprusside 'Roche' d
®Reg. Trade Mark o
Hoffmann-La Roche Limited 
Vaudreuil, Quebec 
J7V6B3
PAAB
CCPP
REVIEW ARTICLE
Clinical Value of Gastrointestinal 
Fiberoptic Endoscopy
A. Groll, mb, ch b, m r cp( lono), fr c p[c]
This review describes the contribution 
of fiberoptic endoscopy and its asso­
ciated ancillary procedures to the 
improved diagnosis of some common 
gastrointestinal disorders. The diagnostic 
approach to esophagitis and carcinoma 
of the esophagus and stomach is 
outlined. Swallowed foreign bodies 
that do not pass out of the stomach 
can be removed with relative ease by 
endoscopic ancillary procedures. The 
role of endoscopy in duodenal ulcer 
disease and the effects on morbidity 
and mortality of the vigorous diagnostic 
approach in upper gastrointestinal 
hemorrhage are discussed. Endoscopy 
is invaluable for assessing the condition 
of the stomach postoperatively.
Colonoscopic polypectomy has lent 
support to the "polyp-cancer” hypo­
thesis. The role of colonoscopy in the 
evaluation of inflammatory bowel 
disease must still be delineated.
Endoscopic retrograde cholangio­
pancreatography is of value in the 
investigation of obstructive jaundice 
and pancreatic disease. In the former, 
noninvasive techniques of ultraso­
nography and computerized tomography 
scanning complemented by fine-needle 
transhepatic cholangiography will 
probably be the preferred methods of 
investigation.
The impact of the contribution of 
fiberoptic endoscopy on health care 
will be maintained only if the physician 
has been properly trained in its use and 
has an understanding of the different 
diseases.
Cette revue fait part de la contribution 
de la fibroscopie et des interventions 
associees qui en decoulent, a I’ame- 
lioration du diagnostic de quelques 
affections gastrointestinales courantes. 
On decrit la technique de diagnostic
From the division of gastroenterology, 
department of medicine, Queen’s 
University and Kingston General 
Hospital, Kingston, Ont.
Reprint requests to: Dr. A. Groll, Division 
of gastroenterology, Queen's University, 
102 Stuart St., Kingston, Ont. K7L 2V6
utilisee dans I’oesophagite et le car- 
cinome de I’oesophage et de I’estomac. 
Les corps etrangers ingeres qui ne 
sont pas evacues de I'estomac peuvent 
etre retires avec une facilite relative 
grace a une technique s'appuyant 
sur I'endoscopie. On discute du role 
de I'endoscopie dans I'ulcere duodenal 
et des effets d'un abord diagnostique 
vigoureux sur la morbidity et la mortality 
associees a I’hemorragie gastrointes­
t in a l  haute. L’endoscopie est de 
plus precieuse pour 1'evaluation de 
I'estomac dans la periode postoperatoire.
La polypectomie au colonoscope 
a apporte des arguments en faveur de 
I'hypothese reliant polype et cancer.
Le role de la colonoscopie dans reva­
luation des maladies inflammatoires 
intestinales reste a etre precise.
La cholangiopancreatographie en- 
doscopique retrograde n'est d’aucune 
utilite pour I’etude de I’ictere par 
retention et des maladies du pancreas. 
Dans le premier cas, des techniques 
douces telles que les ultrasons et la 
tomographie sur ordinateur assistes 
par la cholangiographie transhepatique 
a I’aiguille fine sera probablement la 
methode d'investigation preferee.
La contribution de la fibroscopie aux 
soins de sante ne pourra se maintenir 
que si le medecin recoit une formation 
satisfaisante sur (’utilisation de cette 
technique et qu'il possede une compre­
hension des differentes maladies.
Since the introduction of fiberoptics in 
19581 technologic advances in endo­
scopy have permitted the direct scrutiny 
of an ever-increasing area of the gastro­
intestinal tract. It is now possible to 
examine the upper gastrointestinal tract 
as far as the fourth part of the duo­
denum, and skilfully performed colono­
scopy will permit the examination of 
the whole colon. Enteroscopy of the 
entire small bowel2 is expected to be 
feasible in the future. The endoscope 
makes possible a range of procedures 
including accurate target biopsies, can- 
nulation of the papilla of Vater, snare- 
cauterization of polyps and removal of
foreign bodies. The latest achievements 
are endoscopic sphincterotomy of the 
papilla of Vater and the extraction of 
gallstones from the common bile duct.3"5 
Research is being conducted into argon 
laser systems6,7 for gastrointestinal 
bleeding.
These advances have occurred rapid­
ly and at times appear to have turned 
the physician from a diagnostician into 
a technician. A correct diagnosis can 
be reached only after a critical analysis 
of the clinical problem and careful in­
terpretation of the endoscopic observa­
tions.
Esophageal Disorders
Flexible fiberoscopes, because of 
their ease of passage and excellent op­
tical systems, have almost completely 
replaced the rigid metal esophagoscopes. 
Patients tolerate the procedure, per­
formed under local anesthesia and seda­
tion, extremely well. The endoscopist 
can examine the mucosa in detail, 
easily identify the gastroesophageal 
mucosal junction and observe, to some 
extent, the nature of esophageal peris­
talsis.
A convincing clinical problem is eso­
phageal acid reflux; when there is 
a commencing and recurrent history of 
this condition it must be fully investi­
gated and the patient not simply advised 
to take antacids. Obviously dysphagia 
as the sole symptom is a mandatory 
indication for endoscopy. Barium eso- 
phagography remains an insensitive 
means for the diagnosis of early eso­
phageal ulceration and inflammation. 
The clinical decision whether to 
treat a patient with reflux conservative­
ly or surgically will be influenced by 
the degree of inflammation seen at en­
doscopy. The presence of even a slight 
stricture, not appreciable on a roent­
genogram, would favour a surgical ap­
proach. However, endoscopy alone is 
not completely reliable as a guide, since 
the mucosa in the study by Ismail-Beigi, 
Horton and Pope8 showed no macro­
scopic evidence of esophagitis in ap­
proximately 20% of patients with se-
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rious acid-reflux symptoms and positive 
esophageal acid-perfusion tests. Esopha­
geal biopsy showed evidence of eso­
phagitis in nearly all these patients, 
confirming that biopsy is a more sensi­
tive method of examination of the eso­
phageal mucosa than endoscopy. We 
agree with Ismail-Beigi and colleagues 
who claim to have had no success in 
making a diagnosis of early esophagitis 
from the small biopsies obtained 
through the fiberoscope, since these do 
not usually contain lamina propria. 
Their criteria for the histologic diag­
nosis of esophagitis were established 
from biopsies done with the multipur­
pose Rubin tube,8 which enabled them 
to define the distribution of the his­
tologic changes of gastroesophageal re­
flux in the distal esophagus.9 The Rubin 
tube can be passed along the side of the 
endoscope permitting multiple biopsies 
to be taken under direct vision, or a 
fairly accurate measurement may be 
made during endoscopy as to where the 
tube should be placed. Such biopsies 
should be undertaken in all patients 
with reflux when the mucosa appears 
normal or when the endoscopic inter­
pretation of esophageal inflammation 
is questionable. In patients with a his­
tologically normal mucosa the decision 
to perform antireflux surgery must on­
ly be taken in select patients after care­
ful documentation of actual reflux by 
pH electrode methods, after obtaining 
evidence from acid-perfusion tests that 
the symptoms are arising from the 
esophagus, and after careful exclusion 
of peptic ulcer and biliary tract disease.
In the case of esophageal narrowings, 
ulcerations, or filling defects detected 
roentgenographically, an accurate diag­
nosis can be made by the combined use 
of endoscopically directed target biop­
sies and brush cytology. The instrument 
incorporates a mechanism by which the 
distal tip may be actively bent through 
an arc of 180°, and contains a long 
channel through which a biopsy forceps 
and a nylon brush can be passed after 
the lesion has been brought into the 
centre of the visual field. By these 
means the histologic confirmation of 
cancer of the esophagus and stomach 
has been made possible in as many as 
95% to 99% of cases in various 
series.1012 Winawer and colleagues13 
showed that brush cytology alone diag­
nosed 97% of esophageal cancers com­
pared with a rate of 66% when biopsy 
alone was employed. When both meth­
ods were combined they attained 100% 
diagnostic accuracy. It should be em­
phasized, however, that submucosal 
infiltrative adenocarcinoma of the eso­
phagus still eludes diagnosis by endo­
scopic biopsies that are often too shal­
low and do not usually contain sub­
mucosa. Flexible fiberoscopes have 
facilitated the diagnosis of carcinoma
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of the cardia and fundus of the stomach 
because of the relative ease with which 
these areas can be viewed and lesions 
biopsied. When biopsies and cytologic 
examination are negative for malignant 
disease and the diagnosis is still sus­
pected, biopsy using fiberoscopy can 
be repeated readily as it is so well 
tolerated by patients.
The removal of a foreign body from 
the esophagus or stomach can now be 
performed with simplicity by one of 
a variety of grasping forceps which can 
be passed through the fiberoscopes.14"16 
Until recently, foreign objects such as 
open safety-pins and hairpins, sewing 
needles and coins could be removed 
from the stomach only by surgery. 
Pediatric endoscopes17 have obviated 
the need for surgery in children who 
have swallowed objects that cannot 
traverse the pylorus.
Recently Kodsi and coworkers18 have 
called attention to Candida esophagitis 
as a cause of dysphagia and odyno­
phagia. Infection may occur in indi­
viduals without any predisposing ill­
nesses. The most accurate diagnostic 
criteria are the white mucosal plaques 
seen on endoscopy and the yeast or­
ganisms seen on microscopic examina­
tion of a direct smear from the plaques; 
elevated serum agglutinin titres are also 
found. Patients with reflux esophagitis 
do not have positive smears for Candi­
da. In contrast, cultures are positive in 
both reflux and Candida esophagitis 
and therefore do not distinguish these 
conditions.
Gastric Disorders
The distinction of malignant from 
benign ulcers is obviously essential. The 
roentgenographic appearance of an ul­
cer cannot exclude malignant disease 
completely and significant healing 
may even occur in malignant gastric 
ulcers.19 Every chronic gastric ulcer 
identified by roentgenography should 
be examined by fiberoscopy, target 
biopsies should be taken and brush 
cytology smears should be made. These 
combined procedures have achieved a 
95% or higher accuracy rate in dis­
tinguishing benign from malignant ul­
cers.20 Complete healing of an ulcer 
should be confirmed by endoscopy and 
its benign nature established by target 
biopsies and brush cytology. The rate 
of healing of large gastric ulcers should 
be determined by repeated roentgeno­
graphy. If no healing has occurred by 
the end of 6 weeks, then repeat endo­
scopy must be undertaken. There is no 
correlation between the number of 
biopsies taken and the accuracy of the 
diagnosis of early cancer.11,12 More im­
portant than the number is the careful 
selection of the biopsy sites and the 
accurate application of the biopsy for­
ceps. / r e a s  of discolouration and nodu­
larity h o u l d  be chosen, not those that 
are cw ered  by apparently normal mu­
cosa. f  a n  ulcer is present, biopsies 
should b e  taken  from the inner edge 
of its t ia rg in .
Endoscopic examination of the stom­
ach ptstoperatively has overcome the 
deficiencies and limitations of roent- 
genogaphy in this group of patients. 
The flexible fiberoscope with its re­
markably maneuverable optic systems 
permits, in  m ost patients, clear visual­
ization o f  pyloroplasty deformities, 
gastroenterostomy stomas and the ef­
ferent m d  afferent loops. Between 10% 
and 3)%  Qf  patients who have had 
gastric su rg e ry  for peptic ulcer will 
suffer f r o m  appreciable symptoms.21,22 
Hirschowitz and Luketic23 described a 
large series o f 580 postgastrectomy pa­
tients in w hom  123 jejunal and marginal 
and 11 g astric  ulcers were found; two 
thirds o f  these were undetected by 
roentgenography. Other diagnoses in­
cluded inflam m ation at the anastomosis, 
extrusion o f  nonabsorbable sutures at 
the stoma and  double-barrelled stomas.
Clinical judgement determines the 
number o f endoscopies that should be 
undertaken in  the presence of “dyspep­
sia” and norm al results from barium 
meal studies. There is a large overlap 
in symptomatology in most gastroin­
testinal diseases and therefore, on 
occasion, patients alleged to have 
the irritable bowel syndrome are 
found later to have malignant dis­
ease, or peptic ulcer or inflammatory 
bowel disease. Patients with a reliable 
history of a pain-food relationship, 
night pain, anemia, or weight loss must 
be fully investigated. Another group 
who present with constant pain through­
out the day fo-r months, have excellent 
appetites, lose no weight and do not 
experience any night pain, do not re­
quire endoscopy. Schuman24 studied 
843 normal roentgenograms and found 
that 13% of the patients had lesions on 
subsequent gastroscopy; these included 
59 gastric ulcers and 4 cancers. How­
ever, the 13% incidence is inflated as 
it includes 28 patients with erosive 
gastritis and 51 with chronic gastritis, 
pathologic conditions that do not show 
up on the roentgenogram. Furthermore, 
there was a poor correlation between 
“dyspepsia” and gastritis.
A radiologic report of any deformity 
or suspicious abnormality must be 
checked by endoscopy. A common prob­
lem is the roentgenographic interpreta­
tion of thickened gastric folds along 
the greater curvature of the stomach. 
Endoscopy will usually elucidate the 
problem when the gastric folds can be 
flattened by air insufflation and mul­
tiple biopsies of the mucosa are ex­
amined.
Endoscopy plays an important role
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in the investigation of acute upper gas­
trointestinal hemorrhage. Several studies 
have indicated the accuracy of endo­
scopy compared with that of barium 
meal studies in identifying the bleeding 
site.25'27 In a recent paper Eastwood28 
correctly asked whether the superior 
diagnostic accuracy of endoscopy con­
fers any therapeutic advantage that will 
ultimately lead to reduced morbidity 
and improved survival. He presented 
evidence from four prospective con­
trolled studies that emergency endo­
scopy has had no effect on either of 
these objectives. He further questioned 
whether the necessity of a definite 
diagnosis before undertaking therapy 
for active upper gastrointestinal bleed­
ing has been proven and whether endo­
scopy may be harmful in some patients. 
Emergency endoscopy for acute gastro­
intestinal bleeding has led to a better 
understanding of the natural history 
of erosive gastritis29 and Mallory-Weiss 
tears30 and to the recognition that 15% 
to 40% of patients with esophageal 
varices bleed from nonvariceal sources.31
Duodenal Ulcer Disease
The role of endoscopy in the man­
agement of patients with duodenal ulcer 
disease is limited but extremely valu­
able. If the clinical response to medical 
therapy is not prompt and lasting in a 
patient alleged to have an ulcer on a 
roentgenogram, endoscopy is mandatory 
to establish its presence and to exclude 
other conditions. A scarred duodenal 
bulb without evidence of a crater is 
often interpreted as indirect evidence 
of the presence of an active ulcer in a 
patient with dyspeptic symptoms. Again, 
a lack of prompt relief of pain with 
antacids in such a patient warrants 
endoscopy. Normal findings on exam­
ination in such patients should lead to 
a re-evaluation of the clinical problem. 
When intractable pain occurs in pa­
tients with known duodenal ulcer dis­
ease, surgery should be undertaken only 
in the presence of an unequivocal ulcer 
on barium meal or endoscopy. Endo­
scopy has no role in the usual follow­
up of asymptomatic and uncomplicated 
ulcers. But a complication such as py­
loric stenosis occurring in patients with 
known duodenal ulcer disease should 
be evaluated by endoscopy to exclude 
a malignant condition.
Duodenoscopy is more accurate than 
roentgenography in determining the 
presence of duodenal ulcers and most 
series show an incidence between 15% 
and 20% where barium studies have 
given normal results.32-34 This figure ex­
cludes patients in whom a diagnosis of 
“duodenitis” is made. The onus falls on 
the clinician to identify which patients 
with “dyspepsia” and a normal barium 
meal require duodenoscopy.
Duodenoscopy has led to a better 
understanding of the natural course of 
duodenal ulcer disease. The apprecia­
tion that ulcers can persist for weeks 
after the disappearance of symptoms 
and long after medical treatment has 
ceased may explain the tendency to 
frequent relapses in some patients. It 
has also revolutionized the approach to 
clinical studies of ulcer healing in re­
sponse to new drugs.35
Colonic Disorders
It is now 7 years since the introduc­
tion of colonoscopy to clinical prac­
tice.86"38 It remains a relatively difficult 
procedure requiring special techniques 
and skills.39'40 A major achievement 
resulting from its use is the diagnosis 
and removal of colonic polyps,41"13 but 
colonoscopic polypectomy is not with­
out risk. In a 1974 survey25,44 25 298 
colonoscopies were reported with a 
morbidity of 0.32% and a mortality 
of 0.008%. The most common com­
plication of a diagnostic colonoscopy 
was perforation (55 cases), which was 
associated with the only two fatalities. 
There were 6214 polypectomies with a 
morbidity of 2.3% and no mortality. 
The most common complication of 
polypectomy was hemorrhage (1.9%). 
The results of colonoscopic polypec­
tomy compare favourably with those 
of surgical polypectomy. The majority 
of pedunculated polyps can be easily 
removed, but special skill is required 
for the removal of large sessile 
polyps.45
Colonoscopic polypectomy has led to 
a better understanding of colonic can­
cer. Evidence is mounting that most, if 
not all, colonic cancers originate in 
neoplastic polyps, the “polyp-cancer 
sequence”.46 The criteria for malignancy 
in a polyp remain undecided, but most 
workers agree that only when definite 
invasion of the muscularis mucosae is 
present should the lesion be regarded 
as “clinically” malignant.47"19 Using 
these criteria, Wolff and Shinya43 found 
invasive carcinoma in 4.5% of 2800 
polyps. If atypia and carcinoma in situ 
were included the overall figure for 
malignant change rose to 10.5%. Col­
onoscopic polypectomy therefore pro­
vides benefit by removing polyps with 
invasive carcinoma. It is obviously es­
sential to examine all excised polyps 
histologically to detect invasive car­
cinoma in the stalk across the line of 
the muscularis mucosae.
Unnecessary colonoscopies to search 
for polyps can be avoided if detailed 
attention is paid to the technique of 
the barium enema studies. The 
Malmo technique accurately detects 
98% of polyps over 1 cm in diameter 
and 78% of polyps 1 cm and under.42
Colonoscopy is indicated for reach­
ing a diagnosis when abnormal areas
are shown by a barium enema and even 
when the barium enema result is nor­
mal in the presence of unexplained 
rectal bleeding, diarrhea and abdominal 
pain. Colonoscopy has a role to play 
in some cases of inflammatory bowel 
disease and in the examination of anas­
tomoses, colostomies and ileostomies. 
In 75 patients with rectal bleeding, in 
whom the barium enema finding was 
normal, Teague, Salmon and Read50 
found 14 carcinomas, but this high in­
cidence would have been lowered had 
double-contrast barium enemas been 
performed routinely.
The exact role of colonoscopy in the 
diagnosis and management of chronic 
inflammatory bowel disease has yet to 
be delineated. Tawile, Priest and 
Schuman51 point out that the procedure 
makes it possible to evaluate the extent 
and activity of inflammatory bowel 
disease and increases the accuracy of 
prognosis. I would question this con­
clusion, as in most patients with Crohn’s 
disease or ulcerative colitis the clinical 
picture, excellent roentgenograms and 
laboratory studies will accurately meas­
ure the activity and extent of the dis­
ease. In another study52 colonoscopy 
proved to be superior to roentgeno­
graphy in defining mucosal abnormal­
ities such as ulcerations and nodular or 
polypoid lesions and in recognizing the 
segmental distribution of the disease; 
granulomas were found in 26% of pa­
tients when biopsies were taken from 
the edge of ulcers. Waye53 observed that 
colonoscopy is of value when stricture 
and filling defects are seen on the ro­
entgenogram following a barium enema. 
He recommended colonoscopy in granu­
lomatous colitis when surgery is con­
templated for providing an accurate 
evaluation of the extent of the disease.
Colonoscopy has an important role 
in ulcerative colitis. In patients with 
frank proctitis when the barium enema 
finding is normal, colonoscopy and 
biopsy may reveal whether the disease 
extends to the transverse or ascending 
colon (as it may do),54,55 or is confined 
to the rectum (when the prognosis and 
natural course of the disease may be 
entirely different).
Colonoscopy and biopsy are called 
for in patients in whom uncertainty 
exists as to the type of inflammatory 
bowel disease present, since therapeutic 
considerations differ in ulcerative colitis 
and Crohn’s disease. In a small group 
of patients in whom roentgenography 
shows an isolated segmental lesion, 
colonoscopy has been helpful in con­
firming Crohn’s disease.
Should patients with total colitis un­
dergo annual colonoscopic examination 
with biopsies and cytology studies in an 
attempt to identify a significant num­
ber of curable carcinomas in chronic 
ulcerative colitis? Morson and Pang56
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noted that in patients with colitis in 
whom colonic carcinoma had already 
developed, rectal biopsy usually showed 
epithelial dysplasia. Cook, Path and 
Goligher,57 however, have shown that 
epithelial dysplasia may be found in 
resected colons without carcinoma and 
that the epithelial changes in the rec­
tum may be patchy or absent. Even so, 
the epithelial changes may indicate a 
special predisposition to the develop­
ment of a malignant growth in the fu­
ture. A number of biopsies from dif­
ferent parts of the colon obtainable by 
colonoscopy could detect those patients 
with epithelial hyperplasia so that they 
can be kept under special scrutiny for 
the possible development of carcinoma.
Biliary and Pancreatic Disease
The recent advance of endoscopic 
retrograde cholangiopancreatography 
(ERCP) has made a major contribution 
to the investigation of jaundice and 
proven or suspected pancreatic dis­
ease.58'61 ERCP has been most valuable 
in patients with persistent or recurrent 
obstructive jaundice where it is impos­
sible to be certain whether the cholesta­
sis is intra- or extrahepatic. Laparotomy 
can be avoided in an appreciable num­
ber of such patients when a patent 
biliary system is found. When the liver 
biopsy shows an equivocal histologic 
picture, ERCP will accurately confirm 
or refute the diagnosis of obstruction. 
Biliary calculi, carcinoma of the bile 
duct, hepatic ducts and pancreas, scle­
rosing cholangitis and postoperative 
stricture have been diagnosed by ERCP. 
Selective cannulation of the biliary 
system usually presents more difficulty 
than does selective cannulation of the 
pancreatic ductal system. Because of a 
risk of ascending cholangitis after 
ERCP, patients should be given sys­
temic antibiotics immediately after the 
procedure if contrast medium has en­
tered poorly draining ducts. Antibiotics 
should also be given if patients with 
known extrahepatic obstruction under­
go ERCP prior to surgery.
The use of ERCP for visualizing the 
bile ducts in obstructive jaundice will 
probably be replaced by percutaneous 
transhepatic cholangiography using the 
“skinny” Chiba needle technique. This 
new technique, which is simple and 
less expensive, has reduced the com­
plication rate of conventional trans­
hepatic cholangiography.62'64 It also re­
quires far less skill than the ERCP 
procedure. Elias and colleagues65 carried 
out a randomized trial to compare both 
methods for bile-duct visualization in 
jaundice. In patients with extrahepatic 
cholestasis, percutaneous cholangio­
graphy was successful in 95% whereas 
ERCP succeeded in only 63 %. On the 
other hand, in patients with intrahepatic
VOLUME 21, NO. 3, MAY 1978 /
cholestasis the figures were 25% and 
76% respectively. Transhepatic cholan­
giography appears to be a more re­
liable method for demonstrating the 
biliary system when extrahepatic cho­
lestasis is known to be present or is 
confidently suspected. Others have been 
able to perform transhepatic cholan­
giography in the presence of nondilated 
ducts63 and in one series in 95.6%64 
of patients, and therefore support its 
use in differentiating intra- from extra­
hepatic cholestasis. However, if intra­
hepatic cholestasis is strongly suspected, 
ERCP is probably still the procedure 
of choice.
There is renewed attention to the use 
of grey-scale ultrasonography to dis­
tinguish intra- from extrahepatic cho­
lestasis. This modality of investigation 
was initiated by Taylor and cowork­
ers66'67 in 1974 and at a recent sym­
posium Goldberg and Ferruci68 pre­
sented ultrasonography and computer­
ized tomography scanning as the 
primary and most important noninvasive 
procedure to identify dilatation of the 
bile duct. Transhepatic cholangio­
graphy, in their opinion, should only 
be done if there is evidence of bile-duct 
obstruction. If the bile ducts are not 
dilated, liver biopsy and, if necessary, 
endoscopic retrograde cholangiography 
should be performed.
While retrograde pancreatography is 
easier to perform than cholangiography, 
the interpretation of the pancreatogram 
is much more difficult. Normal pan­
creatograms have now been analysed 
and measurements have been made of 
the main duct in the pancreatic head, 
body and tail, as well as the length of 
the duct.69 Abnormal findings in pan­
creatography must take into account 
the study of the normal pancreatogram.
The distinction between chronic 
pancreatitis and pancreatic carcinoma 
has been carefully studied.70"72 In car­
cinoma the main pancreatic duct is 
affected by an irregular segmental 
stricture or defect. There may also be 
complete obstruction, with the end of 
the main duct appearing irregular or 
smooth. The major findings in chronic 
pancreatitis are tortuosity of the main 
pancreatic duct and rigidity of its wall 
and, sometimes, bead-like dilatations or 
irregular or marked dilatations with 
partial stricture of the main pancreatic 
duct. In advanced pancreatitis there 
may be complete obstruction, but in 
most instances it is incomplete. The 
differentiation between these two con­
ditions is even more complicated be­
cause chronic pancreatitis and carci­
noma may occur together. Detailed 
examination of the duodenal sweep and 
papilla is part of the ERCP procedure 
and periampullary carcinoma may be 
diagnosed by biopsy and brush cyto­
logy.
The early diagnosis of pancreatic 
cancer is still a challenge. Pancreato­
graphy may well be an accurate and 
reliable method for diagnosing peri­
ampullary and pancreatic carcinoma, 
but nearly all reports describe results 
in the easily recognizable clinical set­
ting of advanced carcinoma.
Chronic relapsing alcoholic pancre­
atitis may confront the physician with 
serious management problems. Persis­
tent pain with frequent severe relapses 
often raises the possibility of a major 
duct obstruction or the presence of a 
pseudocyst. Contemplated surgical ex­
ploration can now be preceded by en­
doscopic retrograde pancreatography. A 
normal ductal system, while not ex­
cluding pancreatitis entirely, should 
discourage the surgeon from carrying 
out such an exploration and rather 
direct him to pay more attention to 
the alcohol problem. If a ductal stricture 
or pseudocyst is found, the surgeon can 
plan his surgical approach and not have 
to depend on an operative pancreato­
gram. Retrograde pancreatography has 
shown pseudocysts73 communicating 
with the pancreatic duct and identified 
fistulas74 between the cysts and peri­
toneal cavity in the presence of pan­
creatic ascites. Common-bile-duct ob­
struction by chronic pancreatitis may 
be clearly delineated by a combined 
pancreatogram and cholangiogram, 
which further elucidates the difficult 
problem of obstructive jaundice.
Complications of ERCP have been 
studied in 10 000 cases in the United 
States.75 Failure of the procedure oc­
curred in 30%, complications in 3% 
and death in 0.2%. Complications in­
cluded pancreatitis, cholangitis, pan­
creatic sepsis, instrumental injury to 
the gastrointestinal tract and drug re­
action. Pancreatitis was associated with 
injection into the pancreatic duct and 
sepsis with an injection into an ob­
structed duct of a pseudocyst. Experi­
enced workers had a 15% incidence 
of complications, whereas the inex­
perienced had four times as many 
failures and twice as many complica­
tions.
Conclusion
The contribution of fiberoptic en­
doscopy to the management of certain 
gastrointestinal disorders is considerable. 
The impact of this technique on health 
care will be maintained only if physi­
cians have been properly trained in its 
use. It is essential to have an under­
standing of the natural course of the 
disease states under investigation and 
to appreciate the indications and con­
traindications of endoscopic procedures. 
An erroneous endoscopic diagnosis will 
lead to inadequate or inappropriate 
treatment.
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The easy availability of fiberoptic 
instruments and the relative ease with 
which these instruments can be inserted 
may lead to their misuse and abuse. 
The indiscriminate and incompetent 
use of these diagnostic techniques may 
become deleterious to the health of the 
population at risk. For these reasons 
the Canadian Association of Gastroen­
terology76 has published guidelines on 
the minimal requirements for training 
in endoscopy.
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SESAP II Question
Items 456-458
The drawing above shows the death rates per 100,000 population for cancers occur­
ring frequently in males in the United States from 1930 to 1969. For each of the 
sites of primary tumors numbered below, select the appropriate curve (A,B,C,D,E) 
on the graph.
456. Lung
457. Colon and rectum
458. Stomach
For the critique of Items 456-458 see page 269 of this issue.
(Reproduced by permission of the American College of Surgeons from SESAP II 
Syllabus: Surgical Education and Self-assessment Program N o. 2. For enrolment in 
the Surgical Education and Self-assessment Program No. 2 please apply to the 
American College of Surgeons, 55 East Erie St., Chicago, IL  60611.)
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CANADIAN ONCOLOGY SOCIETY
Symposium on Colorectal Cancer 
1. Pathology of Colorectal Cancer
B.C. M orson, dm , frc path*
Most colorectal cancers arise from 
pre-existing adenomas (the adenoma- 
carcinoma sequence). The histology, 
cytology and malignant potential of the 
adenoma group of tumours are de­
scribed. From a study of the life 
history of the adenoma-carcinoma 
sequence in cases of both familial 
polyposis and isolated adenoma it would 
appear that most colorectal cancers 
evolve over a long period.
The adenoma is important as a marker 
for increased risk of colorectal cancer, 
in clinical practice and in epidemiologic 
studies. Local excision for carefully 
selected early colorectal cancers is 
justified on the basis of the results of 
a long-term prospective study.
La plupart des cancers colorectaux 
prennent naissance a partir d'adenomes 
preexistants (la sequence adenome- 
carcinome). On decrit I’histologie, 
la cytologie et le potentiel de malignite 
des tumeurs du groupe des adenomes. 
De I’etude du developpement de la 
sequence adenome—carcinome dans les 
cas de polypose familiale et d'adenomes 
isoles, il semble que la plupart des 
cancers colorectaux evoluent sur une 
longue periode. L'adenome est impor­
tant comme marqueur d’un risque
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accru de cancer colorectal, aussi bien 
en clinique que pour les etudes 
epidemiologiques. Si Ton s’appuie sur 
les resultats d'une etude prospective 
a long terme, I’excision locale dans 
les cancers colorectaux precoces bien 
choisis est justifiee.
This review will concentrate on two 
aspects of the pathology of large-bowel 
cancer. First, the role of polyps as 
precancerous lesions will be considered 
and how knowledge of their pathology 
can help in the design of cancer pre­
vention programs. (Precancer defines 
a situation in which the risk of cancer 
is substantially increased but is not 
inevitable.) Second, the pathology of 
early colorectal cancer, and how knowl­
edge of this can help in the choice 
of treatment, will be discussed. The 
expression early is used not in the 
histogenetic sense but with reference 
to curability.
The Relation of Large-Bowel Polyps 
to Cancer of the Colorectum
The evidence in favour of the 
adenoma-carcinoma sequence is now 
so overwhelming that this sequence 
must be considered as the major pre­
disposing situation for large-bowel 
malignancy.1,2 For pathologists the 
word polyp has only clinical meaning 
and “polyps” that result from neoplas­
tic overgrowth of epithelium we call 
adenomas. The clinical condition of 
familial polyposis in which the large 
bowel is covered with thousands of 
adenomas might better be called fam­
ilial adenomatosis. None of the other 
histologic varieties of polyp in the 
large bowel have any important con­
tribution to make to the totality of 
large-bowel cancer.
The adenoma group of polyps can 
be subclassified in two ways: accord-
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ing to their histology or tissue architec­
ture and by their cellular or cytologic 
characteristics.8
Histology
The adenoma group of polyps pre­
sents a spectrum of tissue architec­
ture. At one end of the scale is the 
tubular adenoma (adenomatous polyp) 
which histologically shows a tubular 
type of proliferation, and at the other 
end is the villous adenoma (villous 
papilloma). There is a sizeable group 
of tumours that have an intermediate 
or mixed pattern and occupy a posi­
tion between these two extremes. The 
American terminology for this group 
is villoglandular adenoma; this and 
the old term papillary adenoma should 
be replaced by tubulovillous adenoma.
Cytology
All adenomas have identical cytologic 
characteristics. This justifies their con­
sideration as one disease. These cytolo­
gic characteristics are called epithelial 
dysplasia or atypia as when they devel­
op in other epithelial surfaces. They are 
fundamentally no different from those 
seen in the cervix.
The Malignant Potential of the
Adenoma Group of Tumours
The tubular adenoma (or adenoma­
tous polyp) is the most common his­
tologic type. The villous adenoma is 
much less common, while the tubulo­
villous type occupies a position in 
regard to frequency midway between 
these two.
The potential of the tubular adenoma 
for malignant change is low while that 
of the villous adenoma is much higher.4 
The malignant potential of the interme­
diate type with a villous component
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more closely approaches that of the pure villous adenoma than that of the pure tubular adenoma. These estimates were produced before the days of colo­noscopy, which has resulted in an in­crease in the number of adenomas seen per patient. But if only 2% of adeno­mas became malignant during the aver­age life span of an individual of the Western world, this would probably be enough to account for the prevalence of colorectal cancer in the general population.
The potential of an adenoma for 
malignant change increases with the degree of epithelial dysplasia. Severe epithelial dysplasia is much more com­
mon in villous tumours than in the pure tubular adenomas. This, of course, is in 
accord with the greater malignant po­
tential associated with “villosity”. Most 
accounts regard dysplasia as a progres­
sive epithelial process, but this pro­
gression, as in the cervix, is not inevi­
table. Indeed, we have very little in­formation about the risk of mild dys­
plasia becoming moderate or severe 
dysplasia; in the colon the latter is 
equated with carcinoma in situ. In situ carcinoma of the cervix may remain 
stationary for many years and may even regress. The same is probably true for severe dysplasia in association with colon adenomas.
Tumours under 1 cm in diameter 
have a low potential for malignant change. As their size increases, so does the malignant potential. The critical size seems to be 2 cm. Thus, as adeno­mas grow large, so the risk of cancer 
increases. But even when their diameter exceeds 2 cm the development of can­cer is not inevitable, although the risk 
of such development is high. What makes adenomas grow and what makes 
them regress? Presumably there are 
environmental influences affecting their capacity to grow.
An uncontrolled clinical study com­
paring adenomas in Japan where 
there is a low prevalence of colorectal 
cancer, with adenomas in England, 
where prevalence is relatively high, 
showed that Japanese adenomas on 
average were much smaller than 
adenomas in England.5 It appears that adenomas in Japan seldom grow to 
the same size as English adenomas.
Moreover, the frequency of ad­enomas in Japan, particularly of the pure villous type, is low. In addition, 
severe dysplasia in adenomas is by and large more common in England than in Japan.
Other such studies have found that in areas where the frequency of col­orectal cancer was low, such as Colom­
bia, the frequency of adenomas was also low* In the southern United States 
where there is a high prevalence of 
colorectal cancer, the prevalence of
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adenomas is much greater. More­over, the same study showed that ad­enomas in American patients were 
bigger than those in Colombian pa­tients. They were also more villous and more often showed severe epithelial dysplasia.
Thus it seems that the adenoma is an important precancerous lesion. It is hoped that epidemiologists will study the adenoma from their particuar point of view in the same way as they have studied invasive cancer. This will re­quire meticulous autopsy studies in 
various parts of the world with differ­
ing incidences of colorectal malignant disease.
Life History of the Adenoma —Carcinoma Sequence
What is the time scale life his­
tory of the adenoma-carcinoma se­
quence? There is anecdotal evidence 
that suggests how this sequence evolves. We have had four patients with tubu­
lar adenomas that were not removed 
because the patients refused treatment.4 The first two cases that presented as 
benign adenomas became proven and obvious cancers 5 years later. In the third case the adenoma took no less 
than 13 or 14 years apparently to 
evolve into cancer. In the fourth the 
adenoma appears almost exactly as it did originally 12 years ago. Similar 
anecdotal observations have been made on carcinoma in situ of the cervix; this entity can retain its in situ charac­
teristics for a great length of time and apparently may even regress. It is 
known that adenomas in the rectal 
stump after ileorectal anastomosis for familial polyposis can regress. This 
must mean that environmental factors are operating that control the growth of this epithelial proliferation.
The same situation is seen with vil­
lous adenomas. One villous adenoma 
under our observation took 10 years 
to become cancerous.4 Another took 30 
years. Yet another patient had a vil­
lous adenoma that remained benign 
for 22 years; the patient died from a 
different cause. So although villous adenomas have high potential for ma­lignant change, they do not inevita­
bly become malignant, either within a few years or indeed at any time in the 
patient’s life span. The situation is in truth unpredictable.
In patients with familial polyposis the average age at diagnosis of ad­
enomas that showed no malignant change is 13 years younger than the average age at which cancer is diag­
nosed.7 This suggests that, on average, 
the adenoma-carcinoma sequence takes about 13 years to evolve. In our series 
there were four patients with familial 
polyposis who received no surgical
treatment and who were kept under 
surveillance for 20 years without the development of cancer in that time. Thus, adenomas can remain dormant for a long period without becoming malignant. Moreover, although there may be thousands of adenomas in the 
colon of a patient with familial poly­posis, only one, two or three, at the most four or five, cancers will develop. Why only five cancers? Why not thou­sands of cancers? It must mean that whatever is influencing the growth of 
adenomas and promoting the advance of the adenoma-carcinoma sequence is operating unequally for different tumours at different sites.
Thus the adenoma-carcinoma se­quence is a process that evolves slowly 
but on average takes 10 to 15 years. It is probably exceptional for it to take 
less than 5 years. It is probably quite 
common for it to take 20 to 30 years. 
In other words, at the site of a large 
cancer of the colon or rectum seen at laparotomy, for example, a morphologi­
cally recognizable lesion has been pre­sent for a very long time. Also, the 
precancerous phase, that is, the ad­
enoma part of the adenoma-carcinoma sequence, is usually asymptomatic, so 
that when we see cancer it is usually at an advanced stage of its development. 
This makes cancer prevention pro­grams more difficult to devise. Most 
adenomas probably do not become cancers during a normal life span, but 
if only a small percentage do so, this 
is sufficient to account for the preva­lence of the disease in our population 
and indicates that the adenoma is a marker for increased risk and no more 
than that. My own view is that the 
great majority of cancers of the colo- 
rectum do evolve through the sequence.
The colonoscope and the air contrast barium enema allow an accurate ex­
amination of the large bowel. It is now 
realized that patients with either ad­
enomas or carcinomas, or both, have 
a substantial chance of having more 
than one tumour. Meticulous examina­tion of the entire bowel is essential in 
any patient who presents with a tumour 
in any one part of it. Likewise patients 
with adenomas and carcinomas have an increased risk of developing further 
(metachronous) tumours. Therefore after polypectomy or removal of a part of the large bowel the remaining 
colon and rectum must be kept under regular careful observation for the fu­ture development of a second, third, fourth or even fifth lesion.
Since adenomas have malignant po­tential, their removal is cancer preven­
tion at a clinical level. The discovery of an adenoma or cancer in any part 
of the large bowel must be followed 
by intensive investigation of the whole organ. After removal of a tumour, if
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an air contrast enema shows the re­
maining large bowel to be free of addi­
tional tumours, the duration of the 
adenoma-carcinoma sequence tells us 
that these examinations need not be 
repeated very frequently. Once every 
3 years would be quite sufficient 
provided that no tumours are present 
in the large bowel that remains. 
Another means of cancer prevention is 
the regular examination of patients 
with a family history of bowel cancer, 
since they are at increased risk.8 Other 
groups requiring screening are patients 
with familial polyposis and those with a 
long history of extensive ulcerative 
colitis.9
Treatment of Early 
Colorectal Cancer
The definition of what is meant by 
cancer in colorectal malignant disease 
is important. Whether the lesion is a 
polyp on a stalk or a sessile lump or a 
flat lesion, there is a fundamental fact 
that must be taken into account for 
the proper management of patients, 
namely, that the neoplastic process has 
no potential for lymph-node metastasis 
or blood-borne metastasis until neo­
plastic cells have crossed the muscularis 
mucosae. Clinical experience from fol­
low-up has proven this.
One peculiarity of large-bowel mu­
cous membrane is that it has few lym­
phatic channels in contrast to the 
abundance of lymphatic channels in 
small-bowel mucosa and in gastric 
mucosa. However, in the submucosal 
layer there are not only lymphatics 
but a much larger venous plexus, 
unlike the capillary plexus in the 
mucosa. For a cancer that has 
spread to the submucosal layer, the 
potential for lymph-node metastasis 
is of the order of 5%. If from that 
group of 5% the poorly differentiated 
adenocarcinomas are excluded, the po­
tential for metastasis for well-differen­
tiated and moderately well-differen­
tiated adenocarcinomas that have in­
vaded the submucosal layer only, is 
merely 1% to 2%. Are major opera­
tions with the removal of the lymphatic 
field justified for early colorectal can­
cers that have invaded the submucosal 
layer only?
To illustrate the point, a tubulovillous 
adenoma on a stalk may show areas of 
carcinoma in situ or focal cancer, but 
no spread beyond the line of the mus­
cularis mucosae can be demonstrated 
in many sections through the whole 
tumour. Despite the presence of cy- 
tologically malignant tissue such an 
adenoma is not clinically malignant and 
therefore treatment does not need to 
include regional lymphadenectomy. 
Complete removal of adenomas is not 
followed by recurrence. An adenoma
on a stalk with invasion of the stalk 
(i.e., the submucosa) by adenocar­
cinoma can also be cured by local ex­
cision. Can we depend further on local 
excision in the treatment of can­
cer of the colon as well as of the 
rectum now that therapeutic colono­
scopy is available? Surgeons are able 
to perform full-thickness local exci­
sions of the rectal wall. At St. Mark’s 
Hospital in London, 143 patients with 
cancers of the distal colon and rectum 
that had invaded the submucosa only 
(a few had gone deeper) were treated 
by local excision initially.10 Careful 
histologic examination revealed that 91 
had been completely removed, in 14 
the local excision had been doubtfully 
complete and in another 14 probably 
incomplete, for a total of 119. In the 
balance of cases the surgeon or the 
pathologist decided that local excision 
had not been sufficient and a major 
operation was appropriate. The age 
range and sex of this group of patients 
in no way differed from those in our 
general series of patients with colo­
rectal cancers. The results of follow­
up for as long as 20 years show that 
among the 91 patients with complete 
local excision there were five recur­
rences. We believe that three of these 
recurrences were failures of the policy 
in the sense that there is sufficient 
evidence that local excision should 
have been followed by a further major 
operation. In the two others it is doubt­
ful whether a further major operation 
would have made any difference to the 
outcome. Among those in whom the 
local excision seemed to be doubt­
fully complete, there were only two 
recurrences and among the patients 
considered to have incomplete excision 
there were five recurrences. Because 
excision was incomplete these cannot 
be considered policy failures. Further 
operation was advised but was not per­
formed for a variety of reasons, mostly 
because of advanced age. It appears 
that when a specimen shows histologic 
evidence of growth at its margin, 
residual tumour may have been de­
stroyed by the diathermy excision. In 
such instances local excision has, in 
fact, been complete. I am not saying 
that the place of local excision is only 
for the elderly or those in poor general 
health with high risk of death after a 
major operation. There is a place for 
local excision as an alternative to 
both abdominoperineal excision and 
anterior resection. We ought to move 
further towards defining the place 
of local excision. A policy of total 
biopsy and examination by the patholo­
gist is necessary. If local excision is 
complete, we do not advise any further 
operation unless the tumour is highly 
malignant. Since 1948 the proportion 
of local excisions to major operations
performed at the St. Mark’s Hospital 
has increased steadily each year. Now 
nearly 10% of our operations for 
colorectal cancer are local excisions, 
admittedly mostly for smaller tumours 
and including those removed by colono­
scopic polypectomy.
A local excision should be a safe 
operation, whereas a major operation 
is far from safe. The postoperative 
mortality reported for major opera­
tions varies from 17% to 1.9%. There­
fore the balance of risks as well as 
the technical aspects of local excision 
have to be considered. This is a chal­
lenge to surgeons to consider local 
excision as an alternative treatment 
for early colorectal cancer.
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Correction
On page 107 of the March 1978 
issue of the Journal, the address 
for reprints of the article “Profund- 
oplasty for Limb Salvage” by T.E. 
David and J.A. Key should read: 
Dr. Tirone E. David, UW8 - 110, 
Toronto General Hospital, Toronto, 
Ont. M5G 1L7.
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2. Epidemiology of Colorectal Cancer
A.B. Miller, mb, b chir, frcp[c]*
Data from international sources and 
from Canada are reviewed concerning 
the incidence and mortality for colorectal 
cancer. Nutritional factors are almost 
certainly relevant in etiology although, 
with differing sex ratios for different 
sites of the colon and rectum, it cannot 
be assumed that they will operate to 
the same extent throughout the large 
bowel. The results of studies currently 
available are conflicting and further 
study is obviously required.
Des donnees d'origine internationale 
et canadienne portant sur I’incidence et 
la mortality du cancer colorectal sont 
passees en revue. Des facteurs nutritifs 
sont presque certainement relies a 
son etiologie, bien qu'avec des rapports 
de sexe differents pour differents 
points du colon et du rectum, on ne 
puisse supposer qu’ils exercent la meme 
influence a travers tout le gros intestin. 
Les resultats des etudes presentement 
disponibles sont divergents et d'autres 
etudes sont, de toute evidence, 
necessaires.
In Canada the lifetime risk of colorectal 
cancer developing is just under 4% 
for men and a little over 3 % for 
women. This expression is somewhat 
artificial but it allows a comparison of 
the lifetime probability of persons in 
various countries having colorectal can­
cer if they were to survive to 75 years 
of age.1 It is a method of age standard­
ization that assumes an equal popula­
tion in each age group. In relation to 
other cancers, in Canada colorectal 
cancer has the second highest incidence 
in both men and women.
Another way of identifying the rela­
tive importance of a malignant disease 
is to calculate the potential years of 
life lost before 70 years of age. This 
figure is an indication of premature
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death. The years of life that appear to 
have been lost owing to a condition are 
cumulated assuming no deaths occur 
from other causes.2 In 1973 in Canada, 
deaths from colorectal cancer before 
the age of 70 resulted in a loss of 
14 000 potential years in men and 
13 000 in women. Compared with other 
cancers, colorectal cancer is second to 
lung cancer in terms of premature 
death in men and second to breast can­
cer in women. Accumulated across 
both sexes, colorectal cancer is sec­
ond only to lung cancer.
Mortality data from Canada show 
little change in the period from 1954 
to 1974.s There is an indication of a 
change in the sex ratio for carcinoma 
of the large intestine, the mortality in 
females decreasing slightly and the 
mortality in males increasing. For can­
cer of the rectum the rates were stable, 
males having a higher mortality than 
females.
International statistics show the in­
cidence of colorectal cancer to be 
highest in Canada (actually in Saskat­
chewan) with the United States (Con­
necticut) not far behind, the United 
Kingdom quite a bit lower on the list, 
Japan close to the bottom and Nigeria 
last.4 Are the substantial differences in 
incidence of colorectal cancer due to 
environmental factors? There is a large 
body of evidence suggesting that they 
are and that at least 80% of cancers 
of the colon and rectum are prevent­
able, if the causes could be found and 
removed from the environment.
By and large, the incidence of breast 
cancer and of colorectal cancer runs 
parallel. There are a number of simi­
larities between the epidemiology re­
ferable to these two sites, suggesting 
that similar factors may be responsible.5
The ratios of age-standardized inci­
dence for the sexes of cancer of the 
colon and cancer of the rectum deserve 
study. These have been calculated from 
the published data.4 For cancer of the 
colon in Canada (Saskatchewan) the 
slight excess in the number of females 
makes the male/female ratio of inci­
dence just below unity. In the US (Con­
necticut) the incidence for males and 
females is identical, in the UK the 
ratio is very close to unity and in 
Sweden it is just above unity. It appears 
that in North America and Europe,
the male/female incidence ratio for 
colonic cancer is approximately unity. 
In the black population of the US 
(California) the ratio falls below unity, 
since more females than males have 
colonic cancer. For rectal cancer the 
sex ratio shows a substantial excess in 
the number of males in Canada, the 
US, the UK and Sweden. It is nearer 
unity for Israel, Finland, Japan and 
South Africa. There seems to be a 
difference in sex ratios for rectal can­
cer between Western and North Amer­
ican countries and other parts of the 
world. This is a factor that has to be 
noted in considering etiology.
In Canada6 the incidence of cancer 
of the cecum and descending colon is 
lower in males than in females, the 
ratio being well below unity. For the 
transverse colon, it is close to unity. In 
males, the incidence of cancer of the 
sigmoid colon has a slight excess, of 
the rectosigmoid junction a greater ex­
cess and of the rectum a significant 
excess over that in females. The sex 
incidence ratios change in proceeding 
from the cecum to the rectum. In 
males the highest incidence of cancer 
of the large bowel is in the rectum. In 
females, the incidence of rectal cancer 
is only slightly higher than that of 
cecal cancer, whereas in males the inci­
dence of cecal cancer is substantially 
lower and that of cancer of the sigmoid 
colon is quite high.
In low-risk populations in Africa and 
Asia the cecum and descending colon 
tend to predominate as the sites of 
large-bowel cancer and females tend to 
have more cancer of the colorectum 
than males. In high-risk populations 
there is more sigmoid cancer than in 
low-risk populations.7 With changing 
trends there seems to be an increase 
first in males, later in females. Migra­
tion results in a rapid increase in colo­
rectal cancer, particularly in sigmoid 
cancer, if persons move from a low- 
incidence population to a high-incidence 
population. When populations migrate 
the expected changes in the incidence 
of breast cancer take a long time to 
occur but changes in incidence of 
colonic cancer take a relatively short 
time. In North America recently there 
has been a decrease in cancers of the 
lower rectum and an increase in the 
male/female ratio for colonic cancers.
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Cancer of the rectum is more com­
monly out of reach of the examining 
finger, so that use of the sigmoidoscope 
is more often necessary for its diag­
nosis.
Epidemiologic studies have identified 
other factors associated with colorectal 
cancer. 8 The disease occurs more fre­
quently in urban than in rural popula­
tions and in persons of higher socio­
economic status. Moreover, colorectal 
cancer seems to be characteristic of 
populations with a short intestinal tran­
sit time, as well as of persons who 
have a high excretion of fecal bile 
acids and steroids. It has also been 
associated with the kind of intestinal 
microflora present, a type of Clostridia 
being implicated. Other associated 
features are a low serum cholesterol 
concentration, a low intake of fibre, 
a high intake of dietary fat and animal 
protein and a high intake of beer.
Two recent case-control studies9,10 
attempted to evaluate diet in relation 
to colonic and rectal cancer. The rela­
tive risk of large-bowel cancer in 
Hawaiian Japanese was higher for those 
who ate small numbers of Japanese 
meals daily (none or one daily) than 
for those who ate more than one daily. 9 
Those who ate a large amount of beef 
(eight or more pounds per month) had 
a high relative risk. Those who ate a 
lot of meat, string beans or legumes, 
and a low amount of starch had a high 
relative risk. The important risk factor 
seemed to be beef, which may account 
for a number of the other associations. 
Some biochemical studies tend to con­
firm this. But beef consumption is ac­
companied by a high fat intake so it is 
by no means certain that beef is the 
responsible factor.
In contrast, a study in Israel ex­
amined fibre consumption. 10 Analysis 
revealed that patients who consumed 
no fibre or only small amounts had a 
higher incidence of bowel cancer than 
those with a high fibre consumption. 
Low fibre content of diets was related 
to the incidence of colonic cancer but 
not of rectal cancer.
What can be the mechanism? Hill 
and associates11 suggest that it is not 
fibre that is important but dietary fat; 
the action of intestinal bacteria on fecal 
bile acids (the amount of which is de­
pendent on fat intake) produces carci­
nogens that cause intestinal cancer. By 
an alternative mechanism dietary fat 
may influence the frequency of breast 
cancer; 12 bacteria in the bowel can pro­
duce estrogens from biliary steroids 
present in the colon.
In summary, nutrition has an im­
portant bearing on the incidence of 
bowel cancer. One of the major changes 
in the lives of persons who migrate 
and one of the major differences be­
tween populations on an international
scale is their diet. It may be difficult 
to confirm such hypotheses, but al­
ready it is being recommended that 
we eat smaller steaks, reduce our fat 
intake and eat more fruit and vege­
tables.
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3. Immunology and Immunotherapy of 
Colorectal Cancer
Phil Gold, md, ph d, frsc, frcp[c]*
Adenocarcinomas of the human colon 
produce carcinoembryonic antigen 
(CEA), one of a family of glycoprotein 
molecules that may be produced by 
various human cancers and, occasionally, 
by other abnormal tissues. The 
physicochemical nature and tissue 
distribution of CEA have been well 
established and a variety of radio­
immunoassays have been developed for 
the detection of this material in the 
circulation of patients with CEA-producing 
tumours. Although the assay should 
not be used as a screening test for 
cancer of the bowel, it may serve 
as a helpful adjunct in the diagnosis 
of digestive system tumours in 
conjunction with other routine investiga­
tions. More important is the utilization 
of the radioimmunoassay for CEA 
under the following circumstances:
1. Preoperatively as an indicator of 
tumour dissemination based upon the 
quantitative concentrations of CEA
in the circulation.
2. As an indicator of potentially 
curative resection manifested by a 
decrease in circulating concentrations 
of CEA to below detectable limits.
3. As an early warning of recurrent 
tumour growth, by detecting the 
reappearance of CEA in the circulation 
of a patient rendered CEA-negative 
after tumour resection, 3 months to
2 years or more before any other 
presently available technology can 
detect clinical evidence of recurrence.
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This last observation is now under 
investigation for its potential value as 
an indicator for second-look surgery 
in patients who have undergone 
potentially curative surgery for colorectal 
cancers.
Chez I'humain, les adenocarcinomes 
du colon produisent I'antigene carcino- 
embryonnaire (ACE), un d'une famille 
de glycoproteines pouvant etre produites 
par divers cancers humains et, 
occasionnellement, par d’autres tissus 
anormaux. La nature physicochimique 
et la distribution tissulaire de FACE ont 
ete bien etablies et plusieurs methodes 
radioimmunologiques ont ete mises 
au point par la detection de cette 
substance dans la circulation des patients 
porteurs de tumeurs productrices 
d’ACE. Bien qu’une telle methode ne 
doive pas etre utilisee comme test 
de depistage du cancer de I’intestin, 
elle peut servir comme mesure d’appoint 
dans le diagnostic des tumeurs du 
systeme digestif conjointement avec 
d'autres epreuves courantes. Plus 
importante est I 'utilisation que Ton 
fait du dosage radioimmunologique 
de FACE dans les circonstances 
suivantes:
1. En preoperatoire, comme indicateur 
de dissemination tumorale en s’appuyant 
sur la quantification de FACE dans la 
circulation.
2. Comme indicateur du succes 
eventuel d'une resection a visees 
curatives, qui se manifeste par une 
baisse de concentrations d’ACE 
circulant en deca des limites de 
detection.
3. Comme signal precoce d'une 
recidive tumorale, en decelant la 
reapparition de FACE dans la circulation 
chez un patient devenu ACE negatif 
apres une resection tumorale, de 3 mois 
a 2 ans ou plus avant que toute autre 
technique presentement disponible ne 
puisse deceler la preuve clinique
d’un recidive.
Cette derniere observation est 
maintenant a I'etude pour sa valeur 
eventuelle comme indicateur d'une 
chirurgie exploratrice chez les patients 
qui ont subit une chirurgie a visees 
curatives pour un cancer colorectal.
All adenocarcinomas of the human 
bowel produce one or more molecules 
of a family of immunologically cross- 
reactive tumour antigens, collectively 
designated carcinoembryonic antigen 
(CEA). Nevertheless, the material 
denoted CEA is found in all endoder- 
mally derived digestive-system tumours 
as well as in the fetal gut, liver and 
pancreas in the first two trimesters of 
gestation. This material is not found 
in other fetal tissues at any other time 
during gestation. Again, CEA-like ma­
terials may be produced by other types 
of cancerous tissues, but their exact 
nature has yet to be elucidated. CEA, 
which is a relatively large glycoprotein, 
is found at least in part in the glyco- 
calvx of the tumour cell. It is from 
this site that the CEA may be released 
into the circulation of the patient.
Since the original publication de­
scribing a radioimmunoassay for 
CEA,1,2 a great many modifications of 
the procedure have been described.1'2 
The assay most frequently employed at 
present, and commercially available, is 
the Z-gel assay marketed by Hoffmann- 
La Roche Ltd.
Although we have been able to 
demonstrate the presence of CEA by 
tissue extraction only in bowel cancer, 
this limitation does not apparently ap­
ply to sera. Some 11% of healthy in­
dividuals were found to have a meas­
urable concentration of CEA in their 
sera (i.e., greater than 2.5 ng/mL of 
serum, the limit of sensitivity of the 
assay). The frequency of elevation of 
serum CEA or CEA-like material 
among smokers is 19%, whereas in 
nonsmokers it is only 3%. If smokers 
stop smoking, the concentration of se­
rum CEA in the majority decreases to 
undetectable levels. In some of them, 
however, it does not. Thus, smokers 
apparently in good health may have 
CEA, or a CEA-like material, identi­
fiable in their sera. Except in the malig­
nant diseases that will be considered 
below, the CEA is usually of low con­
centration (range, 2.5 to 5.0 ng/mL). 
Moreover, in such individuals the values 
tend to fluctuate between these re­
latively low values or to reach a pla­
teau, and do not show a tendency to 
increase. When increases do occur, it is
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likely that the disease has begun to 
progress.
In malignant diseases of the colorec- 
tum, the more advanced the stage of 
the disease, the higher is the frequency 
of positive assays and, indeed, the 
higher is the concentration of CEA in 
the serum or plasma. The frequency 
of elevated CEA concentrations is high 
in patients with carcinoma of the 
stomach and of the pancreas. It is 
somewhat lower in cases of primary 
hepatoma. Nonenteric cancers may 
produce positive CEA assays (e.g., 
cancers of the breast, bladder, fe­
male pelvic organs, etc.). Some non- 
malignant diseases, such as cirrhosis of 
the liver and ulcerative colitis may also 
be associated with elevations in the 
concentration of CEA.
Why are such “false-positive” assays 
observed? These probably result from 
some of the determinants on a mole­
cule of CEA resembling those produced 
by other pathologic conditions or even 
by normal tissues. If the antibodies 
against these determinants are not com­
pletely removed from the reagent anti- 
CEA antiserum used in the assay, a 
positive reaction with the materials pro­
duced by other pathologic, or even nor­
mal, tissues may occur. The absorption 
of the reagent antiserum is, therefore, 
crucial.
Use of CEA in Diagnosis of
Colorectal Cancer
The CEA assay is not a screening 
test for cancer. It should never be em­
ployed in this fashion except in situa­
tions where a clinician strongly sus­
pects cancer. In such situations a 
positive CEA assay may be obtained 
up to 24 months or more prior to the 
demonstration of the tumour by either 
endoscopic or radiologic means. In 
addition, the CEA assay may be of 
value in the examination of populations 
at high risk of developing CEA-associ- 
ated cancers. Hence, in the community 
of Busselton, Australia, 960 serum 
samples were examined for CEA con­
centration in 1969 and this procedure 
was repeated on the same population in 
1973.1 In 18 (2%) of the 912 initially 
CEA-negative subjects CEA-associated 
cancers had developed in the interval, 
whereas in 8 (18.5%) of the 44 initially 
CEA-positive subjects such tumours 
had developed. Six of the latter group 
had already died of their cancers and 
two were found to have occult malig­
nant lesions of the colorectum upon 
subsequent examination. Whether the 
cost-benefit ratio is worth while in 
such populations remains tc be deter­
mined.
It has been demonstrated1 quite clear­
ly that in cases of pancreatic and
based on rising CEA values in controlled 
settings.
Immunotherapy of Colorectal Cancer
The studies done so far in the area 
of immunotherapy of colorectal cancer 
have provided no definitive informa­
tion on the efficacy of this mode of 
treatment. Indeed, at the moment im­
munotherapy does not appear to have 
much to offer in the management of 
patients with colorectal cancer. How­
ever, from a theoretical standpoint it 
can be claimed that the tumour must be 
reduced in bulk in order to lower the 
total number of cells remaining to 105 
or fewer. In addition, the patient must 
have a functional immunologic system, 
since without this form of reactivity 
immunotherapy cannot possibly be ef­
fective.
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colonic cancer, a combination of the 
standard, generally available diagnostic 
techniques with the CEA assay pro­
vides a higher degree of diagnostic 
accuracy than either method alone.
What information can be supplied 
by the CEA assay prior to surgery in 
a patient with an established colorectal 
cancer? Here it has been proved that 
the CEA value provides most important 
preoperative prognostic evidence. If the 
CEA value is either low or undetect­
able, resection of a localized tumour 
has an excellent possibility of being 
curative. The higher the preoperative 
value of CEA, the less likelihood there 
is of truly curative resection and the 
greater the chance of tumour dissemina­
tion during the operation and of early 
observation of metastatic lesions post- 
operatively.
After resection of cancers that ap­
parently have not metastasized, the 
CEA value tends to decrease in some 
cases, while in others it remains ele­
vated. If it remains elevated over 
a period of weeks, almost invariably 
metastases are found quite soon 
after operation. On the other hand, 
in individuals in whom the CEA 
value falls below the limits of detectabil­
ity postoperatively, and remains unde­
tectable or of the order of 2.5 to 5.0 
ng/mL without showing progressive 
rise, clinical recurrence of tumour is 
seldom seen. If, however, after an 
initial fall in CEA value to undetectable 
concentrations postoperatively there 
should be a persistent reappearance of 
CEA in the circulation and an increas­
ing concentration, the recurrence of 
malignant growth is almost certain.
At present its predictive value as a 
marker for the recurrence of colorectal 
cancer growth is perhaps the most use­
ful function of the CEA assay. This 
observation has been made repeatedly 
in a number of laboratories throughout 
the world and has, very recently, been 
translated into a practical approach to 
the postoperative management of pa­
tients with colorectal cancer.3"6 Thus, 
in a number of centres in both North 
America and abroad, a rising value of 
CEA, under well-defined and well-con- 
trolled circumstances, is being used as 
an indication for second-look surgery 
for cancer recurrence. The reports of 
this type of procedure are most encour­
aging in that localized lesions have 
apparently been found and resected 
with excellent results.4 A great deal 
more study is required of this approach, 
and caution should be exercised in 
utilizing this new tool as a basis for 
second-look surgery. It is noteworthy 
that the Society of Surgical Oncology 
in the United States is now planning a 
nation-wide trial in patients with cancer 
of the colon of second-look surgery
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4. Surgery of Colorectal Cancer
S. Arthur Localio, md, d sc(med), facs*
Studies on lymphatic spread of rectal 
cancer have established the rationale 
for sphincter preservation in the 
treatment of midrectal cancer. This 
entity comprises lesions located 5.5 
to 10 cm above the anal verge in 
women and 7 to 11 cm in men.
Abdominosacral resection is a logical 
means for restoring intestinal continuity 
after radical resection for midrectal 
cancer. Direct posterior exposure of 
the distal limit of resection above the 
pelvic floor allows accurate construction 
of the anastomosis without disturbing 
the anorectal structures or their in­
nervation and maintains essentially 
normal anal continence. The procedure 
is preferable to the various pull-through 
operations. Survival rates for patients 
undergoing anterior resection, abdomi­
nosacral resection and abdominoperineal 
resection are comparable.
Des etudes portant sur I'envahissement 
du systeme lymphatique par un cancer 
rectal ont degage les conditions 
necessaires a la conservation du 
sphincter lors du traitement d’un cancer 
du centre du rectum. Ceci comprend 
les lesions situees de 5.5 a 10 cm 
au-dessus du bord de I'anus chez la 
femme, et de 7 a 11 cm chez I’homme.
La resection abdominosacre est un 
moyen logique de retablir la continuite 
intestinale apres une resection radicale 
pour un cancer du centre du rectum.
Un abord posterieur direct de la partie 
distale de la resection, au dessus du 
plancher pelvien, permet la construction 
de I'anastomose sans affecter 
I'innervation des structures anorectales 
et maintient une continence anale 
essentiellement normale. Cette 
intervention est preferable aux diverses 
operations transanales. Les taux de 
survie pour les patients qui subissent 
une resection anterieure, une resection 
abdominosacree ou une resection 
abdominoperineale sont comparables.
Presented at the Canadian Oncology 
Society symposium on colorectal cancer, 
held at the annual meeting of the Royal 
College of Physicians and Surgeons of 
Canada, Toronto, Ont., Jan. 27, 1977
*Professor of surgery, New York 
University Medical Center, school of 
medicine, New York; Johnson & 
Johnson distinguished professor of 
surgery
Reprint requests to: Dr. S.A. Localio,
560 First Ave., New York, N Y  10016, 
USA
The American Cancer Society esti­
mates that in 1977 in the United States 
there will be 101 000 new cases of 
cancer of the colon and 51 000 deaths 
from this disease. About 50% of the 
patients in whom carcinoma of the 
colon develops will be alive and well 
5 years after the tumour has been 
diagnosed but the other 50% will have 
died within that period.
The stage of disease determines the 
chance of survival. The Dukes’ classifi­
cation1 reflects the duration and bio­
logic behaviour of the growth. About 
15% of patients have a Dukes’ A lesion 
and virtually all are curable. Patients 
whose tumour is classified as Dukes’ 
B represent about 35% of all patients 
and have a 70% chance of being 
alive and free of disease after 5 years. 
About 50% of patients have a Dukes’ 
C lesion and in these persons the suc­
cess rate decreases to about 30%. The 
salvage rate for patients with distant 
metastases is virtually zero.
One way to increase the salvage rate 
of patients with carcinoma of the colon 
is to make the diagnosis at an earlier 
stage. The American Cancer Society 
tries to accomplish this by educating 
the public, the physician and the 
surgeon. Screening by rectal examina­
tion, examination of the stool for oc­
cult blood and sigmoidoscopy are 
easily done. The small group of per­
sons at great risk — those with mul­
tiple polyps or congenital polyposis, 
patients with long-standing ulcerative 
colitis (particularly if the disease had 
its onset during youth), the individual 
who previously has had carcinoma 
of the colon and those who have a 
family history of carcinoma of the 
colon — require more intensive in­
vestigation. Further evaluation by 
barium contrast enema and colono­
scopy should be performed in the 
presence of any of the above indica­
tions.
Even the poor-risk patient can un­
dergo surgery for cancer of the colon 
with the expectation of modest mor­
bidity and acceptable mortality. A 
mortality of 2% in a large series of 
unselected patients is possible. For 
the past 10 years we have made a spe­
cial attempt to preserve normal sphinc­
ter function in a specific group of pa­
tients with cancer of the rectum. Our 
policy has been to treat cancers of the 
upper third of the rectum by anterior
resection, those in the lower third of 
the rectum by standard abdomino­
perineal resection2 and cancers of the 
middle third of the rectum by abdomi­
nosacral resection.
We define upper third cancers as 
lesions more than 11 cm from the 
anorectal junction in men and 10 cm in 
women. Lesions less than 7 cm from 
the anorectal junction in men or 5.5 
cm in women lie in the lower third. 
For the intermediate group (lesions 
between 7 and 11 cm from the ano­
rectal junction in men and between 
5.5 and 10 cm in women) we perform 
abdominosacral resection with preserva­
tion of the sphincters. This operation 
preserves both the sphincters and the 
mucosa as well as the sensory receptors 
of the lower rectum and anus. We be­
lieve the abdominosacral resection is 
justified because the spread of carci­
noma of the midrectum is upward. 
Lateral or downward spread occurs 
only when the higher lymphatics have 
been choked with tumour.3
Technique of Abdominosacral
Resection
The patient is placed in the lateral 
position so that the pelvis can be ap­
proached simultaneously through an 
abdominal incision and through a 
posterior incision after the coccyx has 
been removed. The abdominal part of 
the operation is similar to other ab­
dominal operations on the rectum ex­
cept that one sees the anatomic struc­
tures from a lateral instead of from an 
anterior view.
The posterior portion of the opera­
tion is begun without turning the pa­
tient or closing the abdominal incision. 
The coccyx is disarticulated from the 
sacrum. The posterior portion of the 
levator ani is detached from the coc­
cyx. The presacral space can now be 
entered and the mobilized colon and 
rectum can be delivered through the 
posterior incision. The bowel is tran­
sected 3 to 4 cm above the lesion after 
measuring the distance with a ruler. A 
standard two-layer anastomosis with 
fine sutures is performed and covered 
with omentum.4 There have been two 
deaths in the 100 patients we have op­
erated on using this technique. One 
death was from peritonitis caused by 
a leak at the anastomosis and the 
other from myocardial infarction on 
the ninth postoperative day.
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Resulls
We are at present reviewing our ex­
perience with carcinoma of the rectum 
in over 400 patients treated in the 
past 10 years by one of the three types 
of operation mentioned above. Our 
preliminary data show an overall 
mortality of 2% . These data indicate
that for the three types of operation 
adopted for the treatment of rectal can­
cer the 5-year survival rates are com­
parable.
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5. Radiotherapy of Colorectal Cancer
W.D. R ider, mb, frcp[c], frcr( lond)*
Radiotherapy has an increasingly im­
portant place in the management of 
patients with colorectal cancer. At 
present the exact indications have 
not been defined, but the following 
suggestions for its use can be made 
based on preliminary experience at the 
Princess Margaret Hospital, Toronto:
1. Radical irradiation could be a 
valuable alternative to the classical 
Miles' abdominoperineal excision of 
extraperitoneal rectal cancer.
2. Preoperative irradiation may be 
used for all patients undergoing surgical 
excision and restoration of bowel 
continuity.
3. Postoperative radiotherapy can be 
administered (a) when the tumour has 
penetrated the bowel wall to the serosa 
or beyond, (b) when the lymph nodes 
are involved secondarily and (c) when 
the distal line of resection is less than 
4.0 cm from the tumour (as measured
in the fixed pathological specimen).
4. Radiotherapy is useful for palliation 
of postsurgical recurrences and symp­
tomatic distant metastases.
La radiotherapie prend une place de 
plus en plus importante dans le 
traitement des patients atteints de 
cancer colorectal. Jusqu’a maintenant, 
les indications precises n’ont pas ete
Presented at the Canadian Oncology 
Society symposium on colorectal cancer, 
held at the annual meeting of the Royal 
College of Physicians and Surgeons 
of Canada, Toronto, Ont., Jan.
27, 1977
' Professor of radiology, University of 
Toronto, and director, radiation oncology, 
The Princess Margaret Hospital, Toronto
Reprint requests to: Dr. W.D. Rider,
The Princess Margaret Hospital, 500 
Sherbourne St., Toronto, Ont.
M 4X 1K9
definies, mais les suggestions suivantes 
peuvent etre avancees a parti r de 
(’experience preliminaire realisee au 
Princess Margaret Hospital, Toronto:
1. L'irradiation radicale pourrait etre 
une alternative acceptable a I’excision 
abdominoperineale classique de Miles 
des cancers rectaux extraperitoneaux.
2. L'irradiation preoperatoire peut 
etre utilisee chez tous les patients 
qui subissent une excision chirurgicale 
et le raccord de I’intestin.
3. La radiotherapie postoperatoire 
peut etre administree (a) quand la 
tumeur a envahi la paroi abdominale 
jusqu'a la sereuse, ou au-dela (b) quand 
il y a atteinte secondaire des ganglions 
lymphatiques et (c) quand la ligne 
distale de resection est a moins de 
4.0 cm de la tumeur (tel que mesure 
sur le prelevement pathoiogique fixe).
4. La radiotherapie est utile comme 
traitement palliatif lors des recidives 
postchirurgicales et en presence de 
metastases eioignees symptomatiques.
Most of the experience in the radio­
therapy of colorectal cancer acquired 
at the Princess Margaret Hospital, To­
ronto, relates to cancer of the rectum, 
but some of the principles learned 
in the treatment of lesions of the lower 
bowel may well be applied to the up­
per large bowel.
The role of radiotherapy in colo­
rectal cancer can be considered under 
three headings:
•  Curative—as an alternative to 
abdominoperineal resection.
•  Preoperative—for all levels.
•  Postoperative—for special cate­
gories.
We must disabuse ourselves of the 
former concept that adenocarcinoma of 
the large bowel is radioresistant. Quite 
clearly it is not. Unlike squamous cell
carcinoma it has a slow disappear­
ance or regression rate (Fig. 1). Indeed, 
the longest period to complete regres­
sion we have documented is 26 
months; at 4 Vi years this patient is 
alive without cancer in his rectum, 
but he has lung and liver metastases.
The acquisition of evidence that 
there is an alternative to the classical 
Miles’ abdominoperineal resection for 
cancer of the rectum is difficult be­
cause of the tradition of surgical treat­
ment and the mistaken idea that the 
tumour is radioresistant.
In the selected group of tumours 
that we have irradiated 75% were 
classified by the surgeon as inoperable 
because of local fixation of the growth. 
Over a span of 20 years we have not 
had a consistent policy with regard to 
irradiation. Each radiation oncologist 
simply did what he thought best (just 
like our surgical confreres) and, in re­
trospect, critical analysis makes it clear 
that in about one quarter of these pa­
tients the choice of irradiation was in 
error.
In a modest attempt to “stage” our
FIG. 1—Comparison of rate of complete 
regression after irradiation for patients 
with squamous cell carcinoma and adeno­
carcinoma of rectum, treated at Princess 
Margaret Hospital, Toronto.
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patients we have assigned them, re­
trospectively, to one of four categories: 
(1) patients who never had a colo­
stomy; (2) patients who had a pro­
phylactic colostomy without evidence 
of obstruction (at laparotomy the tu­
mour was thought to be inoperable and 
a colostomy was done); (3) patients 
who underwent colostomy either dur­
ing or within 3 months of irradiation; 
and (4) patients who had a colostomy 
because of total obstruction.
Using an actuarial method of cal­
culation we found the 5-year survival 
rates for these four categories to be, 
respectively, 45%, 26%, 0% and 0% 
(no patient in category 4 survived 2 
years).
The results for patients in category 
1, who are comparable to operable 
cases, are not dissimilar to the best 
surgical results. Certainly this pilot ex­
perience suggests the curability of rec­
tal cancer by irradiation.
Preoperative Irradiation
The results of the Toronto trial of 
preoperative irradiation in operable 
rectal cancer have already been re­
ported in this Journal.1 Suffice it to 
say that in cases staged as Dukes’ C2 
there was a statistically significant im­
provement in survival after a single 
dose of 500 rads delivered a few hours 
before surgery. This approach could 
easily be used for all colorectal can­
cers, with appropriate modification in 
radiation technique.
Postoperative Irradiation
This is a situation that I believe is 
still sub judice. While the recurrence 
rates for Dukes’ B2 and C lesions are 
high, particularly if the line of resec­
tion is less than 4.0 cm distal to the 
lesion, the place of postoperative irra­
diation is not clear. The risks of irra­
diation-induced small-bowel complica­
tions must be weighed against the 
benefits, if the classical high doses are 
used.
Irradiation for recurrence after the 
Miles’ operation will alleviate pain in 
about 80% of patients, but as a rule 
the relief is short-lived. Patients with 
the “phantom rectum” syndrome 
should be treated on the basis of symp­
toms without waiting for proof.
Admittedly radiation oncologists are 
neophytes in the application of this 
modality to malignant tumours of the 
gastrointestinal tract and have much 
to learn. For instance, the classical 
5 days a week treatment protocol may 
not be the best way of irradiating pa­
tients with colorectal cancer. In a pilot 
study we have been impressed with a 
fractionation regimen of 500 rads every 
2 weeks to a total of 3000 rads; this 
afforded appreciable palliation and 
about 50% tumour regression. This 
study is at an early stage but merits 
further scrutiny. Perhaps the principles 
of management of laryngeal cancer 
can be applied to rectal cancer, that is, 
irradiation in doses that are tolerable 
and not excessive should be admin­
istered and surgery should be used sub­
sequently for salvage.
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6. Chemotherapy of Colorectal Cancer
D.J. K la a ssen , m d , f r c s [c]*
Although considerable research effort 
has been expended to improve the 
drug treatment of colorectal cancer, 
progress has been slow. 5-fluorouracil 
(5-FU) is still the agent of choice and 
no other drug or combination of drugs 
has been found superior. When com­
bined with radiation therapy 5-FU is 
superior to irradiation alone in the 
treatment of localized carcinoma of 
the rectum. When used as an adjuvant 
in the management of patients with
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a poor prognosis after definitive 
surgical resection, 5-FU has not im­
proved survival or delayed the time to 
recurrence. Further controlled trials are 
indicated to find new agents or 
modalities of therapy to improve these 
results.
Bien qu'un effort de recherche 
considerable ait ete consacre a 
■ 'amelioration de la chimiotherapie 
du cancer colorectal, les progres 
ont ete lents a venir. Le 5-fluorouracil 
(5-FU) demeure I'agent de choix et aucun 
autre medicament ou association de 
medicaments ne lui a ete superieur.
En association avec la radiotherapie, 
le 5-FU est superieur a I'irradiation seule 
dans le traitement du carcinome 
localise du rectum. Employe comme 
traitement d'appoint chez les patients 
ayant un pronostic reserve apres une 
resection chirurgicale definitive, 
le 5-FU n'a pas ameliore la survie ou 
retarde I’apparition des recidives.
De nouvelles etudes controlees sont 
indiquees afin de trouver de nouveaux 
medicaments ou de nouveaux modes 
de traitement destines a ameliorer 
ces resultats.
Chemotherapy should have a major 
role in the treatment of colorectal can­
cer for the following reasons: aside 
from skin cancer, colorectal cancer is 
the commonest form of malignant dis­
ease when men and women are con­
sidered together, and is the second 
commonest cause of death from such 
disease, being exceeded only by lung 
cancer in men and breast cancer in 
women. Also, surgery and radiation 
therapy have not changed cure rates 
over the past 20 years and the 5-year 
survival rate continues at approximately 
45%. Therefore, 55% of patients could 
benefit from systemic therapy. The 
mean duration of life from time of 
proven unresectability or metastasis is 
9.5 months (median, 7 months), 50%
218 VOLUME 21, NO. 3, M AY 1978 /  THE CANADIAN JOURNAL OF SURGERY
of patients dying of complications of 
local recurrence and 50% dying of 
distant metastases.1"3
Unfortunately, colorectal cancer has 
proven exceptionally resistant to chemo­
therapeutic agents. Virtually every 
chemotherapeutic agent now available 
has had extensive trials in this disease 
and only a few drugs are active. They 
are listed in Table I, in descending or­
der of effectiveness.3,4 It can be seen 
that the antimetabolites with 5-fluorou- 
racil (5-FU) and 5-fluorodeoxyuridine 
(5-FUDR) are the most active as a 
class, followed by the nitrosoureas, mi­
tomycin C, then the alkylating agents, 
dimethyl-triazeno-imidazole carboxa­
mide (DTIC) and the new agent 
1,2-bis(3,5-dioxopiperazin-1 -yl) propone 
(ICRF-159). Of the new agents being 
tested the most promising is fluorinated 
pyrimidine (Ftorafur). It is apparent 
that no drug is particularly good and 
obviously new agents are desperately 
needed.
5-FU has been extensively evaluated 
as to the best schedule and route of ad­
ministration (Table II).3,5 At present 
the standard 5-day loading course by
push injection is still the best for in­
duction. For maintenance therapy there 
is little to choose between the 5-day 
course once a month and a weekly 
injection. Oral administration has been 
found unreliable because of erratic ab­
sorption. Two studies, one by the West­
ern Cancer Study Group5 and the 
other by the Mayo Clinic,6 have shown 
that, although induction rates may be 
the same as with the intravenous route, 
with the oral route the length of remis­
sion is substantially shorter. Most 
authorities now recommend the intra­
venous route except possibly for pa­
tients with liver metastases because of 
portal absorption of the drug. Hepatic 
artery infusion produces higher regres­
sion rates and slightly longer remis­
sions. However, these advantages are 
at the cost of increased morbidity, time 
in hospital and technical difficulties, 
which make the route unattractive com­
pared with standard intravenous ad­
ministration. Therefore hepatic artery 
infusion is now used only in special 
institutions, usually when systemic 
therapy has failed.
Patients who respond to 5-FU do
Table 1 --Active Single Chemotherapeutic Agents3
No. of patients 
treated / 
no. collected
Response
rates,
%
Duration of survival, mo
Drug Median Mean Range
5-fluorouracil (5 -FU ) 454/2107 21 5 7.3 2-25.5
(5-fluorodeoxyuridine) (144/617) (23) (6) (9.6) (2-35.5 )
Methyl-cyclohexyl-chloroethyl-
nitrosourea (MeCCNU) 12/77 15 4.0 — —
Bischloroethyl-nitrosourea 15/104 14 2 4.8 2-7.5
Mitomycin C 25/218 16 2 2.3 2-4
Cyclohexyl-chloroethyl-
nitrosourea 7/75 10 4.5 5.0 2-9
Cyclophosphamide, 
Mayo Clinic4
24/89
(2/25)
27
(8)
— — —
M ethotrexate, 
Mayo Clinic4
19/111
(2/38)
17
(5)
— — —
Melphalan 19/110 17 — — —
Hexamethylmelamine 10/86 11.5 — — —
Dim ethyl-triazeno-im idazole-
carboxamide (D T IC ), 
Mayo C linic4
8/71
(0/17)
11
(0)
l,2 -b is (3 ,5-d ioxop iperazin -l-y l) 3/25 12 — — —
propone (ICRF-159), 
Mayo C linic4
Table I I - -Results of 5-FU Administration 3
Route schedule (collected
No. of patients 
receiving drug/ Response rate, Survival,
series from literature) total no. of patients % mo
Intravenous, standard loading dose 257/1355 19 5-6
Intravenous, standard loading dose 
+  w eekly maintenance 52/134 39 5-6
Intravenous, weekly 42/197 21 5-6
Intravenous, 5-d loading 68/227 30 5-6
8-24-h infusion 18/106 17 5-6
Oral (Mayo Clinic5) 17/88 19 2
Hepatic infusion 190/381 50 8
have an improved length of survival 
compared with nonresponders and un­
treated controls as shown in Figs. 1 
and 2.7 However, when all patients 
treated by 5-FU are considered toge­
ther and compared with untreated con­
trols, there is no evidence of improved 
survival, which is not surprising con­
sidering the low level of response to 
this drug. Younger patients and pa­
tients with slowly growing tumours 
have a higher response rate. Patients 
with lung metastases have a lower re­
sponse rate than patients with metas­
tases in other areas have, as shown in 
Table III.1
Combination chemotherapy has also 
been disappointing. Many combinations
FIG. 1—Comparison of survival in 
responders and nonresponders in group of 
patients treated with 5-fluorouracil (5-FU) 
at Mayo Clinic and historical untreated 
control group of patients. Reproduced by 
permission from Moertel CG, Reitemeier 
RJ: Advanced Gastrointestinal Cancer,
New York, Har-Row, 1969.
FIG. 2—Survival of all patients treated 
with 5-FU compared to matched historical 
untreated control group at Mayo Clinic. 
Reproduced by permission from Moertel 
CG, Reitemeier RJ: Advanced Gastroin­
testinal Cancer, New York, Har-Row, 
1969, p 132.
Table I I I— Response of Patients w ith M etas­
tases to Adm inistration of 5 -F U *
Site of indicator 
lesion
No. of 
patients  
treated
Objective
regressions,
%
Liver 118 24f
Lungs 78 6 .4 |
Abdomen 
Cutaneous and
34 32f
subcutaneous 31 16
Peripheral nodes 8 25
Other 8 25
‘ Reproduced by 
CG.1
permission from M oertel
fP  <  0.01.
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have been evaluated and Table IV lists 
only the well-documented studies, 
which show that combination chemo­
therapy is better than treatment with 
5-FU alone.8"10 In these studies, methyl- 
cyclohexyl-chloroethyl-nitrosourea (Me- 
CCNU) combined with 5-FU appeared 
to produce higher rates of remission 
than 5-FU alone. Unfortunately, the 
length of remission produced was no 
better than with single agents. Com­
bination chemotherapy does produce 
more morbidity. More recent studies 
have failed to confirm these results 
and it now appears that the combina­
tion of 5-FU and MeCCNU is no bet­
ter than 5-FU alone.11'12
Chemotherapeutic agents, particu­
larly 5-FU, have been used in com­
bination with other modalities such as 
surgery, irradiation and immunotherapy 
to treat colorectal cancer.
The value of chemoimmunotherapy 
is being assessed. Preliminary studies 
from the M.D. Anderson Hospital13 
and South West Oncology Group10 
have shown that 5-FU plus bacille Cal­
mette Guerin (BCG) may produce a 
longer disease-free period with in­
creased survival in patients with a poor 
prognosis when used as an adjuvant to 
surgery (Table V). All these studies, 
however, need to be confirmed by ran­
domized controlled trials from other 
institutions and groups.
When 5-FU is combined with radia­
tion therapy, there is a modest im­
provement in length of remission and 
survival compared with results of radia­
tion therapy alone in patients with lo­
cally inoperable or recurrent disease. 
This has been shown by a single study 
from the Mayo Clinic (Table VI)1 and 
needs to be confirmed by other studies 
that are in progress at present.
5-FU and 5-FUDR have been ex­
tensively evaluated as adjuvants to sur­
gery in patients classified as having 
Dukes’ stage B2 or stage C disease. Un­
fortunately, all the large randomized 
controlled clinical trials have shown no 
benefit from 5-FU with respect to sur­
vival or disease-free life.14 Later studies 
using new combination regimens and 
multimodality therapy may change this 
picture.
To summarize:
1. 5-fluorouracil (5-FU) is still the 
best single chemotherapeutic agent for 
colorectal cancer. However, response 
rates are low and new drugs are 
desperately needed.
2. There are no drug combinations 
that are superior to 5-FU alone either 
with respect to percent remission or 
duration of remission.
3. Chemoimmunotherapy may be 
better than chemotherapy alone, espe­
cially in the adjuvant setting, but further 
controlled trials are needed.
4. 5-FU combined with irradiation 
gives slightly better results than irra­
diation alone.
5. 5-FU has not prolonged the dis­
ease-free interval or survival when used 
as adjuvant therapy after surgery in 
patients with a poor prognosis. Further 
controlled trials with new agents and 
various combinations of drugs and 
therapies are in progress.
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5-FU -|- MeCCNU +  vincristine  
(V C R )8’9 17/39 43 Not reported
16/45 37 5
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Adjuvant regimen
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relapses
No. of 
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Bacille C alm ette Guerin 
(BCG) (a t 20 mo) 33 6 2 P =  0.03 vs control P = 0.05 vs control
BCG +  5-FU  (100 
m g/m 2, ora lly  qid X  
5, q4wk (a t  15 mo)
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5-FU +  BCG
0.01 vs control 
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5-FU +  BCG
Table V I—Controlled T ria l of 5-FU and Radiotherapy in Colorectal Cancer1
Median duration
No. of Response rate, of remission, Median survival,
Regimen patients % mo mo
5-FU 15 m g/kg daily X  3
+  4000 rads 32 50 (symptom atic) 10 \ 23 v>  P <  0.01 >  P <  0.05
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7. Discussion on Management of Colorectal Cancer
Panelists: P. Gold, D.J. Klaassen, S.A. Localio,
A.B. Miller, B.C. Morson and W.D. Rider
At the close of both sessions of the 
symposium members of the audience 
were invited to submit questions. These 
were assigned to the various speakers. 
A number of representative questions 
and answers appear below.
Question: What further treatment is 
indicated when, after the local exci­
sion of a carcinoma of the rectum, 
the pathologist recognizes venous or 
lymphatic invasion?
Answer (Dr. Morson): So far I have 
seen no evidence that the observa­
tion of lymphatic invasion in locally 
excised specimens in any way changes 
the prognosis. It may, of course, be 
difficult to be sure on histologic 
grounds that lymphatics are invaded. 
In regard to venous invasion, there is 
not as much information available 
as we really need. Our experience sug­
gests that venous invasion limited to 
the submucosa does not alter the 
prognosis except in the exceptional 
case. On the other hand, spread within 
the veins of the extramural tissues is 
associated with a very poor outlook. 
So a distinction must be made between 
submucosal venous spread and extra­
mural venous spread.
Question: Does carcinoma arise in the 
hamartomas of the Peutz-Jeghers syn­
drome?
Answer (Dr. Morson): The Peutz- 
Jeghers syndrome is rare and any con­
tribution it makes to the totality of 
cancer of the colon and rectum must 
be exceedingly minute. Cancer does 
occur in this syndrome but it is rare. 
Question: May we have some comment 
on the distribution of the villous ad­
enoma throughout the rectum and 
colon and its relation to carcinoma? 
Answer (Dr. Morson): The modern 
methods of investigation of the colon 
with colonoscopy and air contrast 
barium enema have made it clear that 
villous adenomas are found in the
Conducted at the Canadian Oncology 
Society symposium on colorectal cancer, 
held at the annual meeting of the Royal 
College of Physicians and Surgeons 
of Canada, Toronto, Out., Jan. 27, 1977
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8650, Ottawa, Ont. K1G 0G8
proximal part of the colon and more 
frequently than was once believed. 
The question of distribution is further 
confused because many surgeons have 
called large sessile tumours “villous” 
without reserving that term for those 
that have the microscopic appearance 
of the villous adenoma. It is now well 
accepted that some tubular adenomas 
have a flat or sessile gross appearance. 
It is therefore somewhat dangerous to 
rely on the older literature.
Question: Are there any other immu­
nologic indicators such as the concern 
tration of an-fetoprotein that have any 
value in either the diagnosis or post­
operative surveillance of patients with 
colorectal cancer?
Answer (Dr. Gold): Measurement of 
cti-fetoprotein is not very useful in the 
postoperative surveillance of patients 
with colorectal cancers. It may occa­
sionally be of help, however, in pa­
tients with gastric cancer. A number 
of other markers of colorectal cancer 
are being investigated at present. On 
the whole, if one uses a variety of 
markers, it may be possible to find 
cancers at an earlier stage and perhaps 
achieve better cure rates than by em­
ploying any one marker alone. 
Question: Is there any development of 
a holistic theory of the etiology of car­
cinoma of the breast and colon? 
Answer (Dr. Miller): It is possible that 
there are two different phases of car­
cinogenesis. The rapid change in the 
frequency of colonic cancer that oc­
curs on migration does not occur with 
breast cancer. This may mean that the 
nutritional channels responsible for 
breast cancer operate only during 
adolescence or early in life and there­
fore require a generation for dietary 
factors to exert their effect. Nutritional 
factors may be responsible for initia­
tion in breast carcinogenesis and for 
potentiation in colorectal carcino­
genesis.
Question: Are there any firm data 
that methyl-cyclohexyl-chlorethyl-nitro- 
sourea added to 5-fluorouracil as ad­
juvant therapy is of any value?
Answer (Dr. Klaassen): None of the 
trials using that combination are fin­
ished yet, not even preliminary data 
are available.
Question: Was radiation treatment to
a dose of 500 rads given to any pa­
tients who had anterior or abdomino- 
sacral resection?
Answer (Dr. Rider): It was given to 
40 who had anterior resection but to 
none who had abdominosacral resec­
tion.
Question: Was it followed by any 
morbidity?
Answer (Dr. Rider): No.
Question: Do you favour 500 rads over 
the higher dose of 4500 rads directed 
over a larger field and given over a 
longer period of time?
Answer (Dr. Rider): The results of 
trials using 500, 2000, or 4500 rads 
have all been the same. Therefore, 
it does not matter as long as a dose of 
500 rads or more is given. The 500- 
rad dose was based on an animal ex­
periment.
Question: What is the significance of 
that time interval? Why insist that it 
be given within 8 hours of surgery? 
What happens when the effect di­
minishes after 8 hours?
Answer (Dr. Rider): I don’t know. But 
in the experimental work the benefit 
of the radiation wore off if the opera­
tion was done more than 8 hours after­
wards.
Question: What was the rate of leakage 
after abdominosacral resection?
Answer (Dr. Localio): In our first 50 
cases we had a 37.5% rate. In the 
second 50 cases we had only a 4% 
rate. The leaks occurred in males in the 
younger age group, a group of patients 
in whom the operation is technically dif­
ficult. We now do defunctioning 
colostomies in males under 65 years 
of age. This is a manifestation of the 
difficulty of the operation in males as 
compared with females who have a 
roomier pelvis.
Question: Dr. Rider, are you at present 
advising patients with operable carci­
noma of the rectum, who are simply 
seeking your opinion, to have radio­
therapy as the primary method of treat­
ment?
Answer (Dr. Rider): Yes, but I don’t 
often get the chance.
Question: Dr. Localio, would you com­
ment?
Answer (Dr. Localio): We are now add­
ing radiation therapy for patients whose 
cancer is classified as Dukes’ stage C
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because we are not happy with our pre­
vious salvage rate. I must make one 
point. I do not think that one can tell 
just by putting a finger in the rectum 
whether a tumour is fixed and in­
operable. This feature is much better 
recognized at operation. Moreover, 
sometimes the fixation is due to in­
flammatory disease, not to cancer. 
Question: Dr. Rider, you tried to cor­
relate survival with whether or not 
the patient had a colostomy. Do you 
use that information to determine 
whether or not colostomy is used dur­
ing the course of therapy if radio­
therapy alone is given? Is it necessary 
to divert the fecal stream during the 
treatment?
Answer (Dr. Rider): There is no good 
reason to do a prophylactic colostomy 
in a patient who is not obstructed. 
None of our patients had the colostomy 
closed later. Some patients do become 
obstructed during. treatment and re­
quire emergency colostomy.
Question: Dr. Localio, would you com­
ment on continence after abdomino- 
sacral resection and on the length of 
rectal stump necessary to ensure it? 
Answer (Dr. Localio): All our patients 
have sphincteric continence. In the im­
mediate postoperative period most pa­
tients have some problem of reservoir 
continence. This is manifested by fre­
quent small motions, but without in­
continence, without losing stool or the 
ability to retain gas. The reservoir 
function improves after a few weeks. 
On the basis of our experience it would 
appear that 3 cm of rectal mucosa is 
sufficient to preserve continence if the 
anal mucosa and sphincters are intact. 
Question: Dr. Localio, what are the 
local recurrence rates for the abdomi- 
nosacral and abdominoperineal resec­
tions in your series?
Answer (Dr. Localio): Recurrence rates 
for abdominoperineal resection often 
can only be estimated because of the 
“phantom rectum” syndrome and can­
not be proved. Recurrences are not 
so much local as pelvic and they occur 
mostly in patients belonging to Dukes’ 
C and B2 categories. The local recur­
rence rate for both procedures is in 
the vicinity of 20% to 30% for Dukes’ 
stage C cases over a 5-year period. 
Thus if there is a 60% survival rate 
after abdominosacral resection, half of 
the patients die of distant metastases 
and half of these show local metastases 
before their distant metastases become 
evident.
Question: What do you believe should 
be the radiation field for a patient in 
Dukes’ stage B2 or C?
Answer (Dr. Localio): It is our practice 
to include most of the pelvis in the pa­
tients belonging to Dukes’ stage C.
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Importance of Mixed Venous Oxygen Saturation 
in the Care of Critically III Patients
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The relation between mixed venous 
oxygen saturation and cardiac index 
was determined in 11 children who 
underwent surgical treatment for 
congenital heart disease. The correla­
tion between these two variables was 
found to be reliable (r =  0.78, P =  
0.001). The simple determination 
of mixed venous oxygen saturation 
provides a useful estimate of myocardial 
performance, particularly when 
sophisticated equipment for measuring 
cardiac output is not available.
La relation entre la saturation veineuse 
mixte d’oxygene et I’index cardiaque 
a ete determinee chez 11 enfants qui 
ont subit un traitement chirurgical 
pour maladie cardiaque congenitale.
La correlation entre ces deux variables 
s’est averee fiable (r =  0.78, P =  0.001). 
La simple determination de la saturation 
veineuse mixte d'oxygene offre une 
appreciation utile de la performance 
myocardique, particulierement lorsqu'un 
equipement sophistique de mesure du 
debit cardiaque n'est pas disponible.
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The quality of care for the critically 
ill patient improved considerably after 
Cournand and colleagues1 instituted 
the practice of obtaining hemodynamic 
measurements, including cardiac output 
(CO), in patients in shock. In large 
medical centres the availability of so­
phisticated equipment permits minute- 
by-minute measurement of hemody­
namic values, thus providing the clini­
cian with a better understanding of 
the rapidly changing physiology of the 
critically ill patient. However, these 
measurements have not been made 
routinely in the majority of community 
hospitals because of the cumbersome 
techniques required.
Part of our postoperative assessment 
in patients who have had surgical re­
pair for congenital heart disease is the 
determination of mixed venous oxygen 
saturation (Svo2), estimations of cardiac 
index (Cl), and continuous measure­
ment of central venous pressure (CVP), 
pulmonary arterial pressure, left atrial 
pressure and radial artery pressure in 
addition to the electrical display of lead 
II of the electrocardiogram. It occurred 
to us that these data could be useful 
for the clinician who lacks the resources 
to measure cardiac output. A flow-di­
rected balloon-tipped catheter posi­
tioned in a branch of the pulmonary 
artery for recording pulmonary capil­
lary wedge pressure has been widely 
used since its value was reported by 
Swan and associates.2 Through this 
catheter samples of mixed venous blood 
can be withdrawn for measuring oxy­
gen tension and saturation. These para­
meters, as we report below, accurately 
reflect the Cl.
Material and Methods
Eleven patients form the basis of 
this report (Table I). Of the seven who 
were infants, an operation for ventri­
cular septal defect (VSD) was per­
formed in five, for a defect of atrial 
septum (ASD) (primum) in one, and 
for recurrent pulmonary valvular steno­
sis in one. Their body weights ranged 
from 3.5 to 9.4 kg. The operations 
were done under conditions of deep 
hypothermia and circulatory arrest.
In four children, aged from 6 to 11 
years, the operation was for total repair 
of ASD (secundum) and pulmonary 
stenosis, for membranous VSD and 
ASD secundum, for subaortic fibromus- 
cular stenosis, or for tetralogy of Fallot.
Tab le  1— P a rt ic u la rs  o f P a tie n ts  S tu d ie d
P a tie n t no. D iagnosis A ge Sex W e ig h t, kg
1 VSD 13 mo M 8.3
2 VSD +  PDA 4 mo M 3.5
3 VSD 19 mo F 9.4
4 VSD +  PDA 7 mo M 6.1
5 VSD 13 mo F 5.7
6 ASD-1 6 mo F 4.0
7 PS (re c u rre n t) 11 mo M 7.2
8 A S D -2 +  PS 11 y r F 37.0
9 VSD +  ASD-2 6 y r M 18.5
10 S uba o rtic
fib ro m u s c u la r 8 y r M 23.0
s tenos is
11 T e tra lo g y  of F a llo t 10 y r F 35.0
VSD =  v e n tr ic u la r  sep ta l d e fe c t; ASD = a t r ia l  se p ta l d e fe c t; PDA =  p a tie n t d u c tu s  a r te r io s u s ;
P S =  pu lm o n a ry  s ten os is .
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Body weights ranged from 18 to 37 kg. 
The operations were performed using 
cardiopulmonary bypass and under 
moderate systemic hypothermia.
A CVP line and a radial artery pres­
sure line were introduced percutaneous- 
ly soon after induction of anesthesia. 
After completion of the surgical repair 
and before the sternotomy incision was 
closed, a small polyethylene catheter 
(Intracath 19GA—- 12"; Deseret Phar­
maceutical Co. Inc., Sandy, UT) was 
inserted into the pulmonary artery 
through the anterior wall of the right 
ventricle and brought out through the 
chest wall. The catheter was sutured 
to the epicardium and to the skin to 
prevent dislodgement. A similar ca­
theter was introduced into the left 
atrium through the right superior pul­
monary vein.
The position of the catheters was 
verified by a chest roentgenogram 
taken in the operating room before 
moving the patient to the intensive care 
unit (ICU).
A plastic stopcock was interposed in 
the manometer line to allow for sam­
pling of blood. The lines were kept 
patent by means of a constant low-flow 
infusion (1 to 2 mL/h) of 5% dextrose 
in water plus 0.2% normal saline solu­
tion and heparin (500 IU/L).
All pressure lines were connected to 
Hewlett-Packard (Palo Alto, CA) pres­
sure transducers, models 267 and 268A 
for high- and low-pressure systems, re­
spectively. A constant display in digital 
read-out and curve wave form was 
obtained of all measurements.
Cardiac index was estimated on ar­
rival in the ICU and 6 and 24 hours 
postoperatively. More determinations 
were done if necessary, depending on 
the circumstances of each case. A spe­
cialized analogue cardiac output com­
puter (Cor 100-A cardiac output com­
puter; Waters Instruments, Inc., Ro­
chester, MN) was used to perform 
these measurements. This computer is 
designed to display digitally the cardiac 
output from the indicator dilution 
curves. The computer obtains its elec­
trical input signals from the indicator 
dilution amplifier and integrates the 
area under the dilution curve from its 
starting point to the downslope side at 
75% of the peak. From this 75% of 
the peak, the computer analyses the 
assumed exponential decay of the curve 
to 50% peak height and extrapolates 
the final part of the curve.
Tricarbocyanine dye (Cardio-Green: 
Hynson, Westcott and Dunning Inc., 
Baltimore, MD) in a dose of 1.25 to 
2.5 mg was rapidly injected as a bolus 
into the CVP line, pulmonary arterial 
line or left atrial line while blood was 
being withdrawn from the radial artery 
through a densitometer cuvette (Cor 
100-A densitometer; Waters Instru­
ments Inc.) consisting of two cell op­
tical systems. The total dose of dye 
injected was kept below the recom­
mended limit of 2 mg/kg. The indi­
cator dilution curve was recorded on a 
single channel recorder (Cor 100-A 
recorder; Waters Instruments Inc.).
Three to five dye dilution curves 
were obtained in each instance. The 
mean of their values served to obtain 
a CO figure. CO was divided by the 
body surface area in order to obtain 
the Cl (L/min •m2).
Arterial blood gases were routinely 
obtained every 4 hours or more fre­
quently as indicated. Mixed venous 
blood was sampled from the pulmonary 
artery every hour, and 10 minutes be­
fore and after the Cl was determined. 
Heparinized syringes were used, em­
ploying a strict anaerobic technique. 
All samples were kept in ice to dimin­
ish oxygen consumption by red blood 
cells.
Blood-gas determinations were per­
formed in an automatic pH/blood-gas 
machine (Corning 175 automatic pH/ 
blood-gas system, Corning Medical, 
Corning Glass Works, Medfield, MA) 
which determined partial pressure of 
oxygen (Po2) with the Clark electrode. 
Oxygen from the blood diffuses across 
a polypropylene membrane; the plati­
num electrode (anode) causes break­
down of oxygen molecules, creating a 
flow of current to the silver electrode 
(cathode). The higher the Po2, the 
greater the current flow.
All results were fed into a calculator 
(Olivetti Underwood Programma Cal­
culator 101) with computerized memory 
to obtain the mean of the observations, 
standard deviations and standard errors. 
To calculate the correlation between 
Cl and Svo2 a program of coefficient 
of linear correlation was used, and to 
ascertain the confidence limits of the 
population parameters, Student’s f-test 
was used.
Results
In Fig. 1 individual Svo2 observa­
tions are plotted against Cl. All Svo2
FIG. 1—Significant correlation (r =  
0.78, P <  0.001) between mixed venous 
oxygen saturation and cardiac index.
values of less than 65% corresponded 
to a Cl of less than 2.5 L/min *m2 ex­
cept in one instance in patient no. 5. 
There was a statistically significant 
correlation among these values (r =  
0.78, P <  0.001).
A similar value (r =  0.67, P <  
0.001) was found when the Svo2 ob­
servations were correlated to Cl in 34 
patients reported by Boyd and his 
group.3 Similarly, Svo2 values below 
65% corresponded to a Cl less than 
2.5 L/min *m2 except in six isolated de­
terminations in which the Cl was 
normal.
The hemodynamic data from three 
patients who postoperatively had a low 
cardiac output syndrome (group 1) are 
presented in Table II. There were no 
deaths in this group. All were treated 
with inotropic agents which produced
T a b le  I I — G ro u p  1 P a t ie n ts  w ith  P ostoper-
a t iv e Low  C a rd ia c  O u tp u t S yn drom e
C a rd ia c
P a t ie n t in d e x ,
no. D ia g n o s is L /m in -m 2 Svo2, %
2 V SD  +  P D A 2.75 65
2.33 63
2.90 68
1.88 60
5 VSD 1.85 47
2.25 58
2.79 61
6 A S D -1 3.0 68
2.3 55
2.3 53
3.0 71
3.27 70
T a b le I I I — G ro u p  2 P a t ie n ts  w ith  N o rm a l 
P o s to p e ra t iv e  P erio d
P a t ie n t
no. D ia g n o s is
C a rd ia c
in d e x ,
L /m in -m 2 Svo2, %
i V SD 5.0 73
4 .4 71
3 VSD 5.52 78
3.84 75
3.58 71
4 V SD  +  P D A 3.3 79
4 .4 74
7 PS ( r e c u r r e n t ) 2 .99 68
3.17 63
8 A S D - 2 +  PS 3.46 80
4.13 79
4.16 80
9 V S D  +  A S D -2 3 .0 70
3.85 72
10 S u b a o rtic 4.4 79
fib ro m u s c u la r
s te n o s is 4.4 81
11 T e tra lo g y  o f 2.98 71
F a llo t 2 .97 71
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a good effect on the values of Svo2 
and Cl. Patient no. 2 showed transient 
improvement soon after inotropic sup­
port was begun, but when the dosage 
of the inotropic agent was increased a 
low Svo2 and Cl ensued. This was 
associated with a sharp increase in the 
pulmonary arteriolar resistances. Svo2 
and Cl correlated well in following the 
response to therapy in these patients 
(r =  0.86, P <  0.05).
The hemodynamic data from the pa­
tients who had an uncomplicated post­
operative period (group 2) are set forth 
in Table III. There was only one Svo2 
value below 65% in the presence of a 
normal Cl; the arteriovenous oxygen 
difference was slightly widened and the 
pulmonary and systemic resistances 
were normal. The only explanation that 
can be offered for this anomaly is that 
the patient’s temperature was elevated 
to 39.5°C at the time the values were 
determined.
In Table IV the Svo2 and Cl of 
groups 1 and 2 are compared.
Discussion
Our study confirms that serial de­
terminations of Svo2 can be used as 
a guide in estimating the CL From the 
data collected from patients having low 
cardiac output syndrome, it is evident 
that an Svo2 of less than 65% is in­
dicative of inadequate myocardial func­
tion. The increment in Svo2 following 
inotropic treatment correlated well with 
the Cl. A notable decrease in Svo2 
was accompanied by a paradoxical de­
pression in Cl following changes in the 
dosage of the inotropic agent in patient 
no. 2.
Oxygen exchange at tissue level is 
determined basically by the metabolic 
rate, the rate of capillary blood flow 
and the microcirculatory perfusion. 
There is a 10% increase in oxygen con­
sumption for each degree Celsius eleva­
tion in temperature above 37°C. The 
transit time of blood in the capillaries, 
together with the metabolic rate, will 
determine the amount of oxygen ex­
tracted from blood. The slower the 
rate at which blood circulates, the 
greater is the arteriovenous oxygen dif­
ference. Cardiac output is the major 
determinant of capillary flow rate and 
is therefore the major factor determin­
Table I V - Comparison of Groups 1 and 2
Group
Cardiac index, 
L/min-m2 Svo2, %
1 2.55 61.5
2 3.86 74.1
P value <0.025 <0.025
ing the oxygen content of venous 
blood.4
The Fick formula, as at (1) below, 
is based on the above set of principles; 
if the formula is rearranged, as at (2), 
it becomes apparent that mixed venous 
oxygen content is directly related to 
arterial oxygen content and inversely 
related to the ratio of oxygen uptake 
peripherally, and cardiac output cen­
trally.5
1. Cardiac 
output 
(mL/min)
oxygen uptake 
arteriovenous oxygen 
difference
2. Mixed venous 
oxygen content =
arterial
oxygen — oyxgen 
content uptake 
cardiac output
If we assume that the metabolic rate, 
pulmonary gas exchange and hemo­
globin concentration remain stable, the 
arterial oxygen content will be constant 
and Svo2 will vary directly with the CO.
If we exclude patients in septic shock 
who, despite a high metabolic rate, have 
a characteristically narrowed arterio­
venous oxygen difference as a result of 
decreased oxygen transport and utiliza­
tion,6 the average surgical patient, in a 
situation of low cardiac output second­
ary to a low intravascular volume, or 
pump failure, or both, will have a sta­
ble metabolic rate. In a normal flow 
state, metabolic activity is the major 
determinant of CO.7
Parr, Blackstone and Kirklin8 studied 
139 infants and children who under­
went cardiac surgery for congenital 
heart disease and concluded that death 
from acute cardiac failure could be 
more reliably predicted using the Cl 
and mixed venous oxygen tension 
(Pvo2) (normal, 40 mm Hg =  Svo2 
70%) together than by either value 
alone. A set of isobars, each represent­
ing a percentage of risk of death from 
acute cardiac failure, was constructed 
to correspond to simultaneous deter­
minations of Cl and Pvo2. According 
to these authors, a patient with a Cl 
of 1.8 and a Pvo2, of 30 mm Hg (ap­
proximate Svo2 60%) ran a risk of 
death from acute cardiac failure of 
less than 10%. In a patient with the 
same Cl but a Pvo2 of 20 mm Hg the 
risk was greater than 75%.
Some workers9,16 have stated that 
Pvo2 or Svo2 is of more clinical value 
than isolated determinations of cardiac 
output in managing the acutely ill pa­
tient.
We believe that Svo2 may predict 
within a matter of minutes a subsequent 
fall in Cl to critical levels. Although 
we lack sufficient technical data to 
substantiate this statement, we have 
found it to be true in two cases not in­
cluded in this report. However, from 
the data presented we are justified in 
concluding that Svo2 is a useful, prac­
tical means of estimating indirectly the 
C l in patients who are critically ill 
and that it correlates well with the re­
sponse to therapy.
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WILDER PENFIELD LECTURE
Nature and Management of Penetrating Head Injuries 
during the Civil War in Lebanon
Fuad Sami Haddad, md, frcs[c], facs*
During the recent war in Lebanon, at 
one hospital one fifth of all casualty 
admissions were patients with skull 
injuries associated with penetrating brain 
damage. Wounds inflicted by high 
velocity missiles carried the greatest 
mortality. The patient’s state of 
consciousness afforded the best guide 
to prognosis.
Craniotomy, when feasible, was 
found preferable to the accepted 
technique of craniectomy in the 
management of these cases. Thorough 
debridement and complete hemostasis 
are essential, and when these have 
been accomplished, deeply placed bony 
fragments may be left in situ with 
impunity. Traumatic aneurysms develop 
by no means rarely and therefore 
postoperative arteriography is advisable.
Durant la guerre qui s’est deroulee 
recemment au Liban, un cinquieme 
des blesses hospitalises dans un des 
hopitaux, etaient des patients ayant 
subit des blessures craniennes associees 
a une lesion perforante du cerveau.
Les blessures infligees par des 
projectiles a haute velocite ont entraine 
la plus forte mortalite. Le degre de 
conscience du patient a constitute le 
meilleur guide pour le pronostic.
Dans le traitement de ces patients 
la craniotomie, quand elle etait 
possible, a ete jugee preferable a la 
technique acceptee de craniectomie.
Un debridement adequat et une
Wilder Penfield lecture of the American 
University of Beirut, delivered at the 
Montreal Neurological Institute, Montreal, 
PQ, Oct. 29, 1976,
Supported by the Louise Massabky Fund.
*Chief neurosurgeon, Orient Hospital 
and clinical professor of neurosurgery, 
American University of Beirut, Lebanon
Reprint requests to: Dr. F.S. Haddad, 
Clinical professor of neurosurgery, 
American University of Beirut, PO Box 
113-6044, Beirut, Lebanon
hemostase complete sont essentiels et 
quand ceux-ci ont ete realises, les 
fragments osseux profondement 
enfonces peuvent etre laisses en place 
sans sequelle. Le developpement d’un 
anevrisme traumatique n’est pas rare et 
I ’arteriographie postoperatoire est done 
a recommander.
Older men declare war. But it is youth that 
must fight and die. And it is youth who 
must inherit the tribulations, the sorrow 
and the triumphs that are the aftermath 
of war.
—Herbert Hoover
Fifteen years ago Dr. Penfield himself 
addressed the Middle East Medical As­
sembly in Beirut as the first orator of 
this named lecture. In his introduction 
he said, “It makes me feel a little post­
humous to stand here and address you.” 
Today it is my duty to deliver the first 
posthumous Wilder Penfield lecture. 
Although he is no more with us in body, 
his spirit permeates not only the Mont­
real Neurological Institute but also 
many other centres whose directors or 
instructional staff trained under this 
unique teacher.
Out of the turmoil in Lebanon a wide 
experience of war surgery in general 
and of brain injuries in particular has 
accumulated. It is this experience that 
I wish to share with you.
At the outbreak of the war Beirut 
had about 1 million inhabitants. The 
fighting broke out between the eastern 
and the western sections. The Amer­
ican University Medical Center is part 
of the university and is located in the 
western section about 720 m from the 
large hotels where some of the fiercest 
fighting took place. The Orient Hospi­
tal, one of the two centres where I 
practise, was in the line of fire between 
the Holiday Inn and the Murr Tower. 
From the outset it was eliminated as a 
hospital and later was pillaged and 
burned. The American University Med­
ical Center together with four other
major hospitals, the Berbir Medical 
Center, the Makassed General Hospital, 
the Arab University Hospital and the 
Beirut General Hospital, drained the 
casualties from the western section of 
the city and its outskirts. While all five 
hospitals had neurosurgeons, only three 
were active.
Our centre was soon turned into a 
field hospital, receiving seriously injured 
patients, as well as a base hospital re­
ceiving referrals from the other four 
major city hospitals and outlying field 
hospitals where no neurosurgery was 
available. The western section was iso­
lated from the world. There was no air 
or sea traffic; land traffic was extreme­
ly difficult and supplies by this route 
were limited to a few essentials. Very 
rapidly we ran out of sheets, pillows, 
mattresses, gauze, bandages, important 
medications and other essential items. 
Early in the conflict we ran short of 
oxygen and anesthetic gases. On many 
occasions our anesthetists had to use 
ether and ambient air. Blood was often 
hard to obtain in spite of goodwill on 
the part of everybody. Many workers, 
nurses and doctors were stranded in 
the eastern section of the city and many 
others fled the country so that the effec­
tive staff quickly dwindled to about 
30% of its original number. Many had 
to live on the premises because it was 
impossible for them to go home. In 
short, the load soared while the ability 
to deal with it shrank, thus increasing in 
rapid progression the hardships and 
responsibilities of those who remained. 
Dr. Sami Nassar, my neurosurgical col­
league, and I were assisted by a very 
willing house staff of two to four resi­
dents who, in addition to working for 
the neurosurgical patients, had to at­
tend to the orthopedic and plastic sur­
gery cases, so that their average pa­
tient-day load was 175.
The casualties were often whisked in 
by truck or on armed jeeps while friends 
in the vehicle improvised sirens by fir­
ing their automatic high-powered rifles
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in the air. The injured were dumped in 
the emergency rooms, often with no 
identification other than what they 
themselves could furnish. Then would 
start the tedious and painful work of 
sorting. Those awake were shouting for 
attention and, if they were accompa­
nied, their attendants often threatened 
us with firearms. It was under such cir­
cumstances that the staff of the emer­
gency rooms laboured night and day 
and cared for the 5250 casualties re­
ceived during the period of this study. 
Those patients fit to be sent home re­
ceived attention in the emergency rooms 
and were later discharged. They num­
bered 3607 (68.7% of the total).
Those who needed observation were 
either transferred to other local hos­
pitals or to our medical centre. Those 
admitted to our centre numbered 1372 
(26.1%). The 271 (5.2%) patients dead 
on arrival were sent to the morgue. The 
injured who needed surgery were 
wheeled immediately to the recovery 
room which was sealed from family and 
fighters. It was there that the patients 
having priority for admission to the 
operating rooms were selected. Usually 
those with chest injuries and cardiac 
tamponade received highest priority, 
then those with injuries to large blood 
vessels, and third in order were patients 
with head injuries.
If two patients with severe head in­
juries were admitted simultaneously, 
the patient with the better prognosis 
was operated on first. For example, a 
patient with a dilating pupil was at­
tended to before one who already had 
bilateral dilated fixed pupils.
The limiting factor was the avail­
ability of staff. In one night 23 major 
operations were performed within 8 
hours. At another time 13 craniotomies 
were done by a single surgeon within a 
period of 36 hours.
Clinical Aspects of War Head
Injuries
This study covers the period of 
1516 months commencing at the be­
ginning of the civil strife on Apr. 13, 
1975 and ending on July 31, 1976. 
During that period 5250 casualties 
were brought to our emergency rooms. 
The lowest monthly number, 11 cases, 
was in August 1975 when there was 
a lull in the fighting. The highest 
monthly number, 1134 cases, was in 
June 1976.
In 1088 patients the diagnosis was 
not recorded, so that the diagnosis is 
known in only 4162. Of these, 527 
(12.7%) had injuries of the skull. In 
271 the skull injury was associated 
with penetrating brain injury. This 
group constituted 19.7% of all hos­
pital admissions and just over half 
of all the head injuries seen in the
emergency rooms. Information is 
available on 219 of these 271 patients. 
It is this last group on which the fol­
lowing discussion is based.
Classification of Clinical Material
Of the 219 patients 179 were male 
and 40 female, a ratio of 4.5:1. The 
reason for the preponderance of males 
is obvious. All the females were civi­
lians. Among the males there were 67 
civilians and 57 fighters; the latter 
were mostly militiamen, but a few 
were from the police and army. The 
fighting status of another 55 male 
patients was not identified. In other 
words there were about two civilians 
for each fighter. This proportion is 
more apparent than real, because 
many fighters were transported direct­
ly to military and other specialized 
hospitals. There were 131 shrapnel 
wounds and 76 bullet injuries; of the 
former 60 were in civilians and 38 in 
fighters, a proportion of 1.6:1. Of the 
bullet injuries 43 were in civilians and 
20 in fighters, a proportion of 2.1:1. 
The unexpectedly high proportion of 
civilians injured by bullets is due 
mainly to three factors: (a) snipers were 
very active and of 12 sniper victims 
only 1 belonged to the fighter cate­
gory; (b) stray bullets can be danger­
ous, as will be shown later, and all 15 
persons wounded in this way were civil­
ians; (c) there were five civilians 
among the six whose injury was due 
to attempted suicide or was accident­
ally self-inflicted at short range.
The youngest casualty was not even 
born; a woman in the eighth month of 
pregnancy was shot in the pelvis and 
the bullet lodged in the head of the 
fetus. The second youngest was 11 
days old; he was injured in his crib 
at home by a nearby rocket blast. The 
oldest casualty was a 70-year-old man. 
The majority belonged to the young 
adult group, between 15 and 30 years, 
which included most of the fighters. 
Half of the females seen were under 
15 years of age while more than half 
of the males were between the ages 
of 15 and 30 years.
Level of Consciousness
We grouped our patients in nine 
categories depending on the level of 
consciousness at the time of operation 
or admission (Table I). Of the 219 
patients, 22 could not be classified; 
16 were unclassified for lack of perti­
nent information and the other 6 
were simply described as being in coma, 
without other information being sup­
plied. As will be seen later this classi­
fication has an important bearing on 
prognosis.
Missile Velocity
A further classification was intro­
duced to compare the clinical and radio- 
logic aspects as well as the results of 
low- and high-velocity projectiles. The 
kinetic energy of a moving object is 
directly proportional to its mass and to 
the square of its velocity. Therefore it 
is militarily advantageous to increase 
the velocity of the bullet while keeping 
its mass reasonably low to allow the 
warrior to carry a larger supply of 
ammunition.
The rifles and submachine guns be­
ing used were of modern and varied 
construction delivering high speed bul­
lets with muzzle velocities ranging be­
tween 700 and 900 m/s.
The rockets used were of the anti­
personnel type with relatively low 
penetrating power, but at the time of 
impact they burst, scattering their 
shrapnel over an area approximately 
30 m in radius. Near the site of impact 
the shrapnel has a high speed which 
diminishes as the distance from the 
point of impact increases.
The velocity of a projectile is there­
fore extremely variable and depends on 
the type of weapon used and the dis­
tance travelled by the projectile. It de­
celerates from a maximum, which cor­
responds to the muzzle velocity for 
bullets or speed at the time and place of 
explosion for shrapnel, to a minimum 
reached somewhere on the course of 
the trajectory. It is therefore difficult 
to make a clear distinction between 
high- and low-velocity projectiles. We
T a b le  1— C la s s if ic a tio n  o f 197 P a t ie n ts  a c c o rd in g  to  L e v e l o f C onsc iousness  a t  T im e  o f O p e ra tio n
o r  A d m iss io n
S tag e L e v e l o f  co n sc iousness N o . of cases
1 F u lly  consc ious  and  w e ll  o r ie n te d 53
2 A g ita te d , not fu l ly  o r ie n te d , b u t res p o n d in g  s e n s ib ly  to  th e  sp oken  w o rd 25
3 N o t s p e a k in g  s p o n ta n e o u s ly  b u t res p o n d in g  to  th e  spoken  w o rd  w ith
m o n o s y lla b le s  o r  in c o h e re n tly 28
4 N o t res p o n d in g  to  th e  spoken  w o rd  b u t re s p o n d in g  to  p a in fu l s tim u li
by m o n o s y lla b le s 5
5 R esp o n d in g  to  p a in fu l s t im u li  by a p p ro p r ia te  m o vem en ts 13
6 R esp o n d in g  to  p a in fu l s t im u li  by in a p p ro p r ia te  m o vem en ts 16
7 R esp o n d in g  to  p a in fu l s t im u li  by d e c e re b ra te  m o vem en ts 23
8 No res p o n s e  to  p a in fu l s t im u li 17
9 D ead on a r r iv a l o r  s h o r t ly  a fte rw a rd s 17
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have considered as high-velocity pro­
jectiles only bullets, with the exception 
of the stray ones. We know that shrap­
nel near the site of explosion has enough 
energy to pierce the skull from side to 
side, but its velocity is certainly less 
than that of bullets fired from modern 
guns.
Sixty-one of the 76 bullet injuries 
were classified as the high-velocity 
type. The remaining 15 bullet injuries 
were due to stray bullets.
Our experience with stray bullets 
antedates the present war by many 
years. It is the custom in our country to 
shoot in the air at any important occa­
sion, especially marriages and funerals. 
It is also customary for people to be­
lieve that a falling bullet is harmless. 
This is certainly wrong and if it were 
not for air friction a bullet shot straight 
up would have at the time of its impact 
on the ground a speed equal to the muz­
zle velocity. In spite of this friction the 
velocity of a stray bullet is such that 
it can penetrate the skull of an adult.
Pathology
A low-velocity projectile produces 
minimal soft tissue reaction that at times 
is difficult to find under modern hair­
styles. Indeed, on two occasions it was 
totally missed in the emergency room, 
only to be discovered by the anesthetist 
during thoracotomy for tamponade. 
The skull is perforated in a manner 
similar to a burr hole, with indriven 
bone fragments lying in proximity to 
the site of entry (Fig. 1). The shrapnel 
lies further from the surface. We have 
noticed that the distribution of these 
bony and metallic particles depends on 
their size and weight, the larger and 
heavier particles usually being driven 
deeper. Therefore, if a larger particle is 
seen on the radiograph to be superficial 
to smaller particles, this often means 
that it has met some resistance, for 
example, a blood vessel, ependyma or 
a reflection of the dura. Low-velocity 
particles may hit the skull and not pene­
trate it, yet underneath the site of im­
pact the brain may be contused. An
FIG. 1—Effect of low-velocity missile 
causing perforation similar to burr hole.
example of this was the case of a 9- 
year-old girl, affected by a blast from 
a rocket, in whom three pieces of 
shrapnel struck the left parietal re­
gion. When a craniotomy was per­
formed it was found that two of the 
three shrapnel fragments had penetrated 
the skull and brain. The third was 
lodged in the outer table of the skull 
beneath which the inner table was in­
tact, yet there was an area of moderate 
contusion subjacent to it affecting a 
volume of cerebral tissue of almost 
2 mL.
High-velocity missiles produce a to­
tally different picture. The soft tissue 
suffers severe damage; often there are 
large gaping wounds especially at the 
site of exit; in at least 23 cases brain 
extruded through the exit wound. Brain 
extrusion was observed in only two 
cases of injury caused by a low-velocity 
missile, in both at the site of entry. 
Because of its greater energy the high- 
velocity missile often traverses the skull 
from side to side. In some cases it comes 
to lie against or within the bone of the 
side opposite the point of entry. Few 
bone chips are seen near the entry 
wound but many are driven deep into
FIG. 2—Effect of high-velocity missile. 
Entry and exit sites are associated with 
multiple linear fracture. White arrow indi­
cates fractures at entry site and black ar­
rows indicate fractures at exit site.
FIG. 3—Effect of tangential impact. 
Bone chips have been driven deep into 
brain.
the brain. At the exit site the skull 
seems to have burst. Multiple linear 
fractures radiate from the sites of en­
try and exit. They are longer, more 
numerous and slightly wider at the site 
of exit (Fig. 2). The dura is lacerated 
and its edges are shredded, with tears 
extending several centimetres away from 
the points of entry and exit. The brain 
is severely lacerated, contused and de­
vitalized along the track of the projec­
tile and immediately surrounding it. 
Often hair is seen a few centimetres 
deep in the severely edematous brain.
A third type of injury that has re­
ceived little attention in the literature 
is the tangential injury (18 cases). The 
higher the velocity of the projectile, the 
more sizeable and serious is the lesion. 
One patient had a severely lacerated 
wound of the scalp with an intact skull 
beneath it. He was in deep coma upon 
arrival at the operating room. Cranio­
tomy revealed severe contusion of the 
brain just beneath the area of impact 
and an intracerebral hematoma which 
had burst into the subdural space. In 
other patients a depressed fracture is 
visible at the site of impact and, if the 
energy is greater, bone chips may be 
driven in as far as the ventricle (Fig. 
3). This type of injury can do great 
harm, especially if it crosses the vertex 
of the skull, when it produces spastic 
paraplegia.
Besides the contusion, laceration and 
destruction of brain tissue, which con­
stitute the common denominator of 
head injuries in wartime, other specific 
pathologic findings were observed: 
there were 23 hematomas, 3 epidural, 
12 acute subdural and 8 intracerebral. 
One patient had an intracerebral hema­
toma associated with an acute subdural 
hematoma.
In eight patients the large venous 
sinuses were involved and in another 
eight the ventricular system was af­
fected.
In nine cases intracranial air was seen 
on roentgenograms. Air usually en­
ters through the paranasal air cells and 
is often accompanied by rhinorrhea. 
However, it may follow the track of 
the foreign body in which case it is an 
indication that the intracranial pressure 
is not raised.
We received five patients with brain 
abscess. All were operated upon. Three 
of these patients had had minor shrap­
nel injuries deemed by their physicians 
to be insignificant and no debridement 
was carried out. The abscesses were 
diagnosed 20, 25 and 30 days, respec­
tively, after the injury. A fourth pa­
tient had a blast injury to her forehead 
involving both frontal lobes. Superficial 
debridement was performed by a gen­
eral surgeon who did not close the dura. 
Shortly afterwards pus started to ooze 
from the wound. She was operated on
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44 days later and a bifrontal abscess 
reaching the ventricles was excised. The 
last case was that of a young man who 
was sitting on his veranda when he 
felt a severe jolt in his head and blood 
trickling over his face. He drove his 
car to the emergency room where he 
was found to have a bullet lodged in 
the left temporal lobe. The wound of 
entry in the right frontal region was 
thoroughly debrided through a cranio­
tomy. The patient apparently recovered 
and was discharged, but 1 month from 
the time of injury he returned complain­
ing of headache and convulsions. An 
abscess around the bullet was discov­
ered. It was excised and the bullet re­
moved. The final result was satisfactory.
Aneurysms
Traumatic aneurysms are extremely 
rare. The survey published in 1966 by 
the central registry of the cooperative 
study of intracranial aneurysms and 
subarachnoid hemorrhage,1 based on 
6368 cases, just mentions trauma as an 
etiologic factor in aneurysm formation. 
This type of aneurysm does not appear 
among the complications listed in a 
reported series of 879 penetrating 
wounds of the brain incurred during 
the Korean conflict.2 Hammon3 re­
ported 2187 cases of penetrating 
wounds of the brain treated in Vietnam, 
in only 2 of which an aneurysm was 
diagnosed; both patients were evacu­
ated to Walter Reed Hospital, Wash­
ington, for surgery. In 1968, Burton, 
Velasco and Dorman4 reported one case 
of traumatic aneurysm. They reviewed 
the literature and collected an addi­
tional 10 cases sufficiently well docu­
mented to justify their classification as 
traumatic aneurysms. Most of these 
were in civilians and the injury was a 
fracture of the skull.
This entity was drawn to our atten­
tion by two patients very early in the 
fighting. The first had a blast injury to 
the face from explosion of a land mine. 
During his recovery he had inappropri­
ate antidiuretic hormone secretion; 
arteriography revealed an aneurysm of 
the external temporal artery. This was 
excised. By mere coincidence, on the 
same day a 59-year-old man was in­
jured by a stray bullet while asleep in 
bed. The bullet had perforated the 
shutter of his window, penetrated his 
skull and lodged in the right temporal 
area. The wound was debrided 8Vi 
hours later and the bullet extracted. He 
did well for 8 days and was about to be 
discharged when he suddenly started to 
suffer from headache and became 
drowsy. Arteriography revealed an 
aneurysm on a branch of the middle 
cerebral artery (Fig. 4). The aneurysm 
was excised. These cases were eye- 
openers, especially since berry aneur­
ysms are extremely rare in the Middle 
East, where for every aneurysm seen 
20 brain tumours are diagnosed. These 
cases made us decide to carry out arte­
riography routinely on every patient be­
fore discharge from hospital. This 
policy led to the discovery of three addi­
tional aneurysms and two carotid 
cavernous sinus fistulas. After the con­
clusion of this study we found three 
more aneurysms and one carotid ca­
vernous sinus fistula within 2 months. 
In all, we have collected a dozen cases 
of traumatic aneurysm of the cerebral 
arteries, which will be the subject of 
another communication.
Treatment
Most of the acute cases were attended 
to and definitive surgery was carried 
out within minutes to several hours after 
the injury. The average time between 
injury and operation was 5 hours and 
20 minutes. An indication of the effi­
ciency of the medical staff is that 30 
patients were operated upon a few min­
utes to a few hours prior to their formal 
admission to hospital.
The treatment advocated for such 
injuries is by now standard: debride­
ment, hemostasis and closure of the 
dura. Debridement is most important 
and should be thorough. It should in­
clude removal of all devitalized tissue 
and foreign bodies whenever possible. 
After evacuation of all clots present and 
debridement of the macerated and 
severely contused brain, the line of de­
marcation becomes obvious. The un­
healthy brain tissue is extremely ede­
matous and can be easily suctioned. 
The brain does not relax unless the clots 
are removed, the damaged tissue is 
excised and all the bleeding arrested. 
Thorough, continuous irrigation is a 
great help. Unlike Hagan,5 in his report 
on his experience from the Vietnam 
war, we found no untoward effect from 
retained bone fragments. Although we 
spared no effort in each case to remove 
all the bone fragments, these were in-
FIG. 4— Arteriogram showing traumatic 
aneurysm on branch of middle cerebral 
artery.
advertently left behind in 14 cases, that 
is in 8.5% compared with 13.4% in 
Hagan’s series. No further surgery was 
carried out on our patients (Fig. 5). 
Although this is against all conventional 
teaching,610 the case load was such that 
we had no time to reoperate especially 
when these patients were doing well. 
Being the only referral centre to which 
these patients could return, we relied 
on a good follow-up. This provided a 
new control series. Most writers have 
noted that should an abscess form it 
will develop within 3 to 6 weeks of in­
jury. This is confirmed by our experi­
ence. Our follow-up extends for 3 to 
15 months and we have not seen a 
single brain abscess in cases in which 
bone fragments were left behind. Fur­
thermore, it is more logical to operate 
on the occasional brain abscess than to 
reoperate on all patients with retained 
bone chips. We believe that a thorough 
debridement of devitalized brain tissue 
and removal of accessible foreign 
bodies, as well as thorough and continu­
ous irrigation of the wound, is much 
more important than groping in normal 
brain for retained bone or metallic 
fragments.
We did not attempt to remove metal­
lic fragments unless they were en­
countered or found to be moving in 
roentgenographic studies. Such mo­
tion means that the fragment is within a 
ventricle, a hematoma, or an abscess.
After removal of what appears to be 
a very large amount of macerated brain, 
it is surprising how relatively little de­
ficit the patient has.
Perfect hemostasis is the second im­
portant step in technique. It certainly 
is unwise to close a head wound when 
the brain is still tense. In such cases, it 
is advisable to follow the track of the 
missile or to perform a second cranio­
tomy over the area where it is lodged 
and meet the track of entry.
The third important step in technique 
is watertight closure of the dura, pri­
marily if possible or by the use of a 
patch obtained from the epicranium or
FIG. 5— Two bone fragments inadver­
tently left in place. No further surgery was 
needed.
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the temporal fascia. In cases of leakage 
of cerebrospinal fluid, immediate oper­
ation is advisable even in the presence 
of infection. There is no point in wait­
ing until the infection subsides or comes 
under control. Precious time is thus 
lost as in the case of one of our col­
leagues. He heard a knock at the door 
of his home. As he opened it he was 
shot by the callers who immediately 
ran away. The bullet grazed his left 
temporo-occipital area. He was trans­
ported to a hospital in Tripoli where an 
operation was performed without clos­
ing the dura. His condition deteriorated 
and he was transferred to our hospital, 
unconscious and responding to painful 
stimuli by movement of one leg. He had 
meningitis caused by Escherichia coli. 
We gave him huge doses of antibiotics. 
His meningitis improved but was not 
cured. We procrastinated. He had a 
relapse and died. Another patient was 
struck tangentially by a bullet on the 
mastoid area. Six days after surgery 
cerebrospinal fluid started to leak from 
the wound and he had a fever of 40°C. 
He underwent surgery immediately and 
the rent was sutured. He recovered.
It is frequently advised that large 
craniectomies should be performed in 
an attempt to reduce the incidence of 
infection, to provide space for decom­
pression and to shorten the operation. 
However, these operations usually leave 
ugly deformities and necessitate a cra­
nioplasty with its associated risks, tem­
porary disability and expense. Early in 
the fighting we decided to operate 
through a craniotomy, at times large 
enough to include the wounds of entry 
and exit if these were on the same side. 
Craniectomy was performed only in 
cases in which the bone was shattered 
beyond the possibility of reconstructing 
the skull and in areas covered with 
muscle as in the temporal and subocci- 
pital regions. As will be seen later, 
craniotomies do not carry a higher risk 
in spite of the abhorrently filthy state 
of the wounds on admission. The only 
bone flap we lost was a frontal one 
where there was already an infected 
frontal sinus. Since we do not fix the 
bone flap in place we do not lose the 
decompressive effect of a craniectomy. 
Moreover, we find it is more expediti­
ous to carry out a craniotomy, because 
there is normal dura subjacent to the 
bone being sawed and because there is 
much more room to work than is usual­
ly afforded by a craniectomy. We have 
also found that the defect in the scalp 
can be closed more easily because of the 
larger flap and the presence of ample 
tissue to patch the dura.
Results
To assess the results we placed the 
patients in three categories: (a) those
who died upon or very shortly after 
admission (18 patients); (b) those who 
were not operated on either because 
their condition did not necessitate an 
operation or because they were obvious­
ly dying (37 patients); and (c) the 
majority, who underwent surgery (164 
patients).
Of those who were not operated on, 
11 died and 26 recovered. Of the 164 
patients who were operated on, 45 
died. In other words about one third 
of the patients admitted to hospital died. 
This high mortality is due to several 
reasons: (a) none of the patients wore 
a helmet; (b) patients arrived in the 
operating theatre very shortly after 
their injury, sometimes within minutes, 
so there was no time for natural se­
lection; (c) we operated on 17 patients 
in deep coma who did not react to any 
stimulus (12 of these had dilated fixed 
pupils) and who probably would not 
have been operated on by other sur­
geons; (d) the unusual forms of head 
injury caused by high-velocity missiles; 
(e) the very difficult conditions under 
which the hospital was operating, lack­
ing oxygen, blood, respirators and 
other essential supplies.
A number of factors affected morta­
lity. Velocity of the projectile was the 
most important factor. Of 61 casualties 
suffering from injury due to high-veloc­
ity missiles, 28 (47.5%) died, while of 
158 casualties in which the missile was 
of low-velocity 40 (25.3%) died.
The latter included all shrapnel injuries, 
some of which were detected clinically 
and were shown by radiologic studies 
to have been high-velocity shrapnel in­
juries. If this were taken into considera­
tion the difference in mortality would 
be even greater than these figures in­
dicate.
When missiles cross the midline 
affecting both hemispheres the mortal­
ity increases. In our series there were 
45 such cases; of these 23 (51.1%) pa­
tients died, which is higher than the 
overall mortality. The higher mortality 
is not really due to the missile crossing 
the mid-line but to its high velocity.
We tried to determine whether ooz­
ing of the brain through the skull 
wounds carried a worse prognosis. We 
had 29 such patients of whom 14 
(48.2%) died. This condition also was 
more common in patients wounded by 
high-velocity missiles.
Injury to the ventricles did not seem 
to increase the mortality (three of eight 
cases, 37.5%).
Also air within the skull did not seem 
to have any effect on the mortality (3 
of 10 cases, 30%).
Because we advise craniotomy rather 
than craniectomy it is only fair to 
compare the mortalities of the two pro­
cedures. Of 59 patients subjected to 
craniotomy, 12 (20.3%) died; of 89 pa­
tients who underwent craniectomy, 26 
(29.3%) died. The higher incidence 
for craniectomy is only apparent. The 
high-velocity bullets, which themselves 
carry a higher risk, shatter the skull and 
thus necessitate a craniectomy. The 
situation is similar in posterior fossa 
injuries.
As well as the velocity of the projec­
tile, the state of consciousness at the 
time of surgery is most important in de­
termining mortality (Fig. 6), and is 
directly related to the velocity of the 
projectile. The deeper the coma the 
gloomier is the prognosis. Of the 16 
patients who could not be classified be­
cause of lack of information, 8 died, 
and of the 6 patients described as being 
in coma without further specification, 
3 died. Of the total of 124 patients clas­
sified as being in stages 1 to 5 of cons­
ciousness (namely from fully conscious 
to responsive to painful stimuli by ap­
propriate movements) only 8 patients 
died (mortality, 6.4%).
Of the total of 56 patients who were 
in stages of deep coma (ranging from 
response to painful stimuli by inappro­
priate movements to no response to 
painful stimuli), 37 died (mortality, 
66%). Of those who recovered there 
was one child with bilateral dilated 
fixed pupils and four patients with uni­
lateral dilated pupils. Of those who 
died, 11 had bilateral dilated fixed 
pupils and 8 had unilateral dilated fixed 
pupil prior to operation.
Conclusions
About 10% of all casualties seen 
during the study period had an injury 
to the skull and a little more than half 
of them suffered a penetrating brain 
injury and were admitted to hospital.
More civilians were victims of bullets 
than was to be expected, owing to 
snipers, stray bullets and apparent 
suicide attempts.
There were three types of injury—
FIG. 6—Histogram showing mortality 
rate related to different stages of cons­
ciousness (see Table I for classification of 
stages).
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To control upper 
gastrointestinal bleeding 
due to stress ulcer, 
hemorrhagic gastritis, stress 
gastritis, bleeding gastric 
erosions, duodenal and 
gastric ulcers...
_New
Tagamet
(cimelidine) injection
The 'Tagamet'effect
The precise mechanism by which 'Tagamet' controls upper g.i. bleeding is not 
understood, although several theories exist, of which these seem the most likely.
■  Significantly Inhibits Gastric Acid Secretion,
raising the pH of the stomach to inactivate pepsinogen (thereby decreasing pepsin which is 
known to digest protein in an acidic environment) and possibly promoting clot formation.
■  May Decrease Gastric Mucosal Blood Flow
due to inhibition of acid secretion, allowing the body's hemostatic mechanism 
to control bleeding.
■  May Prevent Further Damage to the Mucosa
by acid through blockade of histamine H2 receptors, thereby encouraging 
healing of the mucosal injury.
65 patients in whom other non- 
surgical measures had failed, or 
for whom surgical intervention 
was considered impossible or 
unduly hazardous, were 
evaluated; the results are 
reported in the adjacent table.1
C om p lete
S u ccess
P a rtia l
S u cce s s
C o m p lete  
& P artia l 
S u cce ss
F a ilu re
Heavy 65% 15% 80% 20%
Moderate 52% 22% 74% 26%
Subacute/recurrent 45% 25% 70% 30%
1. Data on file, SK&F Medical Department
The H2 Receptor Antagonist-A major clinical 
advance for uncontrolled g.i. bleeding
SMITH KLIME SrFREMCH CANADA LTD.
Montreal, Quebec H4M 2L6
Tagamet®
(cimetidine SK&F)
Tablets
Injection
Prescribing Information
(Product Monograph available to practitioners on request)
ACTION
Cimetidine competitively inhibits the action of histamine 
at the histamine H2  receptor, and thus represents a new 
class of pharmacological agents, the histamine 
H2 -receptor antagonists.
Cimetidine is not an anticholinergic agent. Studies have 
shown that cimetidine inhibits both daytime and nocturnal 
basal gastric acid secretion. Cimetidine also inhibits 
gastric acid secretion stimulated by food, histamine, 
pentagastrin, caffeine and insulin. Its ability to inhibit 
gastric acid secretion via this unique mechanism of action 
permits a new approach to the treatment of acid-related 
gastrointestinal disorders.
Cimetidine is absorbed rapidly after oral administration. 
The plasma half-life is approximately two hours. The 
principal route of excretion is the urine.
The degree and duration of inhibition of basal and 
stimulated gastric acid secretion are dose-related; the 
data suggest that 80%  or higher inhibition throughout a 
2 4  hour period can be achieved by a dosage regimen of 
3 0 0  mg four times daily given with meals and at bedtime. 
Cimetidine 3 0 0  mg reduced total pepsin output as a result 
of the decrease in volume of gastric juice. The drug had no 
effect on the rate of gastric emptying or lower esophageal 
sphincter (LES) pressure.
INDICATIONS AND CLINICAL USE
Tagamet® (cimetidine) is primary therapy for conditions 
where the inhibition of gastric acid secretion is likely to be 
beneficial, such as:
□  Duodenal ulcer
□  Non-malignant gastric ulcer
□  Gastroesophageal reflux disease
□  Management of upper gastrointestinal hemorrhage
□  Pathological hypersecretion associated with Zollinger- 
Ellison Syndrome, systemic mastocytosis and multiple 
endocrine adenomas.
CONTRAINDICATIONS
There are no known contraindications to the use of 
'Tagamet' (cimetidine).
PRECAUTIONS
Use in Pregnancy: Nursing Mothers:
There has been no experience, to date, with use of 
'Tagamet' (cimetidine) in pregnant patients. Reproduction 
studies performed in rats, mice and rabbits have revealed 
no evidence of impaired fertility or harm to the fetus due to 
'Tagamet'. Studies have demonstrated that 'Tagamet' 
crosses the placental barrier. It is also secreted in the milk 
of animals. 'Tagamet' should be used in pregnant or 
lactating patients or women of child-bearing potential only 
when, in the judgement of the physician, the anticipated 
benefits outweigh the potential risks.
Use in Children
Clinical experience in children is limited. Therefore, 
'Tagamet' (cimetidine) therapy cannot be recommended 
for children unless, in the judgement of the physician, 
anticipated benefits outweigh the potential risks. In very 
limited experience, 20 -40  mg kg per day has been 
administered in divided doses by mouth or intravenously. 
Use in Impaired Renal Function
Because 'Tagamet' (cimetidine) is excreted by the kidney, 
a reduced dosage should normally be administered to 
patients with impaired renal function. (See DOSAGE AND 
ADMINISTRATION)
Drug Interactions
Studies in animals revealed no pharmacological inter­
action between 'Tagamet' and commonly used drugs. No 
significant interactions have been observed in man.
ADVERSE REACTIONS
Mild and transient diarrhea, muscular pain, dizziness and 
rash have been reported in a small number of patients 
during treatment with 'Tagamet' (cimetidine). There have 
been reports that a few patients have developed mild 
nonprogressive gynecomastia during prolonged treatment. 
No evidence of induced endocrine dysfunction was found, 
and the condition remained unchanged with continuing , 
'Tagamet' treatment. Some increases in plasma creatinine 
and serum transaminase have been reported.
OVERDOSAGE
In cases reported to date, involving oral ingestion of up to 
10 grams of 'Tagamet' (cimetidine), no untoward effects 
have been noted, and recovery has been uneventful. 
Treatment
The usual measures to remove unabsorbed material from 
the gastrointestinal tract, clinical monitoring and 
supportive therapy should be employed. Studies in animals 
indicate that assisted respiration may be of value and that 
any tachycardia may be controlled by administration of a 
B-blocker.
DOSAGE AND ADMINISTRATION
ADULTS:
(Experience with 'Tagamet' in children is limited and it has 
not been evaluated in clinical studies—see PRECAUTIONS) 
In clinical studies 'Tagamet' (cimetidine) has been used in 
divided doses of up to 2 4 0 0  mg/day.
DUODENAL ULCER, NON-MALIGNANT 
GASTRIC ULCER, AND GASTRO­
ESOPHAGEAL REFLUX DISEASE
The recommended adult oral dosage for duodenal ulcer, 
non malignant gastric ulcer and gastroesophageal reflux 
disease is 300 mg four times a  day. with m eals and at 
bedtime.
While healing with 'Tagamet' often occurs during the first 
week or two, treatment should be continued for at least 
four weeks unless healing has been demonstrated by 
endoscopic examination.
Some patients may require concomitant antacids until 
symptoms disappear.
MANAGEMENT O F UPPER 
GASTROINTESTINAL HEMORRHAGE
In patients with upper gastrointestinal bleeding of 
sufficient magnitude as to require blood transfusions, 
'Tagamet' should be administered parenterally, 
preferably by intravenous injection or intermittent 
infusion or, if necessary, by constant intravenous infusion 
until 4 8  hours after active bleeding has stopped. At this 
time an oral dosage regimen may be instituted and should 
be continued for at least 7 -10  days.
Recommended dosage for oral administration:
3 0 0  mg every 6 hours.
Recommended dosage for intramuscular injection 
administration:
3 0 0  mg every 6 hours. Inject the entire contents of a 2  ml 
ampul.
Recommended d osage for intravenous injection 
administration:
3 0 0  mg every 6  hours. Dilute 'Tagamet' in Sodium 
Chloride Injection (0.9% ) (or other compatible i.v. 
solution) to a total volume of 2 0  ml and inject over 1-2 
minutes.
Recommended dosage for intermittent intravenous 
infusion administration:
3 0 0  mg every 6  hours. Dilute 'Tagamet' 3 0 0  mg in 1 0 0  ml 
of Dextrose Injection (5%) (or other compatible i.v. 
solution) and infuse over 15-20 minutes.
In some patients it may be necessary to increase dosage. 
When this is necessary, the increases should be made by 
more frequent administration of a 3 0 0  mg dose, but total 
daily dosage should not exceed 2 4 0 0  mg.
Recommended dosage for constant intravenous 
infusion administration:
2 mg/kg/hour. Dilute 'Tagamet' for injection in a 
compatible i.v. solution, such as Sodium Chloride Injection 
(0.9% ) or Dextrose Injection (5% or 10%). In some patients 
it may be necessary to increase dosage. Dosage should 
usually not exceed 4  mg/kg/hour.
DOSAGE ADJUSTMENT FOR PATIENTS WITH 
IMPAIRED RENAL FUNCTION
Patients with severely impaired renal function have been 
treated with 'Tagamet'. However, such usage has been 
very limited. On the basis of this experience the 
recommended dosage is 3 0 0  mg every 12 hours orally or 
by intravenous or intramuscular injection. Should the 
patient's condition require, the frequency of dosing may be 
increased to every 8  hours or even further with caution. In 
severe renal failure accumulation may occur and the 
lowest frequency of dosing compatible with an adequate 
patient response should be used. Hemodialysis removes 
circulating cimetidine, therefore, the timing of dosage 
should be adjusted to the dialysis schedule.
PATHOLOGICAL HYPERSECRETORY 
CONDITIONS
(e.g., Zollinger-Ellison Syndrome)
Recommended adult oral dosage:
3 0 0  mg four times a day with meals and at bedtime. In 
some patients it may be necessary to administer 3 0 0  mg 
doses more frequently to control symptoms. Dosage should 
be adjusted to individual patient needs, but usually should 
not exceed 2400 mg per day. If intravenous administration 
is required, the dosage schedule should be the same as 
that recommended for control of upper gastrointestinal 
bleeding.
SPECIAL CASES
In patients in whom control of gastric acid secretion is 
desirable, the recommended oral dosage of 'Tagamet' is 
3 0 0  mg four times a day, with meals and at bedtime. If 
intravenous administration is required, the dosage 
schedule should be the same as that recommended for 
control of upper gastrointestinal bleeding.
STABILITY OF INJECTABLE FORM
'Tagamet' injection, when added to or diluted with most 
intravenous solutions, such as Sodium Chloride injection 
(0.9% ) or Dextrose injection (5% or 10%), is stable for 48 
hours at normal room temperature ’Tagamet' Injection 
should not be refrigerated.
AVAILABILITY
Tablets:
Pale green circular biconvex film coated tablets, each 
containing cimetidine 3 0 0  mg (monogrammed SKF T13). 
Bottles of 100 tablets.
Injection:
Each 2  ml dose contains cimetidine HCl equivalent to 3 0 0  
mg of cimetidine, in Sterile Water for Injection. Preserved 
with phenol, 0 .5% . Ampuls of 2  ml, packaged in 10's.
Cl/fX SM ITH  KLIN E & FR EN C H  C A N A D A  LTD. 
O f  l C F l  M ONTREAL, Q U E B EC  H 4M  2L6
TM;M18CA
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high velocity, low velocity and tangen­
tial.
Craniotomy whenever feasible was 
found to be superior to the accepted 
technique of craniectomy. It affords a 
wider field, better exploration and 
greater decompression and does not 
have the disadavanlage of requiring a 
second operation for cranioplasty. The 
mortality and morbidity are no higher 
than for craniectomy. We strongly rec­
ommend its use.
Retained fragments of bone are not 
as dangerous as is widely believed. If a 
thorough debridement of the brain is 
carried out with perfect hemostasis, one 
or two deeply placed bone fragments 
have no deleterious effect, at least for 
the period of our follow-up ranging 
from 3 to 15 months. Patients with re­
tained bone fragments should be close­
ly observed for at least 6 weeks.
Traumatic aneurysms are not as rare 
as the literature indicates. Routine post­
operative arteriography is advised since 
it will disclose aneurysms and lead to 
definitive surgery.
The most important element in mor­
tality is the high velocity of the projec­
tile at the time of impact and the most 
important prognostic factor is the state 
of consciousness of the patient at the 
time of surgery.
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ORIGINAL CONTRIBUTIONS
Annular Pancreas:
A New Classification and Clinical Observations
D.W.B. J ohnston , m d , frcs[c ], facs*
Seven cases of annular pancreas are 
described. In all the diagnosis was 
confirmed at autopsy or at operation. 
This study provides a new, original 
classification for annular pancreas.
Two distinct subtypes are described: 
type 1, extramural and type 2, intra­
mural. In type 1 the presenting 
symptoms are those of high gastro­
intestinal obstruction. In type 2 the 
symptoms are those of duodenal 
ulceration. For extramural obstructing 
annuli surgical intervention, if indicated, 
should be a bypass procedure; for 
intramural types with duodenal ulcer, 
subtotal gastrectomy with or without 
vagotomy is the procedure of choice.
On decrit sept cas de pancreas 
annulaire. Dans tous les cas, le 
diagnostic a ete confirme a I'autopsie 
ou a I'operation. Cette etude a fait 
naitre une classification nouvelle et 
originale des cas de pancreas annulaire 
ou Ton distingue deux sous-types: 
le type 1 ou extramural et le type 2 ou 
intramural. Dans le type 1, les 
symptomes sont ceux d’une obstruction 
gastrointestinale haute. Dans le type 
2, les symptomes sont ceux de 
I’ulcere duodenal. Pour un etranglement 
extramural, I'intervention chirurgicale, 
lorsqu'elle est indiquee, consiste a 
pratiquer une anastomose; pour les 
types intramuraux avec ulcere 
duodenal, une gastrectomie subtotale, 
avec ou sans vagotomie, constitue 
I’intervention de choix.
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Annular pancreas is a congenital ab­
normality which Ravitch and Woods1 
claim was first described by Ecker2 
in 1862.
Under normal conditions the head 
of the pancreas lies in the arms of 
the duodenum. When congenital an­
nular pancreas exists the position is 
reversed; the duodenum lies in, and 
may be constricted and distorted by, 
an encircling arm of pancreatic tissue. 
This anomaly is generally believed to 
result from failure of the ventral lobe 
of the pancreas to rotate with its duct.3 
As a result the duct is carried dorsally 
and to the right, leaving a ring of pan­
creatic tissue encircling the second part 
of the duodenum. In addition, aberrant 
pancreatic tissue accounts for another 
type of annular formation.4
As a result of our experience in 
seven cases we believe that annular 
pancreas comprises two distinct sub- 
types, not previously recognized, that 
can be classified as: type 1, extramural 
and type 2, intramural.
In type 1 (Fig. 1) the ring of pan­
creatic tissue lies on the muscular wall 
of the duodenum and is covered by a 
thin layer of peritoneum. A definite 
plane of cleavage may be established 
between the annulus and the duo­
denum. This type always has a main 
duct which sweeps dorsally and to the 
right around the duodenum to empty 
into the common bile duct or into the 
main pancreatic duct.5
In type 2 annulus (Fig. 2) the pan­
creatic tissue lies buried in the wall 
of the duodenum; any attempt to dis­
sect out the annulus results in opening 
the lumen of the duodenum. This type 
of annulus has no main ductal system 
but is provided with a network of small 
canaliculi.
It has been our experience that type 
1 is usually associated with a dilated 
duodenum or megalobulbus and pro­
duces symptoms of high intestinal ob­
struction. Type 2, however, is usually 
associated with duodenal ulceration 
and the clinical symptoms are due to 
the ulcer rather than to the annulus.
The clinical and pathological find­
ings in seven cases of annular pancreas 
are presented to support this new 
classification.
Case Reports
Case 1.— A 57-year-old man complained
FIG. 1—Extramural annulus. FIG. 2—Intramural annulus.
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of epigastric distress of 5 years’ duration 
and shortness of breath on exertion. 
The only abnormality on physical ex­
amination was obesity. Radiologic exam­
ination revealed an ulcer in the first 
part of the duodenum; irregularity of the 
second part of the duodenum did not sug­
gest a specific diagnosis (Fig. 3). Seven 
months later the patient was again ad­
mitted complaining of recurrent attacks 
of epigastric pain. He was not vomiting and 
his weight was 108 kg. Roentgenographic 
findings were identical to those seen previ­
ously. On this occasion a diagnosis of 
annular pancreas was made. Surgery was 
considered, but we believed this patient 
should first lose weight and be brought 
into a more favourable operative condi­
tion. Three months later he was admitted 
again after having lost 18 kg while on a 
low calorie diet. He was still complaining 
of epigastric pain and had had one bout 
of melena and hematemesis. At operation 
the duodenum was found to be bound 
down in its second part by a wide band of 
hardened pancreatic tissue. In view of his 
history of pain and hematemesis and 
melena, a subtotal gastrectomy was done. 
When a finger was inserted into the open 
end of the duodenum it was found that 
the whole of the second part of the 
duodenum was compressed by an extrinsic 
and an intrinsic mass; the wall of the 
duodenum felt hard and corrugated. The 
patient made a good recovery following 
this operation. He was seen again 12 
months later complaining of epigastric 
distress radiating through to the back and 
into his chest. He had had a black stool 
on two occasions. Roentgenography re­
vealed the presence of a stomal ulcer. 
A transabdominal vagectomy was car­
ried out. The patient died 14 days later 
of pulmonary embolism. Autopsy con­
firmed the cause of death and examina­
tion of the duodenum showed an annular 
pancreas of the intramural type.
Case 2 .—A 66-year-old man was ad­
mitted to hospital complaining of vomit­
ing and weight loss for 7 weeks. The 
vomiting had become progressively worse 
during that period; in the preceding week 
he had retained no food whatsoever. The 
vomitus was grey and occasionally bile- 
tinged. Physical examination was essen­
tially negative except for the classical 
findings of dehydration. Examination of 
the abdomen showed peristaltic waves, 
beginning in the left upper quadrant and 
passing across to the right of the um­
bilicus. The left upper quadrant appeared 
to be fuller than the right upper quadrant 
and a gastric splash was easily detected. 
Roentgenography revealed dilatation of 
the duodenal bulb with gross retention of 
the barium in the stomach after 2 hours 
(Fig. 4). A diagnosis of annular pancreas 
was made. At operation performed 7 days 
after admission, a large mass was found 
in the loop of the duodenum. The pylorus 
was easily located and the grossly dis­
tended part of the duodenum was pal­
pated. The cystic duct and the common 
bile duct were normal. The dilated duo­
denum was mobilized by dividing its 
lateral attachments; there was a tongue 
of pancreas running laterally around the 
second part of the duodenum. No attempt
was made to divide the annulus and an 
antecolic isoperistaltic duodenojejuno­
stomy was carried out. The patient made 
a quick recovery following this procedure 
and remained well for 3 years. He then 
was admitted to hospital in a cachectic 
state and died. At autopsy, an anaplastic 
carcinoma of the pancreas was found. 
Although no relation has been noted in 
the literature between annular pancreas 
and malignancy, Barbosa, Dockerty and 
Waugh8 noted a greater frequency of 
malignant lesions in aberrant than in nor­
mal pancreatic tissue. This case is an ex­
ample of annular pancreas resulting in 
duodenal obstruction. It is strange that a 
congenital abnormality should give rise to 
obstruction so late in life. Perhaps the 
malignant change with associated tissue 
proliferation and edema played a part. 
Probably the large duodenal bulb, when 
filled with food and fluid, fell over on 
itself and created a volvulus type of ob­
struction; the fixed point was the annulus 
around the second part of the duodenum 
(Fig. 5).
Case 3.—A 64-year-old man had com­
plained of symptoms typical of duodenal 
ulcer for many years. Fifteen years ear­
lier a perforated duodenal ulcer had been 
closed. Since that time he had experi­
enced a sensation of fullness in his upper 
abdomen and had had frequent bouts of 
vomiting. The vomiting was worse late in 
the evening. Physical findings included 
some fullness in the epigastrium and 
peristaltic waves passing from left to 
right across the upper abdomen. Gastro­
intestinal radiologic findings included a 
deformity but no dilatation of the duodenal 
bulb and a small ulcer crater in the first 
part of the duodenum. In addition, emp­
tying of the stomach was delayed. The 
radiologic findings led to a diagnosis of 
scarring deformity of the duodenum with 
active duodenal ulcer.
At operation the stomach appeared 
grossly dilated and the duodenum was 
scarred. Dissection disclosed a tissue mass
FIG. 3—Case 1. Narrowing and irre­
gularity of second part of duodenum.
completely encircling the duodenum and 
causing constriction to a diameter of 
about 0.5 cm (Fig. 6). Further dissection 
in the area identified an annular pancreas 
with associated duodenal ulcer. A sub­
total gastrectomy was performed with an 
antecolic gastrojejunostomy type of anas­
tomosis. The pathological examination 
showed a small ulcer in the first part of 
the duodenum and pancreatic tissue within 
the duodenal wall (Fig. 7). The postoper­
ative course was smooth. This patient 
represented a case of intramural annular 
pancreas associated with duodenal ulcera­
tion and obstruction.
Case 4.—A baby boy, weighing 2184 
g, was admitted to hospital at the age of 
4.5 days with a history of nonbilious 
vomiting since birth. A flat film showed 
gas in the stomach and first part of the 
duodenum (double bubble)7 but no gas in 
the rest of the gastrointestinal tract. The 
baby’s general condition was good except
/
FIG. 4— Case 2. Megalobulbus (B) of 
duodenum and retention of barium. Ar­
rows indicate pylorus, S =  stomach.
FIG. 5— Case 2. Probable explanation 
for delayed obstruction. Megalobulbus 
rotates creating volvulus type of obstruc­
tion.
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for moderate dehydration. A diagnosis of 
duodenal obstruction above the ampulla 
was made. At laparotomy a malrotation 
was found together with annular pancreas 
around the first part of the duodenum. 
An anterior gastroenterostomy was done 
as there was not room enough for a 
duodenojejunostomy. The postoperative 
course was smooth and the baby was 
discharged from hospital 20 days after 
admission weighing 2700 g. A postoper­
ative film showed gas in the small bowel 
indicating that the obstruction was re­
lieved. On follow-up almost 3 months 
after operation, the baby appeared in good 
health. He was taking food well and 
weighed 3600 g.
Case 5.—This young man was brought 
to hospital with severe burns suffered in 
an industrial accident. He died a few 
hours after admission. Autopsy revealed 
an annular pancreas of the extramural 
type with marked dilatation of the duo­
denal bulb (Fig. 8). Unfortunately the
FIG. 6— Case 3. Annulus (arrows) en­
circling duodenum and causing constric­
tion.
FIG. 7— Case 3. Intramural pancreatic 
tissue (hematoxylin and eosin, reduced by 
49% from original magnification X40).
previous history of this man is unknown 
so we cannot tell whether he suffered 
from bouts of duodenal obstruction.
Case 6.—Autopsy of a 66-year-old 
woman whose death was unrelated to pan­
creatic disease (myocardial infarction) 
revealed an annular pancreas of the in­
tramural type with no other evidence of 
disease (Fig. 9). The patient had a his­
tory of dyspepsia for which she had un­
dergone cholecystectomy several years 
before.
Case 7.-—A 68-year-old man was ad­
mitted with a diagnosis of duodenal ulcer. 
Radiologic examination of the gastroin­
testinal tract showed a penetrating ulcer 
of the duodenum and a filling defect dis­
tal to it suggestive of annular pancreas 
(Fig. 10). His symptoms subsided and 
he was discharged. He returned to hos­
pital 1 month later with several rib frac­
tures sustained after falling from a tree. 
Bilateral pneumonia developed and the 
patient died. Autopsy confirmed the diag­
nosis of annular pancreas.
Discussion
As a result of this study of seven pa-
FIG. 8— Case 5. Autopsy specimen 
shows annulus (arrow) of extramural type 
with obstruction. D =  second part of 
duodenum, B =  megalobulbus, P =  
pyloric canal, S =  stomach.
FIG. 9— Case 6. Duodenum opened to 
show annulus, intramural type.
tients with annular pancreas a new 
classification for the condition is sug­
gested. There appear to be two distinct 
subtypes: extramural annular pancreas 
and intramural annular pancreas. In 
the former, pancreatic tissue along with 
the pancreatic duct, lying on the serosal 
surface, constricts the duodenum. The 
symptoms are those of high gastroin­
testinal obstruction as in our cases 2, 
4 and 5. The obstruction is probably 
due to volvulus of the megalobulbus 
or, perhaps, to low-grade pancreatitis 
secondary to abnormal pancreatic duct 
anatomy.8 Surgical treatment is most 
successful if a simple bypass procedure 
is carried out.
In the second type, aberrant pan­
creatic tissue lies intramurally and the 
complications are those of duodenal 
ulceration as in cases 1, 3, 6 and 7. 
This ulceration is most likely due to 
antral distension9'10 with release of the 
hormone gastrin. This makes the 
etiology consistent with that of type 
3 stimulating phase of gastric secre­
tion.11 Surgical treatment in type 2 an­
nuli is subtotal gastrectomy, with or 
without vagotomy.
I thank Dr. Donald Marshall for per­
mission to describe his patient, Case 4, 
and would also like to acknowledge the 
financial assistance provided by Mr. G. 
Dingman of St. Thomas, Ontario.
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Nonoperative Removal of Retained 
Common-Bile-Duct Stones
C.S. Ho, MB, BS, FRCP[C]
The discovery of retained common- 
bile-duct stones after operations on the 
gallbladder continues to be a frustrating 
experience for the general surgeon. 
Until recently this problem was solved 
in most patients by surgical 
re-exploration of the common bile duct. 
However, several alternatives to surgery 
are gradually gaining acceptance because 
of their lower morbidity and mortality. 
These methods are discussed with 
special emphasis on the use of a 
catheter with a steering mechanism 
and the Dormia basket (Burhenne's 
technique). This is the best alternative 
to surgery as it has no reported 
mortality, few complications and causes 
the least discomfort to the patient.
It is highly successful and requires 
no hospitalization.
La decouverte de calculs retenus dans 
le canal biliaire apres une operation de 
la vesicule continue d'etre une source 
de frustration pour le chirurgien general. 
Jusqu’a recemment, ce probleme etait 
resolu chez la plupart des patients par 
une reintervention chirurgicale du canal 
biliaire. Toutefois plusieurs alternatives 
a la chirurgie gagnent graduellement 
en popularity grace a leur morbidity et 
leur mortality plus faibles. Ces
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methodes sont discutees, une attention 
speciale etant donnee a ['utilisation 
du catheter a mecanisme de direction 
et a pannier Dormia (technique de 
Burhenne). C ’est la la meilleure 
alternative a la chirurgie puisqu’aucune 
mortality n'a ete signalee en rapport 
avec cette intervention, qu'elle entraine 
peu de complications et qu'elle cause 
le moins de malaises au patient. Elle 
a un fort taux de reussite et ne requiert 
pas I’hospitalisation.
In the United States, about 400 000 
cholecystectomies are performed each 
year.1 About 15% or 60 000 of the 
patients have stones in the common 
bile duct (CBD) that require operation; 
4000 will have residual stones in their 
biliary tree following surgery.1 Taking 
the Canadian population to be one 
tenth of that of the US, one can as­
sume that each year at least 400 Cana­
dians, if not more, will face this dis­
tressing situation.
Five methods are available for the 
management of retained CBD stones: 
(a) leaving the stones in situ and with­
drawing the T tube; (b) surgical re­
exploration; (c) dissolution of stones 
using ether or chloroform, heparin, or 
bile acids or bile salt solutions; (d) en­
doscopic papillotomy; and (e) nonopera­
tive extraction with Dormia basket 
(Burhenne’s technique).2
Leaving Stones in situ
In patients who are elderly and sick, 
the risk of complications from retained 
stones is lower than that of surgical 
re-exploration. Leaving the stones be­
hind and withdrawing the T tube used
to be an accepted mode of manage­
ment. From a review of the literature, 
Way1 concluded that the majority of 
retained CBD stones are asymptomatic. 
However, when the patient eventually 
has to be operated on because of com­
plications, he is a less satisfactory can­
didate for operation than previously. 
Antibiotics usually bring the acute pro­
cess under control. This method of 
management is no longer acceptable as 
the first alternative and should be con­
sidered only when other methods are 
not available.
Surgical Re-exploration
Re-exploration of the CBD is not 
only technically more difficult but also 
carries a higher morbidity and mor­
tality than simple cholecystectomy. 
Furthermore, the success rate for re­
moving retained stones at re-exploration 
is 73% to 83%,3-4 so that a third or 
even a fourth operation may be re­
quired. Surgery should be reserved as 
the last resort when other methods have 
failed.
Dissolution of Retained Stones
This would be an ideal method of 
treatment if suitable agents were avail­
able. In the 1930s ether5 and, later, 
chloroform6 were used for stone dis­
solution. Both these solvents are effec­
tive in dissolving cholesterol stones. 
However, ether can produce severe 
right upper quadrant pain when intro­
duced into the CBD, and chloroform 
is potentially toxic to the liver paren­
chyma. Their use in this situation has 
been abandoned.
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Infusion of the CBD with heparin 
was described by Gardner, Ostrowitz 
and Masur7 as an effective method for 
stone dissolution. Heparin, by supply­
ing negative charges that adsorb to the 
micelles, is believed to produce an in­
crease in the dispersion of micelles in 
the bile. Others attempting to duplicate 
this method have not met with equal 
success.1 The use of heparin for disso­
lution of gallstones must be evaluated 
further.
Cholesterol stones constitute 95% of 
gallstones. The formation of these 
stones is believed to be related to the 
excess of cholesterol in relation to bile 
salts and lecithin in the bile. The find­
ing that cholesterol stones can be dis­
solved in test tubes containing bile salt 
solution has been applied to dissolu­
tion of gallstones in the gallbladder8 
and to retained stones in the CBD.9
Currently, dissolution of retained 
CBD stones by bile salts is achieved 
either by oral administration of bile 
acids or by direct infusion of bile salt 
solutions into the CBD through the 
T tube. Chenodeoxycholic acid (ap­
proximately 1 g/d, orally) is prescribed 
for 8 to 13 weeks. The oral method 
may take a long time and the success 
rate is not impressive. Nevertheless it 
does not require the presence of a 
T tube and may have a place after all 
other conservative methods have failed.
Direct infusion of bile salt solutions 
into the CBD requires hospitalization 
for 10 to 14 days because the rate and 
pressure of infusion have to be care­
fully regulated. Infusion at excessive 
pressure can induce pain, cholangitis, 
or leakage. This method has a success 
rate of about 67%.9 The complications 
of dissolution by bile salt solutions are 
insignificant. The use of the drug is 
still restricted and available to only a 
few investigators.
Endoscopic Papillotomy
Modern fiberoptic endoscopy has in­
troduced a new dimension to the man­
agement of CBD stones. By means of 
a duodenoscope and a papillotome, en­
doscopic papillotomy or sphincterotomy 
can be performed without general 
anesthesia. The construction of a papil­
lotome is simple; it consists of a poly­
ethylene cannula and a small wire that 
passes through it and is attached to 
its distal end. High-frequency currents 
can be passed through the wire for cut­
ting. In endoscopic papillotomy the 
papillotome is passed into the ampulla 
of Vater through the duodenoscope. 
When correctly positioned as checked 
by fluoroscopy, the wire of the papil­
lotome is pulled to produce bowing of 
the distal cannula. High-frequency cur­
rent is then passed, resulting in cutting 
of the ampulla. After a successful
papillotomy a Dormia basket can be 
threaded through the duodenoscope 
into the CBD and the stones retrieved. 
More commonly, the stones are allowed 
to pass spontaneously into the duo­
denum after the papillotomy. Endo­
scopic retrograde cholangiopancreato­
graphy (ERCP) is performed later to 
check for the presence or absence of 
stones. First introduced in the early 
1970s by the Japanese10 and Germans,11 
the method has gradually gained popu­
larity in Europe. Table I shows the 
complications of the procedure as per­
formed by various authors17"14 in 344 
patients in different European centres. 
The mortality rate of 1.5% and mor­
bidity of 11 % compare favourably with 
the figures for surgical re-exploration 
or surgical sphincteroplasty. However, 
these results are less impressive than 
those for extraction with the Dormia 
basket (Burhenne’s technique)—no
deaths and 5% morbidity.15 The pro­
cedure requires an expert endoscopist
Table I—Complications of Endoscopic 
Papillotomy in 344 Patients*
Complication No. of patients
Hemorrhage 11
Pancreatitis 4
Perforation 15
Cholangitis 5
Trapped basket 2
Total morbidity 37 (11%)
*5 patients (1.5% ) died.
with extensive experience in perform­
ing ERCP. In expert hands a success 
rate of 85% can be expected. It should 
be the treatment of choice for retained 
CBD stones in high-risk patients whose 
T tube has slipped out and in those 
with CBD stones who are too ill to 
undergo surgery. The routine use of 
endoscopic papillotomy for treatment 
of CBD stones is not advocated.
Nonoperative Removal
of CBD Stones
The first successful retrieval of CBD 
stones by a specially designed forceps 
was described by Mondet in 1962.10 Maz- 
zariello17 popularized the concept of 
nonoperative retrieval of stones, using 
both forceps and the Dormia bas­
ket. Burhenne2 and Bean and Ma- 
horner18 have simplified the procedure. 
As it is performed under fluoroscopic 
control, more and more radiologists 
are now familiar with it so that it is 
a readily available therapeutic proce­
dure in many centres. The details of 
the method have been well described 
by Burhenne who incorporated in the 
catheter a steering device (Fig. 1) to 
facilitate the Dormia basket reaching 
the calculus in the CBD.
The procedure is not performed until 
4 to 5 weeks after the initial surgery 
in order to allow a firm, fibrous 
tract to form. Preliminary T-tube chol­
angiography is performed to check the 
number and location of the stones if 
still present. The T tube is then with­
drawn. Under fluoroscopic control the 
steerable catheter is introduced into the
FIG. 1—Steerable catheter with four wires passing through its wall to its distal 
end. By pulling open end of wire, tip of catheter can be manipulated to desired position. 
Dormia basket can be threaded through catheter.
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CBD along the T-tube tract. When the 
tip of the catheter reaches the calculus, 
the Dormia basket is threaded into the 
catheter to reach the stone. By opening 
and closing the basket under fluoro­
scopic control, the stone can be 
trapped; the basket, stone and catheter 
are then removed together. The entire 
procedure, depending on the number 
of stones present and the skill of the 
operator, usually takes from 15 min­
utes to 2 hours. When there are num­
erous stones, more than one session 
may be required. In order to facilitate 
retrieval and reduce morbidity, a T 
tube of adequate size should be used, 
preferably no. 14 French or larger. The 
T-tube tract should be straight, as a 
tortuous tract makes retrieval difficult. 
Hard and large stones (diameter, ^  
2 cm) are difficult to remove.
Table II lists the complications in 
643 patients who underwent nonopera­
tive retrieval of CBD stones in dif­
ferent centres in the US and Canada18 
and includes my own cases. No deaths, 
perforations of the CBD or subphrenic 
abscesses have been reported. A mor­
bidity of 5% is recorded and 0.5% of 
patients have required reoperation.
The nonoperative extraction can be 
performed on an outpatient basis. A 
success rate of 95% in expert hands 
can be expected. It can also be per­
formed on patients considered to be 
of high surgical risk. If the procedure 
is unsuccessful, a red rubber catheter 
is reinserted into the CBD to maintain 
drainage and nothing is really lost. It 
is certainly a cost-effective procedure 
and it also produces less discomfort 
for the patient than other methods. It is 
currently the choice for retained CBD 
stones in patients who still have the 
treatment T tube in place.
The following case report illustrates 
that despite a meticulous search for a 
CBD stone known to be present, it may 
occasionally be missed at operation. It 
also shows that reoperation does not 
necessarily guarantee the complete re­
moval of a residual stone.
Case Report
A 47-year-old housewife had had a
T a b le  I I — M o rb id ity  o f N o n o p e ra t iv e  R em o va l
o f R e ta in e d  C o m m o n -B ile -D u c t S tones
in  643 P a t ie n ts
C o m p lic a tio n N o . o f  p a tie n ts
P e r fo ra t io n  o f s in u s  t r a c t 8
S u b h e p a tic  b ile  co lle c tio n 2
F e v e r 12
S ep sis 2
P a n c re a t it is 2
V a s o v a g a l rea c tio n s 2
T ra p p e d  b a s k e t 2
T o ta l  m o rb id ity 30 ( 5 % )
cholecystectomy 10 years earlier. Forty- 
eight hours before admission to another 
hospital, she experienced severe colicky 
pain in the right upper quadrant, asso­
ciated with vomiting. Twenty-four hours 
later she became febrile, jaundiced and 
mentally confused. Her blood pressure 
was 60/40 mm Hg, pulse 160/min and 
her temperature 40°C. The diagnosis was 
septic shock due to ascending cholangitis. 
She was resuscitated by means of intra­
venous fluid and antibiotics and admitted 
to the Toronto General Hospital for fur­
ther management.
On admission her blood pressure was 
120/60 mm Hg, pulse 130/min. Abdom­
inal examination revealed tenderness in 
the right upper quadrant but no mass was 
palpable. The hemoglobin value was 12.1 
g/dL, the leukocyte count 17 X 10VL, 
the platelet count was 94 x  109/L 
and the prothrombin time 14 seconds (nor­
mal, 11 seconds). Her urine was strongly 
positive for bile and urobilinogen. Entero­
cocci were cultured from the blood.
At emergency operation the CBD ap­
peared dilated and aspiration showed 
murky looking bile. Exploration of the 
duct permitted removal of several stones. 
A choledochoscope was also used to seek 
for other stones and an operative cholan- 
giogram was obtained (Fig. 2). No residual 
stones could be demonstrated.
A T-tube chol angiogram obtained 1 
week after the exploration showed a stone 
(diameter, 1 cm) at the junction of the 
left and right hepatic ducts (Fig. 3). The 
patient was discharged and instructed to 
return in 5 weeks for nonsurgical extrac­
tion. Shortly before the end of the 5th 
week the T tube slipped out and she again 
experienced right upper quadrant pain. 
Upon readmission an ERCP visualized 
obstruction of the CBD by a large stone 
at its lower end (Fig. 4).
At a second operation, despite a thor­
ough search, the stone could not be lo­
cated. A sphincteroplasty was performed 
and a large T tube left in place. Again 
operative cholangiography showed no re­
sidual stone (Fig. 5). The biliary tree, how-
FIG. 2— Operative cholangiogram show­
ing no evidence of residual stone in biliary 
tree.
ever, was uniformly distended. Postoper­
ative T-tube cholangiography revealed a 
large stone in the left hepatic duct (Fig. 
6). This was subsequently removed by the 
nonoperative technique using the Dormia 
basket.
Summary
The best method of management of 
retained stones in the biliary tree is 
to ensure that they do not occur. The 
use of cholangiography and choledo­
choscopy at operation will reduce the 
incidence to a minimum. Even these 
measures may fail, and in these cir­
cumstances it is now a great relief both
FIG. 3— T-tube cholangiogram demon­
strating stone at junction of left and right 
hepatic ducts (arrow).
FIG. 4— Endoscopic retrograde cholan- 
giopancreatogram showing air in biliary 
tree and large stone located at distal end 
of dilated common bile duct (CBD).
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to the surgeon and to the patient that a 
second operation need not be neces­
sary. In  fact, if an adequate sized T  tube 
is left, the chances of successful re­
moval of the stones without operation 
are extremely high and, conversely, the 
likelihood of having to  consider an 
alternative method is quite low. Sur­
gery should be the last resort. U ndoubt­
edly a radical change in the approach 
to the management of retained stones 
has taken place during the last decade.
I am most grateful to Miss Sue Harris, Mrs. Eileen Lunny and Miss Ingrid Breitenauer for secretarial assistance.
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Slimpses of 
Surgical History: 
U for Universities
D avid  A .E . Sh e ph a r d
Universities have so shaped the educa­tion and training of surgeons in an ac­cepted tradition that we forget that these “thinking shops” are of relatively recent origin. They have served us for barely 800 years. Galen died in 200 AD; after him came almost a millenium 
of darkness and in the West a new 
dawn did not break until the school of Salerno rekindled interest in Greek and 
Latin texts. Then, within two centuries 
there arose universities_ in whose debt 
surgeons will always remain.
The first university, at Salerno, was 
in fact a medical university. A great 
tradition thus began— the tradition that grew through the Renaissance of the 
12th century and the second Renais­sance of the 14th and 15th centuries, 
and then the “invisible college” of the 17th century, to the growth of knowl­
edge closer to our day. Salerno was followed by Naples, Montpellier, Bolo­
gna, Paris and Padua, and then, in the 13th century by Oxford and Cam­
bridge. All these universities were established in bookless days— at the 
end of the 14th century the Paris med­ical school library contained but a dozen manuscripts— yet they forged 
new ways of learning.
The growth of universities changed the ways scholars could learn. No 
longer was learning restricted to the Church; learning was made available 
to all. Moreover, “the ancient and uni­
versal company of scholars” broke 
down the barriers of custom and au­
thority that had previously closed men’s 
minds. One such scholar was a surgeon — Guy of Chauliac, “the restorer of sur­
gery”. Surgeons thus have every reason 
to be proud of the contributions their 
forbears made to the university tradi­
tion.
But what is this tradition? It is not physical— stone and glass crumble and 
splinter and cap and gown fray and fall apart. What have lasted are the word university, the curricula leading to degrees and the faculty concept. The tradition is “the training of scholars and the maintenance of the tradition of learning and investigation”. This tradi­
tion has lasted to our day; it is a tradi­tion today’s surgeons can share with 
scholars of former times, surgical and lay alike. Surely surgeons will continue 
to preserve such a fine tradition.
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Survival after Late Disc Dislodgement of a 
Mitral Wada-Cutter Prosthesis
E llio t  T . G e l fa n d , m d , f r c s [c ], J oh n  C. C allaghan , m d , f r c s [c ], fa cs, facc  and 
R u s s e l l  F. T aylor , m d , f r c p [c |, fa c p
A 33-year-old woman, 6 years after 
placement of a Wada-Cutter prosthesis, 
suffered from free mitral regurgitation 
secondary to the dislodgement of the 
disc occluder into the left atrium.
She was operated on approximately 
14 hours after the onset of symptoms 
and survived; this patient is the third 
reported survivor following dislodge­
ment of a Wada disc.
Six ans apres la pose d'une prothese 
Wada-Cutter, une femme de 33 ans 
a presente une regurgitation mitrale 
continue a la suite du detachement du 
disque refermant I'oreillette gauche.
Elle a ete operee environ 14 heures 
apres I’apparition des symptomes et 
a survecu; cette patiente est la 
troisieme dont on a signale la survie 
apres le detachement d’un disque de 
prothese Wada-Cutter.
One of the most disastrous complica­
tions to beset the patient with a pros­
thetic heart valve is complete dislodge­
ment of the disc occluder. In the litera­
ture to this time only two survivors of 
Wada disc dislodgement have been re­
ported.1,2 We report the case of a third 
patient who survived disc dislodgement.
Case Report
A 27-year-old woman with severe aor­
tic and mitral regurgitation underwent 
replacement of her aortic valve with a 
Cutter-Smeloff prosthesis and mitral 
valve with a Wada-Cutter prosthesis. Her 
postoperative course was uncomplicated 
and in the following 6 years she had no 
related problems. Suddenly, shortly after 
arising in the morning, the patient noted 
severe lightheadedness and shortness of 
breath. She was admitted to a local hos­
pital 960 km from the University of 
Alberta Hospital, where she was noted 
to have frank pulmonary edema. Through­
out that day she was treated with diuretics; 
in addition, an endotracheal tube was in­
serted and positive pressure ventilation
From the divisions of cardiovascular and thoracic surgery and cardiology, University o f Alberta Hospital, Edmonton, Alta.
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begun. The patient was transported to the 
University of Alberta Hospital by air 
ambulance 12 hours after she first experi­
enced difficulty.
At the time of admission the patient’s 
heart rate was 120 beats/min; she was in 
sinus rhythm with runs of ventricular 
tachycardia. Her blood pressure was 60/ 
40 mm Hg and she was anuric. Her jugular 
venous pressure was considerably elevated 
and even with volume ventilation through 
an endotracheal tube her condition did 
not improve and the pulmonary edema 
persisted. Aortic prosthetic sounds seemed 
normal, but no mitral prosthetic sound 
was audible. An echocardiogram failed 
to disclose any movement of the mitral 
valve prosthesis; severe malfunction of 
the Wada valve was diagnosed.
Two hours after admission the patient’s 
previous sternotomy wound was reopened 
and perfusion for cardiopulmonary by­
pass was carried out through the right 
femoral artery. Hypothermic myocardial 
protection was provided by the infusion 
of 600 mL of buffered lactated Ringer’s 
solution at 4°C into the aortic root after 
placement of an aortic cross-clamp. When 
the left atriotomy was made the Wada disc 
occluder was found lying free in the 
left atrium. The valve ring was well 
seated in the mitral annulus and no 
evidence of thrombus or abundant pannus 
was noted. The occluder was removed, 
the valve ring excised and a Lillehei- 
Kaster supra-annular mitral prosthesis 
was sutured into place with interrupted 
horizontal mattress sutures on Teflon felt 
pledgets. The patient made an uneventful 
postoperative recovery and at present is well.
Discussion
The Wada-Cutter hingeless mitral 
prosthesis was proposed to provide bet­
ter central flow and less turbulence 
than other mitral prostheses available 
at that time. Since the first report on 
the use of this valve by Wada and col­
leagues3 in 1969, however, numerous 
complications of the prosthesis have 
been reported,4'6 and this device is no 
longer used clinically in the mitral posi­
tion. In a discussion of a paper by Roe 
and his group2 in 1975 Wada stated 
that his institution had discontinued 
use of this prosthesis in the mitral posi­tion in 1974.
Despite the fact that this prosthesis
is no longer used, large numbers of 
patients in whom it was implanted are 
still being followed up. Because of the 
complications associated with this 
valve, and in particular the potentially 
disastrous disc dislodgement, careful 
re-evaluation of these patients is man­
datory. Perhaps in this group of pa­
tients prophylactic removal of the 
Wada prosthesis and replacement with 
a more durable device would be pru­
dent.
The development of severe over­
whelming regurgitation in an implanted 
heart valve is a medical and surgical 
emergency. The absence of prosthetic 
heart sounds and perhaps a quick echo- 
cardiographic study are all that is 
necessary to substantiate the diagnosis, 
and operation should be undertaken 
immediately. Cardiac catheterization in 
these severely ill patients is probably 
not necessary, delays the intervention 
that is required and imposes an in­
ordinate burden on the already de­
sperately overworked myocardium.
We thank Dr. G. Rao who provided us with an echocardiographic study.
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Long-Term Follow-Up of Triple Arthrodesis
R onald Monson, md, frcs[c] and D onald A. Gibson, md, frcs[c]
Thirty-seven children in whom 46 triple 
arthrodeses had been performed were 
followed up for 19 to 33 years 
(average, 24 years). Better results 
were evident in patients who had 
been operated on because of polio­
myelitis, pes cavus or pes planus than 
in patients operated on for club foot, 
cerebral palsy or spina bifida. The use 
of staples appeared to improve the 
result. A neutral position of the heel 
is desirable. Varus positions required 
revision in three patients. A heel-toe 
gait was noticeable in 74% of patients. 
Osteoarthritis occurred in 24% and 
pseudarthrosis in 4% of our patients.
In 91% of patients the functional result 
could be described as good or 
excellent.
On a suivi devolution de 37 enfants 
chez qui on avait effectue 46 arthro­
deses triples, pour des periodes 
allant de 19 a 33 ans (moyenne, 24 
ans). Les resultats observes chez les 
patients qui avaient ete operes a cause 
de poliomyelite, pied arque ou pied 
plat ont ete meilleurs que pour les 
patients avec pied bot, paralysie 
cerebrale ou spina bifida. L’emploi de 
broches semble ameliorer les resultats. 
II est souhaitable de donner une 
position neutre au talon. Les positions 
varus ont necessity une revision chez 
trois patients. Une demarche talon- 
orteille etait evidente chez 74% des 
patients. De I’osteoarthrite est apparue 
chez 24% des patients et de la pseud- 
arthrose dans 4% des cas. Chez 91% 
de patients, les resultats fonctionnels 
peuvent etre decrits comme bons 
ou excellents.
Fifty years have passed since the prin­
ciples of triple arthrodesis were de­
scribed by Ryerson.1 Since then, many 
short-term, but few long-term, follow­
up studies of the operation have been 
reported.2"5 The three joints concerned 
are the talocalcaneal, the talonavicular 
and the calcaneocuboid, which are fused 
to give stability, to correct deformity
From the division, of orthopedic 
surgery, the Hospital for Sick Children, 
Toronto, Ont.
Reprint requests to: Dr. Donald A. Gib­
son, Division of orthopedic surgery,
The Hospital for Sick Children, 555 
University Ave., Toronto, Ont. M5G 1X8
VOLUME 21, NO. 3, M AY 1978 /
and to relieve pain. Several modifica­
tions have been devised, the most not­
able being that of Lambrinudi6 for cor­
rection of drop foot.
From time to time surgeons are con­
fronted with difficult problems arising 
from poor results of triple arthrodesis 
and some have expressed the opinion 
that the operation is a poor one and 
should be discarded. We conducted a 
study to determine the long-term re­
sults of triple arthrodesis in patients 
treated at the Hospital for Sick Chil­
dren, Toronto, and whether poor results 
represent the norm or the exception.
Material and Methods
Patients
Of the 402 patients who had a triple 
arthrodesis in the 15 years from 1942 
to 1956 inclusive, 39 could be traced. 
Two patients were unable to return for 
follow-up, hence only 37 were re-ex­
amined and could be included in the 
study. In 9 of the 37 the operation had 
been bilateral, to produce a total of 
46 operations. The low rate of follow­
up is due to the high mobility of the 
Canadian population and the long time 
that had elapsed before any effort was 
made to trace the patients. Certainly 
the patients we were able to contact 
were unselected with respect to whether 
their operative result was good or bad, 
and therefore we consider the review 
of their condition to be meaningful.
The average age at operation was 
11.7 years (range, 8 to 15 years). One 
of three types of arthrodesis was per­
formed: the standard three-joint fusion, 
the Lambrinudi fusion, or the Hoke 
fusion.7
The average duration of follow-up 
in all patients was 24 years (range, 19 
to 33 years). Thirty operations were 
performed in boys, 16 in girls.
Assessment of the Long-Term Result
From the clinical records of all pa­
tients re-examined we determined the 
sex, diagnosis, age at operation, pre­
operative position of the foot, type of 
operation performed and whether 
staple fixation had been used.
Functional.—Based on the patient’s 
response to questioning, grading was 
established as follows:
•  Excellent: no limitation of activ­
ity, no pain.
•  Good: walking unrestricted but 
some limitation in running; no pain.
•  Fair: limitation in walking and 
mild pain.
•  Poor: presence of pain.
Objective.-—The grading based on
physical examination of the foot and 
roentgenograms of the foot and ankle 
was as follows:
•  Excellent: all joints fused. Heel 
and foot normally aligned with no 
varus or valgus. Heel-toe gait, no osteo­
arthritis.
•  Good: all joints fused. Minimal 
joint changes. No callosities on the foot.
•  Fair: fusion of at least two joints. 
Mild callosities, incomplete correction 
of deformity. Mild joint changes.
•  Poor: pseudarthrosis of talocal­
caneal joint. Marked plantar callosities. 
Undercorrection, overcorrection, or re­
currence of deformity.
Results
The sex of the patient had no in­
fluence on the result. The operation 
produced a better result when the pre­
operative condition was poliomyelitis, 
pes planus, or pes cavus than when the 
patient had cerebral palsy, spina bifida, 
or a club-foot deformity (Table I).
The age of the patient at the time of 
the operation affected the degree of
Table I— Objective Result of Triple Arthrodesis
Diagnosis Excellent Good Fair Poor Total
Pes cavus 4 1 0 0 5
Pes planus 3 4 0 0 7
Poliomyelitis 10 1 1 0 12
Peripheral neuropathy 1 1 1 0 3
Cerebral palsy 1 1 3 0 5
Club foot 0 4 5 1 10
Spina bifida 0 1 2 1 4
Total 19 13 12 2 46
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success. The result could be classified 
as excellent or good in 88% of the 18 
patients operated on at age 13 years 
or older. In those operated on at a 
younger age the result was less satis­
factory; in only 54% was it rated as 
good or excellent.
Staples for internal fixation were 
used in 23 operations and in 78% of 
the patients good or excellent results 
were obtained. In the absence of in­
ternal fixation the corresponding figure 
was 63 %. In the two cases of nonunion 
encountered in the series staple fixation 
had not been employed. We did not 
find that staples produced better align­
ment of the foot.
Lambrinudi triple arthrodeses, though 
fewer, appeared to give better results 
than standard triple arthrodeses (Table 
II). The Lambrinudi procedure was 
performed in patients who, in all cases 
but one, had neurologic problems, such 
as poliomyelitis or muscle imbalance. 
It was not selected for any patient in 
this group with club-foot deformity.
Revision of the fusion was required 
in three patients for undercorrection 
of the varus deformity of the heel.
In general, good or excellent results 
were found slightly less often in the 
patients whose follow-up was of the 
longest duration (Table III). Seven of 
15 patients seen more than 25 years 
after the operation had mild pain. Ten 
of 31 patients in whom the interval was 
less than 25 years had mild pain. The 
frequency of osteoarthritis in the two 
groups was the same. A heel-toe gait 
was observed in 75% of patients, 
equinus gait in 13%, plantigrade gait in 
7%, drop foot in 4% and antalgic gait 
in 2%.
Roentgenograms verified that pseu- 
darthrosis had developed in two joints, 
the talocalcaneal in one patient and the 
calcaneocuboid in another. There was 
a 24% incidence of osteoarthritis, 20% 
in the ankle joint and 4% in the tarsal 
joint. Of the 10 patients with club-foot 
deformity who had a triple arthrodesis, 
7 had osteoarthritis of the ankle joint.
The present position of the foot op­
erated on was found to be normal in 
45% of the patients seen on follow-up. 
If the foot was normally aligned the 
functional result was good or excellent 
(Table IV).
The functional results were good or 
excellent after 42 (91%) of 46 opera­
tions. The overall objective results 
were also good or excellent after 32 
(70%) operations.
Discussion
These results indicate that the long­
term functional results of triple arthro­
desis are good.
Drew,8 in his long-term study of 
patients after 31 operations, found full
function present in 65% and moderate 
function in 26%. Thus 91% of his 
patients had moderate to full function, 
a result similar to our own. He also 
noted roentgenographic evidence of 
osteoarthritis in 10 (32%) of 31 pa­
tients. This is slightly higher than the 
figure of 24% in our series.
Lemperg4 found a good result in only 
10 (24%) of 42 feet he examined after 
triple arthrodesis for club foot. In our 
patients with this deformity there was 
no result that could be classified as 
excellent and in only 40% was it con­
sidered good. These figures reflect the 
inherent problems in treating a club 
foot.
Patterson, Parrish and Hathaway5 
found that the standard triple arthro­
desis gave good results in 53.9% of 
their 89 patients; for the Lambrinudi 
type of triple arthrodesis, the figure 
was 45.5% of 55 patients. Howland3 
obtained a good or excellent result in 
73.4% of 60 patients treated with the 
standard triple arthrodesis and in 50% 
of 8 patients subjected to a Lambrinudi 
fusion.
Friedenberg2 noted that pseudarthro- 
sis had developed in 20% of 65 patients 
who had a triple arthrodesis. We noted 
pseudarthrodesis in only 4% of our 
cases.
Staples, which formerly were not 
routinely employed, were used in 23 of 
the operations we reviewed. They make
possible accurate and firm maintenance 
of the desired position and therefore 
may be responsible for a decrease in 
the incidence of pseudarthrosis. There 
were no pseudarthroses in this group, 
but, since in the nonstapled group there 
were only two instances, each of late 
navicular pseudarthrosis, no conclusion 
can be drawn.
The slight decrease in the number 
of good results in patients who were 
seen after the longest interval from 
operation is possibly indicative of the 
alteration in joint mechanics acting 
over many years.
Conclusions
Ninety-one percent of the operations 
of triple arthrodesis have been found to 
furnish a good or excellent functional 
result when the patients were reviewed 
19 to 33 years later. However, if the 
overall objective result is considered, 
with attention to position of the foot, 
gait and roentgenographic appearance, 
this favourable figure must be reduced 
to 70%.
We thank the surgeons at the Hospital 
for Sick Children who allowed us to study 
their patients, and the surgical studies 
fund of the Hospital for Sick Children 
which made this study possible.
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Trichobezoar: An Uncommon Pediatric Problem
R a fa el  R e is f e l d , m d , W il l ia m  D a m m e r t , m d  and  J am es S. Sim p s o n , m d , f r c s [c ], fa c s , fa a p
Trichobezoar, the "hair-ball” occasion­
ally found in the stomach of emotionally 
disturbed adults, particularly women, 
is an uncommon finding in the pediatric 
age group. The diagnosis often rests 
on the suspicion of the alert physician 
since most patients will not volunteer 
information about swallowing hair.
The presence of a palpable upper 
abdominal mass associated with 
progressive intolerance to food, 
with weight loss and with weakness, 
and the roentgenographic appearance 
of a mass after a barium meal confirms 
suspicion. Treatment consists of 
laparotomy and gastrotomy to permit 
removal of the foreign material. 
Psychiatric assistance should be sought.
Le trichobezoard, cette “balle de 
cheveux” qui est decouverte occasion- 
nellement dans I’estomac d'adultes 
emotivement deranges, particulierement 
chez les femmes, est peu frequemment 
observe chez les patients d’age 
pediatrique. Le diagnostic repose sou- 
vent sur les soupcons d'un medecin 
vigilant puisque les patients n’avouent 
pas d’eux-memes avaler des cheveux.
La presence d'une masse palpable 
dans la partie superieure de I’abdo- 
men associee a I’apparition progressive 
d’une intolerance alimentaire, d’une 
perte de poids et de faiblesse et 
I’examen radiologique apres repas 
baryte, confirment les soupcons. Le 
traitement comprend une laparotomie et 
une gastrotomie afin de permettre de 
retirer le materiel etranger. Une 
aide psychiatrique devrait etre recher- 
chee.
From the departments of surgery,The Hospital for Sick Children and University of Toronto, Toronto, Ont.
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Bezoar is defined as a concretion found in the alimentary canal of animals, 
especially ruminants, and occasionally in man.1 The term is derived from the Persian “padzhar”, meaning antidote. 
In olden times bezoars were considered to have magical properties and there­fore to be useful as medicinal agents.
There are four main types: tricho­bezoar, consisting of hair; phytobezoar, composed mainly of vegetable fibres (skin and seeds); trichophytobezoar, a 
combination of hair and vegetable mat­ter; and concretions, usually composed of foreign substances such as shellacs.
The diagnosis of trichobezoar is un­common, particularly in the pediatric age group. It is of interest that we have recently encountered two such cases.
Case Reports
Case 1. — A 16-year-old girl was ad­
mitted because of anorexia, weight loss, 
thinning of the hair and amenorrhea for 
4 months. For the last 3 weeks she had 
experienced intermittent epigastric pain 
and nausea, which had prevented her 
attending school. She had not vomited, 
and the rest of her medical history and 
the family history were noncontributory.
The girl was thin but in no distress. 
Her scalp hair was thin and sparse, but 
she emphatically denied trichophagia. The 
only positive physical finding was a pal­
pable epigastric mass (diameter, approxi­
mately 15 cm) that was firm, slightly 
tender, irregular and movable; no bruits 
were audible. Results of laboratory inves­
tigations were normal.
The tentative diagnosis was liver tu­
mour, but a roentgenogram obtained dur­
ing intravenous pyelography revealed a 
trichobezoar (Fig. 1). Psychiatric con­
sultation preoperatively revealed no ob­
vious mental disorders; the patient’s intel­
lectual level was considered to be low 
normal.
Laparotomy was performed and a large 
trichobezoar extracted through the gas­
trotomy (Figs. 2 and 3). Apart from su-
FIG. 1—Gastrografin demonstration of trichobezoar in stomach.
FIG. 2— Trichobezoar extruding through gastrotomy.
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perficial wound infection, the patient’s 
recovery was uneventful.
Case 2. — A 6-year-old girl was re­
ferred because her mother was concerned 
about the child’s habit of eating her hair 
and that of her doll. Areas of alopecia 
were noticeable but she had no symptoms 
related to her curious eating habits. She 
appeared well adjusted and was at her 
expected level at school. On examination 
there was a firm epigastric mass in the 
abdomen that was movable and nontender. 
A barium roentgenographic examination 
of the stomach outlined an amorphous- 
looking mass extending from the fundus 
to the pylorus; this was interpreted as 
a trichobezoar. At laparotomy and gas- 
trotomy a large hairy mass, the shape 
of the stomach, was removed. She had an 
uneventful recovery with no signs of wound 
infection. Her mother later reported that 
her appetite had improved and that the 
habit of eating her hair seemed to have 
been broken.
Discussion
Trichobezoar, the commonest form 
of bezoar, is found chiefly in women 
over 20 years of age. The most often 
cited cause is some form of emotional 
disturbance. The mechanism of its 
form ation is not certain, but that 
proposed by Meilchen in 1911 is 
widely accepted.2*3 He theorized that 
hair strands became retained and at­
tached in the folds of the gastric 
mucosa because the friction surface is 
insufficient for propulsion by peristal­
sis.
The diagnosis of trichobezoar is sug­
gested by a history of hair ingestion, a 
palpable epigastric mass, upper ab­
dominal pain, the presence of hair in 
vomitus, progressive intolerance of
FIG. 3— Specimen after removal.
solid foods, weight loss, weakness and 
inanition. Obstructive jaundice has 
been reported.4 Suspicion of the diag­
nosis depends on the physician’s alert­
ness, since few patients voluntarily give 
a history of trichophagia5'8 and, like 
our first patient, may deny it on ques­
tioning.
Examination may discover pallor, 
nervousness, malnutrition and a rela­
tively mobile epigastric mass. The 
diagnosis can be established radiolo- 
gically as in these cases, or by gastro­
scopy.9
The treatment is laparotomy with 
gastrotomy and removal of the foreign 
material.5 The surgeon should also 
search the small intestine for residual 
hair balls that might cause obstruction, 
hemorrhage, ulceration, perforation or 
peritonitis. Recovery is usually unevent­
ful.6 Psychiatric evaluation is desirable 
and treatment of emotional disorders 
should be instituted.
Trichobezoar is uncommon in chil­
dren, in whom the condition may 
remain undiagnosed for a long time.10 
These case reports are intended to alert 
pediatricians and surgeons to  this pos­
sibility.
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Survival in Colorectal Cancer
Luc D eschenes, m d , fr c s[c], J acqueline  F abia, md , sd (hyg) , Yvan D ouville , md  and C laude D ufour , md
The authors studied the hospital 
records of 258 patients with colorectal 
cancer diagnosed between 1965 and 
1974 at I'Hopital du Saint-Sacrement, 
Quebec and computed expected and 
relative survival rates to adjust for 
deaths from other causes. Life-table 
methods based on full intervals only 
were used to analyse survival.
The patients (138 men and 120 
women) ranged in age from 24 to 96 
years (mean, 64.9 ±  12.7 years). The 
5-year relative survival rate expressed as 
a percentage was 48.6 ±  4.7 for the 
total group and 64.1 ±  5.6 for patients 
in stages A, B and C of Dukes’ classi­
fication. The overall operative mortality 
rate of 2.7% compared favourably 
with that reported elsewhere. Among 
patients with cancer of the sigmoid 
colon or rectum (the most readily 
detectable), the diagnosis was made at 
stage A in one out of nine and at 
stage D in approximately one out of 
four. Despite the introduction of uni­
versal medical insurance in Quebec 
in 1970, there has been no significant 
trend towards earlier diagnosis.
La survie de 258 patients atteints de 
cancer colorectal diagnostique a 
I’Hopital du Saint-Sacrement, Quebec 
de 1965 a 1974 compris a ete etudiee 
par la methode actuarielle basee sur des 
intervalles annuels complets. L'ajuste- 
ment pour les deces par autres causes 
a ete obtenu en calculant les taux de 
survie esperes et relatifs.
L'age des malades (138 hommes et 
120 femmes) variait de 24 a 96 ans 
avec une moyenne de 64.9 ±  12.7.
Le taux de survie relatif (% ) a ete 
48.6 ±  4.7 pour le total des patients 
et 64.1 ±  5.6 pour ceux porteurs d’un 
cancer au stade A, B ou C de Dukes. La 
mortalite operatoire globale (2.7%) se 
compare favorablement a celle rapportee 
ailleurs. Parmi les malades atteints 
de cancer du sigmoide ou du rectum 
(les plus facilement detectables), un 
sur neuf a ete diagnostique au stade 
A et environ un sur quatre au stade
From the department of surgery, H6- 
pital du Saint-Sacrement and the depart­
ment of social and preventive medicine, 
Laval University, Quebec, PQ
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D. Malgre (’introduction, en 1970, de 
I'assurance maladie couvrant toute 
la population du Quebec, il ne s'est 
manifesto aucune tendance significative 
vers un diagnostic plus precoce.
In Quebec, as well as in Canada as a 
whole, colorectal cancer is the second 
most frequent cause of death by can­
cer for both sexes, being next in order 
to lung cancer in men and breast can­
cer in women.
We have previously reported the sur­
vival experience of breast cancer pa­
tients.1 Our present purpose is to 
describe the survival of patients with 
colorectal cancer admitted to our hos­
pital.
Methods
Sources of Data and Period of Study
The records were reviewed of all pa­
tients in whom colorectal cancer was 
first diagnosed from Jan. 1, 1965 to 
Dec. 31, 1974 at the Hopital du Saint- 
Sacrement, Quebec City. Also reviewed 
were the records from the tumour clinic 
supervising follow-up and from the 
department of histopathology. Death 
certificates filed at the Quebec popula­
tion registry were also searched.
Follow-up continued to Dec. 31, 
1975. All patients known to be still 
alive were contacted at the close of the 
study. There were no losses to follow­
up.
Criteria for Entry into Study
Entry into the study was restricted 
to patients who had not previously re­
ceived any treatment for cancer in ac­
cordance with the criteria used by the 
end results group of the United States 
National Cancer Institute.2
Survival
Survival was measured from the date 
of the first hospitalization during which 
colorectal cancer was diagnosed. Life- 
table methods3 based on full intervals4 
only were used to analyse survival. As 
recommended by Drolette,4 patients due 
to withdraw because the study was being 
terminated were removed at the start 
of the interval and not during it.
Deaths from all causes were included 
in the analysis.5 The necessary adjust­
ment for mortality from causes other 
than colorectal cancer and for associa­
tion between age and risk of death from
other causes was provided by computing 
the relative survival rate.6
The relative survival rate is defined 
as the ratio of the observed survival 
rate to the survival rate expected over 
the same period of time in a group of 
persons from the general population 
with the same age and sex distribution 
as the patients.5
The expected survival rates were 
computed from the 1970-72 sex-speci­
fic life tables for the population of the 
Quebec City region,7 since 92% of the 
patients in this series came from this 
region.
The standard error of the observed 
survival rate was computed from Green­
wood’s formula8 and was divided by the 
expected survival rate to obtain the 
standard error of the relative survival 
rate.5
Site
Cancers located within 15 cm of the 
pectinate line were classified as rectal.
Assessment of the Extent of Disease
Assessment of the extent of disease 
was based on all information available 
at first hospital discharge.2 Disease was 
divided into four stages: A (lesion con­
fined to the bowel wall), B (lesion 
reaching the serosa or pericolic fat) 
and C (lymph-node involvement) ac­
cording to Dukes’ classification,9 and a 
stage D that included cases with distant 
metastases.
For patients with synchronous le­
sions at different stages, the extent of 
disease was regarded as that of the 
most advanced lesion.
Results
The age distribution of the 258 pa­
tients included in the study appears in 
Fig. 1. There were 138 men and 120 
women. For men, age ranged from 24 
to 96 years (mean, 64.8 ±  12.9 years; 
median, 65.7 years). For women, the 
age range was 24 to 93 years (mean, 
64.8 ±  13.5 years; median, 66.2 years). 
The sex distribution of patients by site 
is illustrated in Fig. 2. As is usually 
observed,10"13 there were more women 
among the 178 patients with cancer of 
the colon and more men among the 74 
patients with cancer of the rectum. Six 
patients had synchronous tumours. The 
diagnosis was confirmed histologically 
in all patients.
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The overall proportion of patients 
with localized disease (stages A and B) 
was 47.3% whereas that of patients 
with lymph-node involvement was 
29.8%. Among patients with cancer of 
the sigmoid colon or rectum (i.e., the 
most readily detectable), the diagnosis 
was made at stage A in one of nine, 
whereas approximately one in four had 
evidence of distant spread of the disease 
at the time of diagnosis. The distribu­
tion according to stage did not vary for 
the different sites (Table I).
The distribution of patients accord­
ing to stage of disease among those 
entering the study from 1965 to 1969 
did not differ significantly from the 
distribution among those admitted from
Age - group
FIG. 1—Age distribution of 258 patients 
with colorectal cancer.
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FIG. 2—Sex distribution of patients by 
site of lesion.
1970 to 1974. From the first period to 
the second, however, there was a de­
crease in the proportion of stage B 
patients from 47.3% to 33.6% and an 
increase in the proportion of stage A 
and stage D patients from 4.5% to 
10.3% and 18.7% to 25.3%, respec­
tively.
There was no association between 
mean or median age and the extent of 
disease (Table II). Patients with stage 
A or stage C lesions were on the 
average younger than those with lesions 
classified as stage B or D.
Cumulative survival rate (°/o)
Year a fte r en try
FIG. 3— Observed and expected sur­
vival rates, 1965 through 1975, all stages.
The observed and expected cumula­
tive survival rates are plotted semilo- 
garithmically in Fig. 3. The two curves 
diverge greatly, leading to a 5-year ob­
served cumulative survival rate of 
37.3% ±  3.6% and an expected sur­
vival rate of 76.8%. The 5-year relative 
survival rate was 48.6% ±  4.7%. The 
observed probability of death was high­
est (0.244) in the second year after 
entry and was also very high (0.233) 
in the first year.
Surgery was performed on 257 of 
the 258 patients. It was considered to 
be “curative” for 162 (63%) patients 
and palliative for 95 (37%). Seven 
patients died within 30 days of surgery: 
one patient with a stage A lesion, one 
with a stage C lesion and five with 
distant metastases. The total operative 
mortality rate (2.7%) in our series as 
well as the operative mortality in 
the group of patients who underwent 
resection in the hope of cure (1.2%) 
compare favourably with the rates re­
ported by other authors for patients in 
whom the diagnosis had been made in 
earlier years.11’13'18
When only patients in stages A, B 
and C are included in the analysis, the 
5-year observed and relative cumulative 
survival rates are 49.0% ±  4.3% and 
64.1% ±  5.6%, respectively.
Two-year cumulative survival rates 
by stage of disease appear in Table III. 
As always, observed and relative rates 
decreased significantly with increasing 
extent of disease, ranging from 95.0% 
±  4.9% and 99.4% ± 5 .1 %  for stage 
A to 21.3% ±  5.6% and 23.2% ±  
6.1% for stage D. Because of small
Table II—Median and Mean Ages at Entry and Age Range for Patients in Study* according to
Extent of Disease
Stage Median age, yr Mean age, yr Standard deviation, yr Range,
A (n = 20) 63.0 62.1 10.6 33-82
B (n = 102) 67.4 66.3 12.7 24-89
C (n = 77) 62.7 62.6 13.6 24-96
D (n = 58) 67.5 66.2 13.0 30-93
*Excludes 1 patient of undetermined stage.
Table I—Distribution of Patients by Site and Extent of Disease
Site
Ascending colon, Transverse colon, Descending colon, Sigmoid colon, Rectum, Total,*
Stage no. (and %) no. (and % ) no. (and % ) no. (and %) no. (and % ) no. (and % )
A i
|  (44.1)
i
(54.8) 1 (47.4)
7
(46.4)
9
(45.9)
20 (7.8)
B 25 16 j 8 25 j 25 102 (39.5)
C 20 (33.9) 7 (22.6) 6 (31.6) 16 (23.2) 26 (35.1) 77 (29.8)
D 13 (22.0) 7 (22.6) 4 (21.0) 21 (30.4) 13 (17.6) 58 (22.5)
Undetermined — — — — — — — — 1 (1.4) 1 (0.4)
Total 59 (100.0) 31 (100.0) 19 (100.0) 69 (100.0) 74 (100.0) 258 (100.0)
‘ Includes 6 patients with synchronous tumours (stage A: 1 patient, stage B: 3 patients, stage C: 2 patients).
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Table III—Two-Year Observed and Relative 
Cumulative Survival Rates by Extent of 
Disease
2-year cumulative survival, %
Stage Observed Relative
A 95.0 ±  4.9 99.4 ±  5.1
B 72.8 ±  4.8 80.0 ±  5.3
C 58.5 ±  5.7 63.5 ±  6.2
D 21.3 ±  5.6 23.2 ±  6.1
numbers and large standard errors, 
survival by stage of disease is not given 
beyond 2 years of follow-up.
Discussion
The overall 5-year relative survival 
rate for our patients with colorectal 
cancer is close to the rates reported by 
Cutler, Myers and Green19 for the very 
large sample of patients included in the 
US end results study.
Survival in the end results study 
improved little over time. For cancer 
of the colon, the 5-year relative sur­
vival rate was 44% for patients ad­
mitted in the period 1950 to 1959 and 
45% for those admitted in the period 
1965 to 1969. For cancer of the rec­
tum, the corresponding figures were 
40% and 41%.
While sex, age, site, local vessel in­
vasion and histologic grade influence 
survival, the variable with the greatest 
impact is the extent of disease.20 The 
static overall survival in the end results 
study reflects a depressing stability in 
the distribution of patients by stage of 
disease: the proportion of patients in 
whom colorectal cancer was diagnosed 
at the localized stage increased from 
42.2% in the period 1950 to 1959 to 
only 43.1% in the period 1965 to 
1969.12 The percentage of patients with 
distant metastases remained well over 
20% ,12
In our study, there has been no sig­
nificant trend towards earlier diagnosis 
despite the introduction of universal 
medical insurance in Quebec in 1970. 
However, the increase over time in the 
proportion of stage A patients, though 
not significant, may be a hopeful sign.
Several authors, in particular Bots- 
ford, Aliapoulios and Fogelson11 and 
Peloquin13 have commented upon and 
deplored the large numbers of patients 
in whom the diagnosis is not made until 
an incurable stage is reached. Although 
the trends in stage distribution may be 
somewhat clouded by shifts in the cri­
teria for stage classification together 
with more accurate ascertainment of 
the extent of disease, the fact is that 
the proportion of patients in whom the 
diagnosis is delayed until very late in 
the disease remains high. In view of the 
apparent lack of association between
stage and reported duration of symp­
toms noted by Keddie and Hargreaves21 
and by MacLeod and colleagues,10 ef­
forts should be made towards early 
detection of asymptomatic lesions 
particularly for the easily accessible 
rectal cancer. Routine rectal examina­
tion for all individuals in high-risk age 
groups coming to the physician for any 
reason may be the only hope of im­
proving prognosis.
We acknowledge the help of Drs. P. 
Auger, R. Cote, J. Couture, C. Fortin, 
H.-P. Noel and E. Poulin of the depart­
ment of surgery; J. La Vertu, P. Cote and 
D. Lambert of the tumour clinic and the 
staff of the medical records section, Ho- 
pital du Saint-Sacrement; Dr. J.-M. Fre- 
dette of the Quebec Population Registry 
and W. Morin of the department of social 
and preventive medicine, Laval Univer­
sity.
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Mortality dans le traitement chirurgical d’urgence des 
hemorragies digestives hautes par ulceres et gastrites
Claude D ufour, m d* et M arcel J. R heault, m d , m  sc, frcs[c], FAesf
Soixante-huit cas d’hemorragies 
digestives hautes operes d'urgence ont 
ete evalues retrospectivement, a la 
recherche des facteurs pouvant 
influencer le taux de mortality operatoire 
et la frequence des recidives 
hemorragiques, L’etude a exclu les 
hemorragies secondaires aux varices 
oesophagiennes. Un taux global de 
mortality operatoire de 29.5% a ete 
observe. L'age des patients et le type 
d’intervention chirurgicale ne semblent 
pas avoir influence ce taux, alors 
que la chronicite des lesions et une 
localisation duodenale I'ont affecte 
favorablement. Le choc hypovolemique 
et ses complications ont cause la 
grande majorite des deces. La resection 
gastrique avec vagotomie a semble 
etre ('operation de choix en terme de 
controle de I'hemorragie. Apres une 
breve revue de la litterature, les 
auteurs insistent sur I’importance du 
diagnostic et de la reanimation precoces, 
de meme que sur la necessity d'un 
traitement chirurgical agressif.
A retrospective study of 68 patients 
with acute upper gastrointestinal 
bleeding (excluding bleeding from 
esophageal varices) revealed that all 
patients had emergency surgery. The 
factors influencing the mortality and the 
recurrent bleeding have been sought.
The overall mortality was 29.5%.
Age of patients and type of surgical 
procedure did not affect the mortality 
rate, while chronicity of lesions and 
their duodenal location had a favourable 
influence. Most deaths were due to
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hypovolemic shock and its 
complications. Gastric resection with 
vagotomy is the operation of choice for 
control of bleeding. The authors present 
a brief review of the literature and 
stress the importance of early diagnosis 
and resuscitative measures, as well as 
the need for aggressive surgical 
intervention.
Les operations pratiquees d’urgence 
pour hemorragies digestives secondai­
res aux ulceres aigus duodenaux ou 
gastriques et aux gastrites aigues, sont 
entachees d’une mortalite quasi prohi­
bitive. II est frequent de retrouver dans 
la litterature medicale des taux de mor­
talite se rapprochant de 30%.1-3 Depuis 
quelques annees, a l’Hotel-Dieu de 
Montreal, nous avions l’impression que 
le nombre d’hemorragies digestives ne- 
cessitant une operation d’urgence aug- 
mentait de fa§on sensible. Nous avons 
done decide de revoir notre experience 
des 10 dernieres annees et nos resultats 
dans ce domaine.
Methodes et patients
Cette etude porte sur toutes les ope­
rations pratiquees d’urgence pour he­
morragies digestives hautes par ulceres 
et gastrites a FHotel-Dieu de Montreal, 
entre le ler janvier 1966 et le 31 octo- 
bre 1975, soit sur une periode de pres 
de 10 ans. Elle inclut les hemorragies 
compliquant les ulceres duodenaux, les 
ulceres gastriques primaires et secon­
daires, les ulceres peptiques, recidi- 
vants ou anastomotiques, les ulceres 
aigus et de stress et enfin les gastrites 
aigues hemorragiques. Elle exclut les 
hemorragies secondaires aux varices 
oesophagiennes et enfin les operations 
pratiquees electivement apres qu’une 
hemorragie digestive haute secondaire 
a une des causes precitees se soit 
tarie. L’etude couvre tous les gen­
res d’interventions depuis la gastroto- 
mie et la simple ligature de l’ulcere 
hemorragique, a la resection gastrique 
avec vagotomie. Les operations d’ur­
gence ont ete pratiquees par les 14 
chirurgiens du service ou par les resi­
dents, et sans discrimination de la qua- 
lite des patients qu’ils aient ete d’un 
secteur prive ou public. Les resultats
ont ete soumis a des tests de y2 pour 
determiner leur valeur statistique.
Soixante-huit patients ont repondu 
aux criteres definis pour notre etude. 
La moyenne d’age etait de 59 ans; 34 
patients avaient plus de 60 ans. On 
comptait deux hommes pour une fem­
me.
Vingt-six patients n’avaient aucun 
antecedent de maladie ulcereuse et les 
42 autres patients donnaient une 
anamnese d’ulcere symptomatique. Dix- 
huit patients avaient presente des he­
morragies anterieures et, de ceux-ci, 
12 avaient eu un seul episode hemor­
ragique, 2 avaient eu deux episodes, 
3 avaient eu trois episodes et 1 avait 
eu quatre episodes. Quatre patients de 
cette serie avaient deja eu une perfo­
ration pour laquelle ils avaient ete 
operes.
Les operations pratiquees chez nos 
68 patients peuvent se repartir en qua­
tre groupes: les resections sans vago­
tomies (20 patients), les resections avec 
vagotomies (18 patients), les vagoto­
mies avec pyloroplasties (16 patients) 
et, enfin, les gastrotomies avec ligatu­
res de l’ulcere hemorragique, mais sans 
vagotomie (14 patients).
Resultats
Etude de la mortalite
La mortalite operatoire, definie com- 
me celle survenant dans les 30 jours 
postoperatoires, s’est elevee a 29.5%, 
soit 20 deces. Le taux de mortalite 
pour les 5 premieres annees de notre 
etude etait de 23%, soit 5 deces chez 
22 patients. II ne s’est pas ameliore 
dans les 5 dernieres annees, malgre une 
augmentation du chiffre total des cas 
operes d’urgence, il est meme monte 
a 33%, soit 15 deces chez 46 operes 
d’urgence.
Mortalite selon l’age
Dans notre serie, l’age des patients 
ne semble pas avoir et6 un facteur 
important dans la mortalite. Dans le 
groupe de patients qui avaient moins 
de 60 ans, on trouve 12 deces pour un 
taux de mortalite de 35%, alors que 
dans le groupe de 60 ans et plus, on 
compte seulement 8 deces pour un
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taux de 23%. Cette difference n’a au- 
cune valeur statistique significative 
lorsqu’elle est soumise a un test de x2-
Mortalite selon les antecedents
cliniques
Theoriquement, le taux de mortalite 
aurait du etre negligeable dans le grou- 
pe de patients sans antecedent de ma- 
ladie ulcereuse. II n’en fut rien, 13 
patients de ce groupe sont decedes, 
pour une mortalite de 50%. Dans le 
groupe de 42 patients ayant une anam- 
nese d’ulcere symptomatique, 7 sont 
decedes pour une mortalite de 17%. 
Cette difference est statistiquement si­
gnificative (x2 =  8.4, P <  0.005); avec 
la correction de Yate pour les petits 
nombres x2 est 6.9 et P <  0.01. Chez 
42 patients, on retrouvait les facteurs 
predisposants classiques, soit la prise 
de medicaments, les operations ante- 
rieures ou l’ingestion d’alcool. Quator- 
ze patients de ce groupe sont decedes 
pour une mortalite de 33%.
Mortalite selon le diagnostic
Dans la litterature, on retrouve des 
differences de taux de mortalite selon 
le diagnostic etiologique de l’hemorra- 
gie. Les ulceres duodenaux ont un 
meilleur pronostic que les ulceres gas- 
triques ou les gastrites aigues. Trente- 
cinq patients avaient un ulcere duode­
nal et leur mortalite a ete de 17%, soit 
six deces. Vingt-trois patients porteurs 
d’un ulcere gastrique ont eu une morta­
lite de 39%, soit neuf deces, alors que 
les huit patients ayant souffert de gas- 
trite ont eu une mortalite de 37%, soit 
trois deces. Au test du x2 ces resultats 
ne montrent pas de difference statisti­
quement significative.
Mortalite selon le type d’intervention
Dans les quatre groupes definis pre- 
cedemment on note immediatement que 
les patients qui ont subi une resection 
gastrique etaient en moyenne plus jeu- 
nes de 3 ans comparativement a ceux 
qui ont subi une vagotomie avec drai­
nage et de 8 ans comparativement a 
ceux qui n’ont subi qu’une gastroto- 
mie.
La mortalite varie beaucoup entre 
ces groupes (Tableau I). Dans le pre­
mier groupe (resection sans vagotomie), 
9 des 20 patients sont decedes pour un 
taux de 45%. Dans le deuxieme groupe
(resection et vagotomie), 2 seulement 
des 18 patients operes sont decedes 
pour un taux de 11%. Dans le troisie- 
me groupe (vagotomie et pyloroplastie), 
on compte 5 deces chez 16 patients 
pour un taux de 31% et dans le der­
nier groupe (gastrotomie sans vagoto­
mie), 4 deces chez 14 patients pour un 
taux de 29%. On note que l’intervalle 
entre 1’hospitalisation et l’operation est 
beaucoup plus court dans le groupe qui 
a le taux de mortalite le plus bas, soit 
88 heures en comparaison de 100 et 
102 heures. Aucun de ces resultats, 
soumis au test de x2, n’a montre une 
difference statistiquement significative.
Recidive hemorragique
Un seul groupe n’a pas presente de 
recidive hemorragique, soit les 18 pa­
tients qui ont eu une resection gastri­
que accompagnee d’une vagotomie. Les 
20 patients qui ont eu une resection 
sans vagotomie ont eu un taux de re­
cidive hemorragique de 15%, soit 3 
patients. Les 16 patients qui ont eu 
une vagotomie avec pyloroplastie ont 
eu 4 recidives pour un taux de 25%. 
Les gastrotomies simples avec ligature 
ont un taux de recidive de 36%, soit 
5 recidives chez 14 patients. Certains 
de ces resultats sont statistiquement 
significatifs. La vagotomie avec resec­
tion comparee a la gastrotomie simple 
et ligature montre une difference avec 
une valeur du P <  0.02. Egalement, 
la vagotomie avec resection comparee 
a la vagotomie avec drainage montre 
une difference significative quant au 
taux de recidive hemorragique (P < 
0.05). Si on regroupe les patients qui 
ont eu une vagotomie, on retrouve 34 
patients dont 4 ont resaigne, soit 
11.1%. Si on etudie ceux qui n’ont 
pas eu de vagotomie, on retrouve 8 
recidives hemorragiques chez 34 pa­
tients pour un taux de 23.5%, soit le 
double, mais ces resultats ne sont pas 
statistiquement significatifs.
Causes de deces
Une etude des causes de deces nous 
revele que 13 patients sont morts d’une 
perte sanguine insuffisamment com- 
pensee: 10 ont presente une exsanguina- 
tion avec choc irreversible et 3 sont 
morts d’insuffisance renale. Six autres 
patients sont morts d’une atteinte pul- 
monaire et un, a la suite d’un desequi-
libre electrolytique secondaire, a une 
obstruction de l’anastomose. Dans cet- 
te serie, 32 patients ont presente au 
moins un episode de choc et de ce 
nombre, 13 sont decedes, soit une mor­
talite de 40.6%. En moyenne, nos pa­
tients ont re§u 11 unites de sang avant 
d’etre operes. Le nombre de deces a 
ete proportionnel a la faiblesse de l’he- 
matocrite en preoperatoire (Tableau
II).
Discussion
Dans un hopital general, les hemor- 
ragies digestives hautes par ulceres et 
gastrites aigues sont frequentes. Heu- 
reusement, la tres grande majorite se 
tarit spontanement avec un traitement 
medical conservateur. La chirurgie d’ur- 
gence n’est utilisee que chez un faible 
pourcentage de patients. Nous n’avons 
pas fait la revue de toutes les hemor- 
ragies digestives hautes traitees a l’Ho- 
tel-Dieu de Montreal pendant la pe- 
riode de 10 ans couverte par 1’etude. 
Cependant, une etude d’une duree de 
20 mois a ete faite en 1970 et 1971 
par le docteur Clermont, a l’Hotel-Dieu 
de Montreal.4 II a compare l’abord 
diagnostique vigoureux par endoscopie 
immediate, a l’attitude traditionelle 
conservatrice. Pendant cette periode, 
153 patients ont ete traites et 27 (18%) 
ont eu une sanction chirurgicale, soit 
urgente, soit retardee apres arret de 
l’hemorragie. De ce groupe 10 patients 
ont ete operes d’urgence et aucun n’est 
decede des suites operatoires. Ces re­
sultats ne peuvent se comparer a l’en- 
semble de nos resultats. On serait tente 
de conclure que la solution pour dimi- 
nuer la mortalite chirurgicale des 
hemorragies digestives hautes consiste 
a adopter une attitude agressive quant 
au diagnostic endoscopique. Une etu­
de prospective et randomisee, emanant 
du Michael Reese Hospital and Med-
Tableau I I— Taux d'hem atocrite preopera-
toire et m ortalite
Hematocrite en No. de No. deces
preoperatoire, % patients (et % )
<  25 38 15 (39.5)
2 5 -3 0 23 4 (17.4)
> 3 0 7 1 (14.3)
Tableau I— Hemorragies digestives operees d’urgence. Hotel-Dieu de Montreal 1966 a 1975
Operation
No. de 
patients
No. deces 
(et % )
Moyen age, 
an
Unites de 
sang regues
Intervalle entre  
1’hospitalisation 
et la chirurgie, h
No. recidives 
hemorragiques 
(et % )
Resection sans vagotomie 20 9 (45) 56.5 i i 146 3 (15)
Resection avec vagotomie 18 2 (11) 57 12 88 0 (0)
Vagotomie et pyloroplastie 16 5 (31) 60 11 100 4 (25)
Gastrotomie sans vagotomie 14 4 (29) 64.5 10 102 5 (36)
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ical Center de Chicago, a montre que 
cet abord n’a nullement diminue la 
mortalite operatoire dans cette institu­
tion, oil elle est demeuree a 30% chez 
20 patients operes d’urgence.1
Des articles publies depuis 1973 ont 
signale des taux de mortalite aussi ele- 
ves que ceux retrouves a l’Hotel-Dieu 
de Montreal. Crook et ses collabora­
teurs3 du Louisiana State University, 
ont rapporte une mortalite de 31% 
dans leurs resultats d’operations d’ur­
gence pour hemorragies digestives hau- 
tes. Yajko, Norton et Eiseman,2 du 
Denver General Hospital ont rapporte 
une mortalite operatoire de 29%. 
Sandlow et ses collaborateurs,1 du 
Michael Reese Hospital and Medical 
Center de Chicago, ont signale un taux 
de mortalite de 30% dans les memes 
circonstances. Ces resultats corroborent 
les notres et montrent que malgre les 
progres de la medecine et de la chirur- 
gie, les operations d’urgence pour he­
morragies digestives massives hautes, 
sont grevees d’une mortalite tres elevee.
Dans notre serie, l’age des patients 
ne semble avoir joue aucun role quant 
au taux de mortalite. Ceci ne corres­
pond cependant pas a la litterature me- 
dicale ou la mortalite s’eleve, en gene­
ral, avec l’age.3'5'9
II est interessant de noter que les 
patients qui n’avaient aucun antece­
dent de maladie ulcereuse ont eu un 
taux de mortalite statistiquement plus 
eleve que ceux qui avaient un passe 
ulcereux connu. Cette constatation con- 
firme en partie les travaux de Byrne, 
Guardione et Williams5 qui ont montre 
un taux de mortalite plus eleve a l’oc- 
casion de la premiere hemorragie, com- 
paree a une deuxieme, une troisieme 
ou a de multiples hemorragies.
La mortalite chez nos patients ayant 
un diagnostic d’ulcere duodenal est in- 
ferieure a la mortalite par ulcere gas- 
trique ou par gastrite aigue. Cependant, 
nos resultats ne sont pas statistique­
ment differents. A la clinique Mayo, 
ou on a etudie la mortalite de 61 pa­
tients porteurs d’ulcere duodenal opere 
d’urgence, la mortalite a ete a 11.5%, 
soit 7 patients decedes.10 Crook et ses 
collaborateurs3 ont observe une mor­
talite de 14% pour les ulceres duode- 
naux operes d’urgence et de 26% pour 
les ulceres gastriques. Foster, Hickok 
et Dunphy9 ont eu des pourcentages de 
20% et 26% respectivement. Yajko, 
Norton et Eiseman2 ont rapporte une 
mortalite de 42% pour les gastrites al- 
cooliques et Crook et ses collabora­
teurs,3 de 49%.
L’operation ideale dans les cas d’ur­
gence n’a pas encore ete etablie scien- 
tifiquement avec certitude. La gastro- 
tomie avec ligature de l’ulcere est a 
rejeter a cause de son taux de recidive 
hemorragique trop eleve. La vagotomie 
avec pyloroplastie est tres populaire,
surtout depuis que Foster, Hickok et 
Dunphy9 ont demontre qu’ils avaient 
reussi a diminuer le taux de mortalite 
de moitie apres etre passes de la resec­
tion gastrique a la vagotomie et pyloro­
plastie. L’objection principale a la re­
section gastrique est le taux de morta­
lite qui serait plus eleve. Byrne, Guar­
dione et Williams,5 Wilkinson,6 Buck­
ingham et Remine10 et nous-memes11 
n’avons pu demontrer une difference 
de mortalite entre ces deux modes 
d’operation. II est tres difficile de ju- 
ger de la superiority de la valeur d’une 
operation comparee a l’autre parce que 
beaucoup de chirurgiens emploient la 
vagotomie avec pyloroplastie chez des 
patients moribonds et juges trop ages 
pour subir une resection. L’objection 
principale a la vagotomie et pyloroplas­
tie est le taux de recidive hemorragique 
qui, dans notre serie, est plus eleve que 
pour la vagotomie avec resection. II est 
a noter que dans notre serie, comme 
dans celle de Yajko, Norton et Eise­
man,2 qu’aucun patient qui a subi une 
vagotomie avec resection n’a eu de 
recidive.
L’etude des causes de deces montre 
que le manque d’agressivite du chirur- 
gien, ou encore son espoir de voir la 
nature juguler d’elle-meme l’hemorra- 
gie, sont responsables, en grande partie, 
d’un taux de mortalite aussi eleve. Nos 
patients ont ete operes en moyenne 
pres de 100 heures apres leur hospitali­
sation, et apres qu’on leur eut infuse, 
en moyenne, 11 unites de sang.
Read, Huebl et Thai,12 dans une 
etude randomisee, ont compare le trai- 
tement chirurgical immediat au traite- 
ment chirurgical retarde. Trente-trois 
patients porteurs d’ulcere gastrique ou 
duodenal ont ete operes, en moyenne, 
5 heures apres leur hospitalisation, et 
apres avoir re?u une moyenne de huit 
unites de sang (4.5 en preoperatoire): 
il n’y a eu aucun deces dans ce groupe. 
Le groupe compare comportait 20 su- 
jets operes, en moyenne, 32 heures 
apres leur hospitalisation et apres avoir 
regu une moyenne de 15 unites de sang 
(9 en preoperatoire): la mortalite de 
ce groupe s’est elevee a 30% (6 deces). 
Si Ton se base sur ces criteres, nos pa­
tients faisaient partie de ce dernier 
groupe et ont presente le meme taux 
de mortalite.
Chez une serie de 456 patients trai- 
tes pour hemorragie, Palmer13 a demon­
tre que la mortalite augmentait de fa- 
gon significative avec le nombre de 
transfusions; les sujets qui avaient regu 
moins de 6 unites du sang ont eu un 
taux de mortalite inferieur a 4%, 
ceux qui ont regu entre 7 et 9 unites, 
ont vu ce taux augmenter a 16% et 
ceux qui ont regu plus de 10 unites 
ont atteint un taux de mortalite de 
26%. Thorne et Nyhus14 ont presente 
des chiffres encore plus dramatiques:
30 de leurs patients ont regu plus de 
10 unites, et le taux de mortalite a ete 
de 70%.
Conclusion
La chirurgie d’urgence de l’hemor- 
ragie par maladie ulcereuse ou par 
gastrite aigue est grevee d’un taux de 
mortalite tres eleve, soit pres de 30%. 
L’age des patients semble etre un fac- 
teur important selon la litterature me- 
dicale consultee, quoique ceci ne se soit 
pas reflete dans notre serie. Le premier 
episode hemorragique montre un taux 
de mortalite plus eleve que les episodes 
ulterieurs. La localisation de l’ulcere 
est importante, les ulceres duodenaux 
ont un meilleur pronostic vital que les 
ulceres gastriques. Les gastrites aigues 
hemorragiques qui ne se tarissent pas 
spontanement ont egalement un taux 
de mortalite tres eleve.
Le genre d’intervention dans notre 
serie ne semble pas jouer un role im­
portant quant a la mortalite, mais il a 
influence cependant la recidive hemor­
ragique. Pour cette derniere raison, 
nous rejetons la gastrotomie simple 
avec ligature de l’ulcere et nous prefe- 
rons la vagotomie et resection a la 
vagotomie et pyloroplastie. Enfin, le 
facteur le plus important pour diminuer 
le taux de mortalite consiste a poser un 
diagnostic precoce par une endoscopie 
de type agressif, et de proceder a l’in- 
tervention chirurgicale dans les plus 
brefs delais, tout en procedant a une 
reanimation rapide et agressive.
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The Gastroplasty
Follow-up of 135 patients who under­
went Belsey gastroplasty because of 
intractable reflux demonstrated that 
44% had continued reflux and 25% had 
symptoms of reflux that were serious, 
despite a very low rate of anatomic 
recurrence. Most of the patients with 
symptomatic reflux had major pre­
existing esophageal pathologic con­
ditions related to previous surgery, 
esophageal ulceration, stricture, or 
scleroderma. In this group Belsey 
gastroplasty was not an effective 
method of reflux control.
Total fundoplication gastroplasty 
(TFG) in 100 consecutive patients has 
so far had the same low rate of 
anatomic recurrence, most likely related 
to the gastroplasty tube; however, 
longer follow-up is necessary to confirm 
this fact. TFG is effective in controlling 
reflux; none of the 100 patients so 
treated had clinical or radiologic 
evidence of reflux on follow-up 
examination.
Le suivi de 135 patients qui ont subit 
une gastroplastie de Belsey pour 
reflux gastrique resistant, a demontre 
que 44% avaient une persistance du 
reflux et que 25% souffraient de serieux 
symptomes de reflux en depit d'un 
tres faible taux de recidive anatomique. 
La plupart des patients presentant des 
symptomes de reflux souffraient deja
From the department of surgery, 
University of Toronto, Toronto, Ont.
Presented at the annual meeting of the 
Royal College of Physicians and 
Surgeons of Canada, Toronto, Jan.
27, 1977
Reprint requests to: Dr. R.D. Henderson, 
Department of surgery, Women’s 
College Hospital, Toronto, Ont. M5S 1B2
res precoces de la vagotomie. Union 
Med Can 101: 2432, 1972 
12. Read RC, H uebl HC, Thal AP: Ran­
domized study of massive bleeding 
from peptic ulceration. Ann Surg 
162: 561, 1965
Tube as a Method
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de pathologie oesophagienne importante 
resultant de chirurgie anterieure, 
d’ulceration oesophagienne, de stricture 
ou de sclerodermie majeures. Parmi ce 
groupe, la gastroplastie de Belsey ne 
s'est pas averee efficace pour controler 
le reflux gastrique.
La gastroplastie par plicature com­
plete du fundus (GPF) effectuee chez 
100 patients consecutifs a, jusqu'a 
maintenant, montre le meme faible taux 
de recidive anatomique, probablement 
grace au tube de gastroplastie; tou- 
tefois, ce fait devra etre confirme par 
un suivi plus prolonge. La GFP est 
efficace pour controler le reflux 
gastrique; aucun des 100 patients traites 
de cette facon n’a montre de signes 
cliniques ou radiologiques de reflux 
aux examens de post-cure.
The fact that many different operations 
have been developed to control gastro­
esophageal reflux indicates that no 
single operation has achieved total suc­
cess. The ability to produce effective 
reflux control and avoid anatomic 
recurrence of the hiatal hernia are the 
two major factors to be considered in 
assessing the results of surgery.
From evaluation of the results of the 
Nissen,1 Hill2 and Belsey3 hernia re­
pairs, the Nissen4 total fundoplication 
appears to be the most successful meth­
od of preventing reflux. Despite its 
effectiveness, this operation and other 
standard repairs all result in a high 
rate of anatomic recurrence. The stand­
ard repair of Belsey, which is the one 
most often studied, has a recurrence 
rate of 11.5% at 10 years.5
When the esophagus is shortened by 
panmural esophagitis or scarring,5 the 
hernia cannot be reduced by surgical 
means. Attempted repair by standard 
methods results in an even higher
13. Palmer ED: Upper gastrointestinal 
hemorrhage. JAMA 231: 853, 1975
14. Thorne FL, N yhus LM: Treatment 
of massive upper gastrointestinal 
hemorrhage: a ten-year review. Am  
Surg 31: 413, 1965
of Reflux Control
rate of anatomic recurrence.6 Collis7 
developed his gastroplasty tube for the 
management of patients with gastroeso­
phageal reflux. With this method, a 
tube is cut from the lesser curve of the 
stomach, in continuity with the eso­
phagus, and the hernia fundoplication 
is created around the gastroplasty tube. 
Pearson8,9 modified this operation by 
using a Belsey fundoplication rather 
than the Collis procedure to fix the 
gastroplasty tube below the diaphragm. 
This operation is commonly referred 
to as a Belsey gastroplasty, but a bet­
ter term is partial fundoplication gas­
troplasty.
In my experience, the Belsey gastro­
plasty has effectively reduced the fre­
quency of anatomic recurrence of the 
hernia to a very low level; nevertheless, 
continued reflux is a major problem.10 
For this reason, a modified Nissen 
fundoplication has been added to the 
use of the gastroplasty tube, in an at­
tempt to reduce both anatomic recur­
rence and reflux to a more acceptable 
level. This operative procedure is re­
ferred to as a total fundoplication gas­
troplasty (TFG).
Patients and Methods
Belsey gastroplasty was performed 
on 135 patients with medically intract­
able gastroesophageal reflux. Follow­
up ranged from 2.5 to 7.5 years (aver­
age, 3.2 years).
In addition to having a detailed his­
tory taken, all patients were evaluated 
by radiology, manometry and endo­
scopy before surgical correction. Eso­
phageal manometry was performed 
with PE 190 catheters with side open­
ings located 2.5 and 5 cm apart. Con­
stant water infusion was maintained at 
6.8 mL/min per tube with a modified
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Harvard pump. Statham P23De strain 
gauges were used as sensing devices 
and data were recorded on a 1508 
Honeywell ultraviolet Visicorder 
(Honeywell, Denver, CO).
Of the 135 patients, 127 were seen 
at follow-up, 5 were contacted by let­
ter or reports were received from the 
family practitioner, 2 were lost to fol­
low-up and 1 died at operation. In 
115 patients radiologic studies were 
undertaken to determine the presence 
of recurrence or reflux and in 39 fol­
low-up esophageal manometry was per­
formed.
Of those treated by Belsey gastro­
plasty, 32 had undergone previous 
hernia repair and 35 previous gastric 
surgery, 27 had a peptic stricture, 7 
had scleroderma, 3 had had previous 
esophageal myotomy and 28 had an 
uncomplicated hiatal hernia.
One hundred consecutive patients 
were treated by TFG because medical 
management had failed; 23 had a recur­
rent hiatal hernia, 10 had had previous 
gastric surgery, 3 had a peptic stric­
ture, 2 had scleroderma, 3 had had a 
previous myotomy and 59 had an un­
complicated hiatal hernia. One patient 
could not be evaluated preoperatively 
by manometry because of a very tight 
stricture, which made the measure­
ments obtained inaccurate. Follow-up 
was from 6 months to 2Vi years (aver­
age 15 months).
The technique of preparing a gas­
troplasty tube is similar for both the 
Belsey8 and total fundoplication10 pro­
cedures. A transthoracic or thoraco­
abdominal incision is used and the 
esophagus is mobilized to the aortic 
arch. The tube is cut over a Maloney 
bougie and the incision in the tube and 
fundus closed with continuous 2-0 
chromic catgut and 3-0 silk sutures in 
two layers. Posterior crural sutures of 
1-0 silk are placed ready to be tied 
following fundoplication (Fig. 1).
The Belsey fundoplication was 
created with four layers of transverse
sutures, fixing the fundus of the 
stomach to the gastroplasty tube and 
distal esophagus and covering 240° of 
their circumference. Fixation to the dia­
phragm was by suturing the fundus 
directly to its under-surface (Fig. 2).
TFG is created by sewing fundus to 
gastroplasty tube and, where possible, 
the distal 2 cm of esophagus with a 
single layer of interrupted mattress 
sutures of 2-0 silk. Following fixation 
the fundus is then wrapped circum­
ferentially and complete fundoplica­
tion effected over a length of 3.5 cm 
with interrupted mattress sutures of 2-0 
silk. In TFG the following measure­
ments are strictly followed: gastro­
plasty tube, 5 cm; lower esophageal 
suturing, 2 cm; complete fundoplica­
tion, 3.5 cm (Fig. 3). Where severe 
disordered motor activity (DMA) or 
scleroderma is present or a previous 
myotomy has been performed, the 
length of total fundoplication is reduced 
to 2 cm to avoid overcompetence and 
dysphagia. To confirm that the repair 
is not too tight, on completion of the 
fundoplication it should be possible 
to admit a finger easily between the 
wrap and the gastroplasty tube.
In 11 patients a previous Belsey 
gastroplasty was converted to a TFG 
because of failure to control reflux, 
severe residual symptoms of reflux and 
a poor response to vigorous conserva­
tive management. Eight of these pa­
tients were followed up for 6 months 
or more and are included in the present 
study. In each patient a short thoraco­
abdominal incision was used and the 
gastroplasty flap taken down with­
out further mobilization. The gastro­
plasty tube was measured and cali­
brated with a no. 60 French bougie 
before conversion to a TFG. Follow­
up ranged from 6 to 13 months (aver­
age, 10.8 months).
Results
Each patient was assessed and the
results were categorized as follows: 
stage la, patients were totally asymp­
tomatic with no radiologic evidence of 
reflux; stage lb, patients had minor 
nonspecific symptoms but were gen­
erally well with no clinical or radio- 
logic evidence of reflux; stage 2, pa­
tients had radiologic evidence of reflux 
and mild symptoms; stage 3a, patients 
had severe symptoms and radiologic 
evidence of reflux; stage 3b, patients 
had anatomic recurrence.
With Belsey gastroplasty, stage la  
results were achieved in 28.7% of pa­
tients; stage lb  in 25% and stage 2 
in 18.9%. The most important finding 
was the high incidence of substantial 
radiologic and symptomatic reflux, 
which occurred in 25.7% of patients.
FIG. 2—Belsey wrap. Modified Belsey 
fundoplication is used for fixation of gas­
troplasty tube. Newly created fundus of 
stomach is sutured to tube and lower 
esophagus to give 240° wrap. This is then 
reduced below diaphragm and crurae are 
closed with interrupted silk sutures.
FIG. 3— Nissen wrap. TFG is completed 
by wrapping 5-cm gastroplasty tube (A) 
and distal 2 cm of esophagus (B) with 
newly created gastric fundus. Total fundo­
plication is complete over 3.5 cm (C).
FIG. 1—Technique for preparing gastroplasty tube. Tube is same for Belsey and 
total fundoplication gastroplasty (TFG). It is cut from lesser curve of stomach over 
Maloney bougie. Sutured tube is then fixed below diaphragm by fundoplication.
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Anatomic recurrence was present in 
1.5% of patients.
Correlation between the results of 
Belsey gastroplasty and the presence 
or absence of pre-existing major eso­
phageal or gastric pathologic changes 
showed a much higher incidence of 
continuing radiologic and symptomatic 
reflux when gastroplasty was performed 
after previous gastric or esophageal 
surgery or esophageal myotomy, or in 
the presence of peptic stricture or 
scleroderma (Table I).
In patients with a TFG, stage la 
results were achieved in 61% of pa­
tients and stage lb in 38%. No patient 
had radiologic or symptomatic reflux 
and 1 % had anatomic recurrence 
(stage 3 b).
Two patients with a TFG had con­
tinued severe dysphagia and required 
modification of their fundoplication. 
Both had very severe DMA and this 
was considered to be a contributory 
factor. The length of fundoplication 
was reduced to 2 cm with effective 
relief of symptoms. In both instances 
the patients were operated upon early 
in the study; now such problems can 
be anticipated and avoided.
Two patients with Belsey gastro­
plasty and one with a TFG had ana­
tomic recurrence and all required fur­
ther surgery to control reflux. Of the 
two with Belsey gastroplasty one had 
a repeat repair with Belsey gastro­
plasty and the other with TFG. The 
third patient who had a TFG had a 
repeat repair with TFG. All these pa­
tients are now asymptomatic.
None of the eight patients in whom 
a Belsey gastroplasty was converted 
to a Nissen gastroplasty had evidence 
of reflux on clinical and radiologic 
evaluation.
Results of Manometry
Esophageal manometry was per­
formed in 39 patients with a Belsey 
gastroplasty 3 to 36 months after op­
eration (average, 11.8 months). In 51 
patients with a TFG, manometry was 
performed 3 to 12 months postoper- 
atively (average, 5.2 months).
With Belsey gastroplasty the average
T a b le  1— B e ls e y  G a s tro p la s ty .  In c id e n c e  o f
S y m p to m a t ic  R e f lu x  in  r e la t io n  to P r e v io u s
E s o p h a g e a l D is e a s e
E s o p h a g e a l  d is e a s e  In c id e n c e ,  %
P r e v io u s  g a s t r ic  s u r g e r y 32
P r e v io u s  e s o p h a g e a l  s u r g e r y 28
P e p t ic  s t r i c t u r e 21
S c le r o d e r m a 45
P r e v io u s  m y o to m y 1 0 0
U n c o m p l ic a t e d  h e r n ia s 3
T o t a l  in c id e n c e 2 5 .7
tone of the high pressure zone (HPZ) 
decreased by -2.4 cm H20  and with 
TFG the tone of the HPZ increased 
by +4.2 cm H20  following operation.
DMA in the distal half of the eso­
phagus decreased by -2.4% with Bel­
sey gastroplasty and by -18% with 
TFG.
The excess of pressure in the gastro­
plasty tube over that in the gastric 
fundus, recorded during manometric 
study, averaged 1.4 cm H20  after Bel­
sey gastroplasty and 1.7 cm H20  after 
TFG.
Discussion
The reported results of Belsey gas­
troplasty vary widely. Pearson reported 
follow-up of 163 patients of whom 11 
(6.8%) had symptomatic reflux; re­
flux was demonstrated radiologically in 
18 (13.6%) of 132 patients, but no 
manometric data were recorded.10 Or- 
ringer reported on 83 patients operated 
on since 1974 with follow-up available 
on 76 (average follow-up of less than 
1 year); 21 (27.7%) had moderate to 
severe reflux and 12 (15.7%) had 
symptoms of reflux.10 In our study the 
total incidence of radiologic reflux 
was 44% and of symptomatic reflux 
25.7%, with a much longer follow-up.
In all three studies the frequency 
of radiologic recurrence of the hernia 
was much below that recorded for 
standard hiatal hernia repair.
An explanation for the difference in 
results is not readily forthcoming but 
must lie in the methods used in follow­
up evaluation, in some aspect of op­
erative technique, or in the extent of 
pre-existing esophageal pathology.
Three aspects of operative technique 
that may vary are the methods of su­
ture fixation, the length and diameter 
of the gastroplasty tube and the ex­
tent of circumferential wrap involved 
in the Belsey fundoplication. Suture 
fixation is unlikely to be important 
since the rate of anatomic recurrence 
is low. Variations in tubal length and 
diameter have been considered a pos­
sible source of difference; however, 
in all three studies a 5- to 6-cm gas­
troplasty tube was used. With regard 
to tubal diameter, Orringer used a no. 
60 French bougie to cut his tubal seg­
ment, Pearson used a no. 50 French 
bougie and I used a no. 46 or no. 50 
French bougie in 85% of patients and 
a no. 56 or no. 60 in 15%.10 I found 
the results were unaffected by the size 
of tube used.
All three authors described their 
fundoplications as being 240°, follow­
ing the original technique reported by 
Belsey so that this is unlikely to ac­
count for differences in results. Pre­
existing pathologic change is of major 
importance and the rate of reflux in­
creases sharply in patients who have 
had previous surgery or who have dis­
orders producing motor damage (Table 
I). This factor may be the key to the 
differences in reported results.
Control o f R eflux
following Gastroplasty
TFG effectively controlled reflux 
regardless of the preoperative condi­
tion. The gastroplasty with Belsey re­
pair, while effective in those with un­
complicated hernias, was ineffective 
when the esophagus had been damaged 
by previous surgery or disease. To ex­
plain this the various properties of the 
gastroplasty tube, the HPZ and the 
fundoplication were examined to de­
termine differences in the operative 
technique that might explain the 
clinical results.
In the normal subject (Fig. 4) the 
distal HPZ and the intra-abdominal 
segment of esophagus are important in 
the control of reflux.11 For effective 
control, the sphincter must be able to 
resist reflux (intragastric) pressures in 
the stomach. Increases in intraperi- 
toneal pressure may occur with pos­
tural change or with lifting. Selective 
increases in intragastric pressure not 
associated with increased peritoneal 
pressure may occur with eating or gas­
tric contraction. Increased intraperi- 
toneal pressure acts on both stomach 
and intra-abdominal esophagus. These 
pressures counterbalance each other 
and the sphincter continues to exert 
a pressure barrier preventing reflux. 
When gastric pressure is selectively in­
creased, the sphincter increases its tone 
through neurogenic and hormonal re­
flexes, and again reflux is prevented.
Gastroplasty tubes provide an intra­
abdominal segment of tubed stomach. 
In the present study, pressure measure­
ments in the gastroplasty tubes were 
very low (1.4 cm H20  after Belsey 
gastroplasty and 1.7 cm H20  after
FIG. 4—Pressure barrier controlling 
reflux in normal subject. Increased intra- 
peritoneal pressure (AP) acts on both intra­
abdominal esophagus and stomach so that 
reflux does not occur. Increases in gastric 
pressure are counterbalanced by sphinc- 
teric tone (Ts) plus neurogenic (N) and 
hormonal (H) reflexes.
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TFG). One paper does describe high 
pressures in gastroplasty tubes studied 
soon after operation; however, these 
measurements were on eight patients 
studied at 1 week to 3 months12 and 
were contrary to those found in long­
term studies of 90 patients in the 
present report and in 76 patients 
studied by Orringer.10 If the pressure 
measurements in the gastroplasty tube 
are considered to be low, then this 
tube acts passively and, while it may 
prevent reflux due to increases in in- 
traperitoneal pressure (Fig. 5), it can­
not resist reflux from selective increases 
in gastric pressure. The effectiveness 
of the HPZ in this situation is critical 
to reflux control. If the HPZ is intra­
abdominal and capable of responding
FIG. 5—Gastroplasty tube. When gas­
troplasty tube is used intraperitoneal pres­
sure increases (AP) act both on stomach 
and tube and are counterbalanced to pre­
vent reflux. Selective pressure increases in 
stomach are counterbalanced by tubal tone 
plus sphincteric pressure (T0). Neurogenic 
and hormonal reflexes may not be active 
owing to previous disease or injury, and 
reflux may occur.
FIG. 6— Belsey gastroplasty. With Bel- 
sey gastroplasty, 240° wrap helps in trans­
mission of gastric pressure to gastroplasty 
(R,); however, bare area of tube (X) pre­
vents total transmission of gastric pressure 
and this may result in reflux.
to neurogenic and hormonal influences, 
reflux will be prevented. If the sphinc­
ter has been damaged by previous sur­
gery or disease, it may be unresponsive 
and reflux will then occur.
The type of fundoplication then be­
comes critical in reflux control. The 
Belsey fundoplication is a 240° wrap 
of gastroplasty and sphincter (Fig. 6). 
Selective increases in gastric pressure 
can be transmitted to the gastroplasty 
tube and sphincter by the fundoplica­
tion; however, this pressure transmis­
sion will be incomplete, as 120° of the 
circumference is not wrapped with 
stomach.
With the TFG, fundoplication is 
360° (Fig. 7) and will transmit intra- 
gastric pressure to the gastroplasty tube. 
Because of this, the TFG effectively 
provides resistance to both passive in­
creases in peritoneal pressure and selec­
tive increases in gastric pressure.
These theoretical considerations have 
not been proved; however, they ex­
plain why Belsey gastroplasty is suc­
cessful in patients with uncomplicated 
hernias yet does not control reflux in 
those with major pre-existing pathologic 
conditions.
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Critique of Items 456-458 (SESAP II)
456—For item 456, response (A) is correct. During the 40 years of its course 
to date, the epidemic of carcinoma of the lung has caused almost a million 
deaths in the United States alone, and another million can be almost certainly 
predicted before the epidemic subsides. The predominance of males among lung 
cancer patients, as well as the remarkable increase in rates observed in the 
countries of western Europe beginning about 1920, suggests that cigarette 
smoking might be responsible. Several dozen studies have subsequently shown 
that the risk of developing lung cancer increases regularly in proportion to 
the number of cigarettes an individual smokes. Smokers of two or more packs 
of cigarettes per day have about 20 times the risk of nonsmokers. About 10 
per cent of smokers of two or more packs per day can be expected to develop 
lung cancer. Smokers of cigars and pipes have lung cancer risks that are 
definitely higher than those of nonsmokers. It is estimated that over 90 per 
cent of the present incidence of lung cancer in this country could be prevented 
by eliminating the effect of cigarette smoking.
A
457—For item 457, response (B) is correct. The overall incidence of cancer 
of the colon and rectum has remained about the same during the past 30 to 
40 years, as is shown on the graph. It was predicted that cancer of the colon 
and rectum would afflict about 75,000 new patients every year and cause 
46,000 deaths per year. This makes the colon and rectum the leading site of 
cancer in both males and females in North America (exclusive of skin cancers 
which are rarely associated with any mortality) and, after lung cancer, the 
second most fatal carcinoma. The high incidence of cancer of the large bowel 
among persons living in the United States, Canada, and western Europe, 
compared to Japan, Africa, and other eastern countries, has aroused much 
speculation regarding etiology. The fact that the death rate among Japanese 
migrating from Japan to the United States rises and approaches the mortality 
in the United States has led some epidemiologists to conclude that the cause 
of cancer of the large bowel is not racial or genetic, but environmental. It has 
been known for decades that degradation products of bile '•re carcinogenic 
to animals. Burkitt (1971) has postulated that, since the inhai itants of the 
United States eat a diet high in refined carbohydrates (with low residue), any 
carcinogen in the bowel lumen would consequently be present in much higher 
concentration, particularly if there is bowel stasis, which appears to be 
prevalent in the United States.
B
458—For item 458, response (C) is correct. One of the most fascinating 
aspects of malignant disease, as outlined on the graph, is the marked reduction 
in the incidence of carcinoma of the stomach in the United States during the 
past 40 years. From 1935 to 1939, there were 17 men with cancer of the 
stomach for every 10 men with cancer of the colon. Colonic cancer did not 
change markedly over the next 30 years as carcinoma of the stomach declined, 
so that by 1960 to 1964 there were only 6 men with stomach cancer for 
every 10 with colonic cancer. The cause of this dramatic decline in carcinoma 
of the stomach has provoked a great deal of speculation but remains an 
enigma.
References
456-458/1. Longmire WP Jr: Carcinoma of the stomach, in Sabiston DC Jr 
(ed): (Davis-Christopher) Textbook of Surgery, ed 10. Philadelphia, WB 
Saunders Co, 1972, pp 860-861
456-458/2. Cohn I Jr, Nance FC: The colon and rectum, in Sabiston DC Jr 
(ed): (Davis-Christopher) Textbook of Surgery, ed 10. Philadelphia, WB 
Saunders Co, 1972, p 965
456-458/3. Cole WH: Cancer of the colon and rectum. Surg Clin North Am 
52:871-881, 1972
456-458/4. Statistics on cancer. CA 17:34-43, 1967
456-458/5. Silverberg E, Grant RN: Cancer statistics, 1970. CA 20:11-23, 1970
456-458/6. Silverberg E, Holleb AI: Cancer statistics, 1974—Worldwide epi­
demiology. CA 24:2-21, 1974
456-458/7. Burkitt DP: Epidemiology of cancer of the colon and rectum. 
Cancer 28:3-13, 1971
VOLUME 21, NO. 3, MAY 1978 / THE CANADIAN JOURNAL OF SURGERY 269
Lipid Alterations in Acute Pancreatitis
E.J. L azaro, m d , frcs[c], facs,* A.K. Bose, sc d, f  R. Spraggins, ph  Df and B.R. D ispen ziere , bs*
The authors studied the lipid profile 
in acute pancreatitis in humans and 
also in dogs in which this disease had 
been induced experimentally. Blood 
samples were analysed by mass 
spectroscopy and gas chromatography. 
During the acute phase of the pan­
creatitis there was a significant reversal 
of the ratio of unsaturated fatty acids. 
There was a marked increase in the 
concentration of fatty acids in the 
blood with monounsaturation in both 
carbon-16 and carbon-18 chains and 
diunsaturation in the later carbon 
chains. These changes have not been 
reported in any disease state.
Les auteurs ont etudie le bilan lipidique 
dans la pancreatite aigue chez des 
humains ainsi que chez des chiens dont 
cette maladie avait ete provoquee 
experimentalement. Les echantillons 
de sang ont ete etudies par spectroscopie 
de masse et par chromatographie 
gazeuse. Durant la phase aigue de la 
pancreatite une inversion significative 
du rapport des acides gras insatures 
a ete observee. II y a eu une augmen­
tation marquee de la concentration des 
acides gras du sang avec monoinsatu­
ration sur les chaines a 16 et 18 
carbones et bisinsaturation sur les 
chaines plus longues. De tels change- 
ments n’ont pas ete signales dans 
aucune maladie.
Lipid abnormalities that are known to 
occur in acute pancreatitis include the 
presence of lactescent serum, hypertri­
glyceridemia, decreased postheparin li­
polytic activity and abnormal lipopro­
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tein electrophoretic patterns.1 In this 
communication we describe important 
and hitherto unreported changes in 
carbon-16 and carbon-18 fatty acids 
of the blood in acute pancreatitis in­
duced experimentally in dogs and also 
in acute pancreatitis in humans.
Materials and Methods
Acute pancreatitis was produced in 
seven dogs (experimental group) by use 
of the Pfeffer closed duodenal loop 
preparation. In 18 dogs (control group) 
various conditions that clinically re­
semble acute pancreatitis and that may 
be associated with elevated amylase 
and lipase concentrations were created 
experimentally. .These included celio­
tomy (in three dogs), bilateral ureteral 
ligation (in three), duodenal perfora­
tion (in three), strangulation obstruction 
(in four), strangulation obstruction with 
manipulation of the common bile duct 
(in three) and hemipancreatectomy (in 
two). Venous blood samples were ob­
tained at 0 hours and 3, 6 and 9 hours 
after completion of each operative pro­
cedure. At the conclusion of each ex­
periment the animal was killed with an 
overdose of pentobarbital sodium and 
an autopsy was performed.
Both mass spectroscopy and gas 
chromatography were used for analysis 
of blood samples. Mass spectroscopy 
interfaced with gas chromotography 
was particularly useful for analysis of 
the fatty acids as methyl esters. This 
method identified the variable we were 
concerned with in this study, that is, 
increased unsaturation of the fatty 
acids.
The fatty acid fractions were recov­
ered by means of saponification with 
1.0 N sodium hydroxide. The acids 
were converted to methyl esters with 
diazomethane and known weight solu­
tions were analysed by gas chromato­
graphy and by the use of arachidic acid 
as an internal standard to obtain quan­
titative results.
The fatty acid profile was studied in 
three patients with acute pancreatitis 
and in five patients with nonpancreatic 
acute abdominal disease (controls).
Results
Histopathologic evidence of acute 
pancreatitis was present in all animals 
with the Pfeffer loop. Mild pancreatic 
inflammation occurred in animals with 
hemipancreatectomy and those with 
strangulation obstruction in which the 
common bile duct was also manipu­
lated.
With our data from initial and final 
samples of the control dogs, and from 
initial samples of the dogs with pan­
creatitis, a baseline was established 
from which we observed the char­
acteristic fatty acid changes. From 
gas chromatographic (GC) peak height 
measurements, control blood samples 
were found to contain carbon-16 un­
saturated acids equivalent to about 
15% of the saturated carbon-16 acid 
peak. In experimental pancreatitis this 
value has been observed to increase 
up to 20 times that amount (Table I). 
On the 6 SE (methyl silicone)-30 
GC column used for this analysis, oleic 
and linoleic acids elute under a single
Table I— Fatty Acid Changes in Surgically Induced Pancreatitis
Dog U-16 (subject) U-18 (subject)
no. U-16* U-16 (control) U-18* U-18 (control)
i 1.07 4.0 4.16 3.0
6 2.80 23.0 7.14 5.5
7 1.31 15.0 4.76 5.0
9 0.43 1.6 1.79 1.4
29 1.40 7.8 6.25 3.0
35 0.86 4.3 3.70 2.0
36 0.37 1.9 3.23 1.7
‘Relative degree of unsaturation is defined as peak height ratio in gas chromatographic peaks 
corresponding to unsaturated and saturated acids— that is, U-16 =  peak (16:1) =  peak (16:0) and 
U-18 =  peak (18:1 +  18:2) -t - peak (18:0). 16:0 =  palmitic (hexadecenoic) acid; 16:1 =  palmi- 
toleic (hexadecenoic) acid; 18:0 =  stearic (octadecenoic) acid; 18:1 =  oleic (octadecenoic) acid; 
and 18:2= linoleic (octadecenoic) acid.
A
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GC peak that is well separated from 
the peak for saturated stearic acid. 
Values of endogenous stearic acid, 
when compared with those of unsa­
turated carbon-18 fatty acids, varied 
from animal to animal. Changes in re­
lative amounts of the unsaturated car­
bon-18 acids are therefore best com­
pared with the amount of stearic acid 
for each individual analysis. It is dif­
ficult to predict normal stearic acid 
values either in the dog or in man. 
Table I also shows typical unsaturation 
changes in the carbon-18 fatty acids 
observed in dogs with experimentally 
induced acute pancreatitis.
Table II shows the changes observed 
by gas chromatography that occurred 
in experimental pancreatitis in the car- 
bon-18 chain fatty acids clearly sepa­
rated on an EGSP-Z* column. A and 
B represent two dogs with mild pan­
creatitis resulting from trauma to the 
pancreas during manipulation of the 
common bile duct. Here both the 
monounsaturated and diunsaturated 
fatty acids are clearly separated and 
were found to increase in concentration 
relative to stearic acid. Typical unsat­
uration changes in carbon-18 are noted, 
in contrast to the small to moderate 
changes in carbon-16 previously men­
tioned.
Varying degrees of the characteris­
tic high concentrations of unsaturated 
fatty acids found in experimental pan­
creatitis were noted in the patients
*Ethylenesuccinate-phenyl silicone copo­
lymer, supplied by Applied Science Labo­
ratories Inc., State College, PA 16801.
Table I I— Typical Changes in Carbon-18 Fatty  
Acids in Surgically Induced Pancreatitis in 
Two Dogs
Composition, % *
Acid In itial Final
Dog A
Saturated 49 28
Monounsaturated 27 31
Diunsaturated 24 41
Dog B
Saturated 47 25
Monounsaturated 25 30
Diunsaturated 28 45
♦Values are expressed as percentage of total 
concentration of carbon-18 fatty acids.
with acute pancreatitis and were not 
observed in control patients. As an ex­
ample, the biochemical analyses of a 
19-year-old woman with surgically 
proven acute pancreatitis are presented 
(Fig. 1). Blood samples were analysed 
at the height of the disease and at in­
tervals as the clinical condition im­
proved. Gas-liquid chromatographic 
determinations of the fatty acids in the 
plasma at the time the diagnosis was 
established at laparotomy are shown in 
tracing 1 of Fig. 1, while determina­
tions during the recovery phase are 
noted in tracings 2 and 3. The elevated 
16:1/16:0 ratio was gradually reduced 
to the normal value during recovery.
Comment
From our findings the formation of 
unsaturated fatty acids in pancreatitis
appears to be at the expense of saturated 
fatty acids. The extremely facile in­
crease in concentration of fatty acids 
with monounsaturation in both carbon- 
16 and carbon-18 chains and with di­
unsaturation in the carbon-18 chains 
was completely unexpected and appears 
to be unreported for any disease. The 
amount of carbon-16 monounsaturated 
fatty acids in most biologic samples is 
about 15% of the amount of carbon-16 
saturated fatty acids present.2
It is well known that all living sys­
tems are able to produce unsaturated 
acids from saturated precursors. Rapid 
changes in fatty acid composition can 
conceivably arise from selective mo­
bilization of fatty acids from adipose 
tissue or from de novo synthesis of 
these acids. If the latter option is ap­
plicable in pancreatitis it would seem 
likely that the pancreas is capable of 
regulating in vivo dehydrogenase re­
actions in dogs and possibly in man.
Mammalian systems are known to be 
able to introduce unsaturation into fatty 
acids at different sites. Probable sites 
of dehydrogenation are at 8-2, -4, -5, 
-6 and -9. However, for the carbon-16 
and carbon-18 fatty acids these possibil­
ities are generally considered to be 
limited to the 8-2, -6 and -9 positions.
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FIG. 1—Gas-liquid chromatographic tracings (X axis, time; Y axis, relative inten­
sity of peak) in patient with acute pancreatitis (1) during phase of maximum clinical 
severity, ( 2)  during phase of improvement and (3) upon recovery. (Compare ratios of 
peak areas C and D in each tracing.)
VOLUME 21, NO. 3, MAY 1978 /  THE CANADIAN JOURNAL OF SURGERY 271
Anevrisme atherosclerotique de I’artere sous-claviere
G il l e s  B e a u c h a m p , m d ,* J ean  L assonde, m d , f r c s [c ] |  e t  F ern and  L au r en d ea u , m d , f r c s [c] |
Nous avons traite recemment un 
patient porteur d'une pathologie assez 
inusitee, soit un anevrisme de i'artere 
sous-claviere droite. La presence 
d'une masse pulsatile cervicale laisse 
soupconner le diagnostic qui est 
confirme par I'arteriographie. L'approche 
chirurgicale utilisee consiste en une 
sternotomie partielle avec extension 
intercostale. L’anevrisme fut reseque et 
la continuite vasculaire retablie avec 
une prothese synthetique.
An aneurysm of the right subclavian 
artery, a rare pathologic entity, is 
described. The presence of a pulsatile 
mass in the cervical region should 
always suggest the diagnosis, which is 
best confirmed by arteriography. 
Approaching the lesion by partial 
sternotomy extending to the third inter­
costal space gives excellent exposure. 
The aneurysm should be resected and 
vascular continuity re-established by 
the use of a synthetic prosthesis.
Les masses de la region cervicale po- 
sent souvent un probleme de diagnos­
tic, sauf lorsque la masse est pulsatile. 
Recemment, il nous a ete adresse un 
patient presentant une masse pulsatile 
a la region cervicale droite, laquelle 
s’est averee etre un anevrisme de l’ar- 
tere sous-claviere droite. Nous decri- 
vons ici l’observation de ce patient et 
nous faisons la revue de la litterature 
sur cette pathologie assez inusitee.
Observation
II s’agit d’un patient de 70 ans qui 10 
jours avant son hospitalisation nota l’ap- 
parition d’une masse douloureuse a la 
region cervicale droite associee a une 
claudication intermittente du membre su- 
perieur droit. D’autre part, ce malade etait 
hypertendu depuis 13 ans mais ne presen- 
tait aucune autre manifestation clinique 
d’atherosclerose.
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A l’examen objectif, l’etat general etait 
excellent; la tension arterielle se chif- 
frait a 210/110 mm Hg; l’on palpait fa- 
cilement une masse pulsatile situee dans 
le triangle cervical anterieur droit. De 
plus, on notait des souffles femoraux bila- 
teraux ainsi qu’un souffle a la region epi- 
gastrique. Le reste de 1’examen etait 
sans particularite.
Le bilan biologique du patient s’est 
avere dans les limites de la normale. 
L’arteriographie selective du tronc bra- 
chiocephalique demontra la presence d’un 
volumineux anevrisme de la sous-claviere 
droite mesurant environ 6 cm de diame- 
tre, originant a 3 cm du tronc brachioce- 
phalique et se terminant a l’origine de 
I’artere axillaire (Fig. 1). En raison de 
l’augmentation rapide de la masse et 
des dangers de thrombose ou de rupture, 
nous avons decide d’en pratiquer l’exerese.
La technique chirurgicale employee ici 
a consiste en une sternotomie partielle avec 
extension dans le troisieme espace inter­
costal et dans la region sus-claviculaire 
droite (Fig. 2). L’approche s’est faite selon 
les principes usuels de la chirurgie arte­
rielle et la reconstruction a ete pra- 
tiquee avec une prothese synthetique de 
type “Weavenit” de 10 mm. L’evolution 
post-operatoire fut sans particularite si 
l’on excepte une pneumonie du lobe infe- 
rieur droit qui a bien repondu a la the- 
rapie convent ionnelle.
FIG. 1—L’anevrisme (An.) de la sous- claviere (S.C.) a son point de depart du tronc brachiocephalique (T.B-C). C — ca- rotide primitive droite.
Discussion
L’anevrisme atherosclerotique de 
I’artere sous-claviere est une entite pa- 
thologique extremement rare.1 L’ane­
vrisme secondaire a une compression 
de I’artere sous-claviere dans le defile 
thoracique, ou celui secondaire a un 
traumatisme de la region sont beau- 
coup plus frequents.2 Dans la littera­
ture, nous retrouvons quelques descrip­
tions d’anevrismes d’arteres sous-cla- 
vieres aberrantes lesquels semblent 
relativement plus frequents.3-* Cepen- 
dant, l’incidence totale des anevrismes 
de I’artere sous-claviere demeure tres 
faible si l’on tient compte du peu de 
cas publies jusqu’a maintenant. Les 
caracteristiques cliniques des patients 
porteurs d’un anevrisme atherosclero­
tique sont: l’age souvent avance et les 
signes generaux d’atherosclerose: hy­
pertension arterielle, infarctus ancien, 
anomalies electrocardiographiques, clau­
dication intermittente, troubles cere- 
brovasculaires, etc. Ces caracteristiques 
se superposent en tout point a celles 
que l’on rencontre dans les autres 
anevrismes de type atheroscleroti­
que (aorte abdominale, femoral, po- 
plite). Les anevrismes des arteres pe- 
ripheriques sont souvent asymptomati- 
ques et decouverts lors de l’examen 
physique.6 En d’autres cas, c’est le pa-
FIG. 2— L’incision du sternum se pro- longeant dans le troisieme espace inter­costal droit et en sus-claviculaire.
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tient qui note l’apparition d’une masse 
pulsatile comme pour le patient ci-haut 
mentionne. Quelquefois, ces anevrismes 
se manifestent par de la douleur dans 
les regions concernees ou par des 
symptomes d’insuffisance arterielle. Le 
diagnostic se fait habituellement a 
l’examen clinique et est confirme par 
l’arteriographie et autres moyens d’in- 
vestigation.
A cause des complications toujours 
possibles comme la compression, la 
thrombose, 1’embolie, la rupture, tout 
anevrisme devrait etre traite chirurgica- 
lement a moins d’une condition medi- 
cale contre-indiquant l’intervention. 
L’approche chirurgicale de l’artere 
sous-claviere represente un vif interet 
en raison de l’anatomie locale. Parmi 
les multiples techniques decrites pour 
absorber les vaisseaux de la base,7,8 
nous avons trouve que la sternotomie 
mediane partielle avec extension cervi- 
cale et intercostale constituait une voie 
d’approche ideale procurant une ex­
position facile du tronc brachiocepha- 
lique et de l’origine de l’artere sous- 
claviere.9 De plus, cette approche per-
met l’adjonction d’incision cervicale ou 
thoracique. La securite obtenue par un 
controle facile des vaisseaux de la base 
et le peu de morbidite associee nous 
porte a recommander ce type d'incision 
pour toute approche des vaisseaux de 
la base du cou a droite. II faut, de plus, 
noter que la clavicule peut etre rese- 
quee sans hesitation si le besoin s’en 
fait sentir. Apres la resection de l’ane- 
vrisme, il est preferable de retablir la 
continuite vasculaire avec une prothese 
synthetique adequate,6 bien que 1’on 
pourrait theoriquement recourir a la 
simple ligature de l’artere sous-claviere 
sans grand danger pour la vascularisa- 
tion du membre, vu la circulation col­
la te ra l abondante a ce niveau. Le 
retablissement de la continuite est 
cependant preferable.
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adressee aux coredacteurs, CP 8650, 
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"Le journal canadien de chirurgie” .
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leur publication dans le Journal. Veuillez 
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Les illustrations telles que des photo­
graphies d'appareils cliniques, des radio- 
graphies, des photomicrographies, des 
graphiques et des diagrammes doivent 
etre fournies sous la forme d'epreuves 
sur papier glace sans montage, les bor-
dures intactes, d un format ne depassant 
pas 12 x 17 cm. Chaque illustration doit 
etre munie d’une legende dactylogra- 
phiee sur une page separee du texte de 
Particle. S'il s'agit d'une photomicrogra- 
phie, indiquez le contraste et I'echelle 
de I'agrandissement. Les lettres qui ser- 
vent a identifier les elements d'une illus­
tration doivent etre d’une dimension 
suffisante atin de demeurer visibles lors- 
que les necessites de I'impression im- 
posent une reduction de I'image fournie.
II ne taut pas qu'on puisse identifier un 
patient grace a une illustration a moins 
qu’H n'y ait expressement consenti par 
ecrit; faute de permission les traits de 
sa physionomie doivent etre obliteres. 
Les illustrations en couleur ne seront 
publiees qu'aux frais de I'auteur. Si 
I'illustration provient d'une autre source, 
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de I’editeur de I'ouvrage dont elle est 
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fins de la publication.
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rediger sur des feuilles separees du 
texte, un tableau par feuille.
Les references doivent etre citees dans 
le texte au moyen d’un chiffre et grou- 
pees dans I'ordre a la fin de Particle en 
se conformant a la maniere de faire 
adoptee par ce Journal. Les references 
a des periodiques doivent etre con- 
formes a celles qu'adopte / ’Index 
Medicus.
Un resume qui ne doit pas depasser 125 
mots doit accompagner chaque article 
sur une feuille separee.
A titre d'approbation, un exemplaire du 
manuscrit redige sera envoye a I'auteur 
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stating that the paper is being submitted as an entry for 
the Davis & Geek Surgical Essay Award.
4. All papers submitted shall be the property of the Cana­
dian Journal of Surgery unless returned to the author 
without publication.
All papers submitted will be judged by an independent 
committee comprising at least one member of the editorial 
board of the Journal, one fellow of the Royal College of 
Physicians and Surgeons of Canada, and one representative 
of The Canadian Medical Association, together with other 
fellows invited to serve at the discretion of the three perma­
nent members of the committee. For the purpose of judging, 
the candidates will be anonymous. The judges’ decision shall 
be final.
The name of the successful candidate and the title of the 
paper will be announced in the November 1978 issue of the 
Journal.
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BOOK REVIEWS
THE ACUTE ABDOMEN. An Approach 
to Diagnosis and Management. 2nd ed. 
Thomas W. Bosford and Richard E. 
Wilson. 325 pp. Illust. W.B. Saunders 
Company Canada Limited, Toronto, 
1977. $8.75, paperbound. ISBN 0-7216- 
1886-3
This book is a revised version of the first 
edition published in 1961. In the preface 
to that edition the authors stressed an 
organized clinical approach to the patient 
with the acute abdomen, emphasizing the 
basic pathologic processes rather than the 
list of organs that may be involved. This 
sound policy has been continued, with 
discussion of newer investigative methods 
and the increased use of abdominal dia­
grams to serve as a visual summary of 
the many important points.
Section I, entitled “The Tools”, includes 
chapters on clinical approach, laboratory 
aids, roentgenography, ultrasonography, 
arteriography and anesthesia. In addition, 
pitfalls in diagnosis of the acute abdomen 
are described. The time-honoured basics of 
examination receive justly more emphasis 
than the more specialized facets, thus em­
phasizing the proper perspective for 
thorough clinical assessment. Numerous 
roentgenograms and schematic drawings 
provide a clear picture of the complete 
variety of conditions discussed.
Section II has two chapters on abdo­
minal trauma; the authors have outlined 
a general approach to the diagnosis and 
management of specific injuries. This again 
presents details that parallel the clinical 
appearance of these conditions.
Section III deals with acute abdominal 
inflammatory disease and is divided into 
abdominal lesions that may perforate, 
nonperforative acute upper abdominal le­
sions and nonperforative acute lower ab­
dominal lesions. This is a well-written sec­
tion. The more common lesions are de­
scribed; these descriptions are supple­
mented by assessment of the rarer diseases 
that may simulate an acute surgical 
abdomen.
The authors describe intestinal obstruc­
tion and hemorrhage in separate sections. 
The topics are divided into upper and 
lower bowel obstruction and intraluminal 
and extraluminal gastrointestinal hemor­
rhage. By this systematic approach the 
authors provide a clinical setting and ap­
proach to emphasize the important aspects 
of these conditions. The postoperative 
management of the abdomen is thorough­
ly discussed in the final chapter.
This is a pocket-sized book which can 
be carried about easily and used on the 
spot in hospital emergency rooms or of­
fices. The authors have supplied a con­
ceptual framework within which the 
physician can map a course of action. 
The nine-page index is suitably headed to 
facilitate on-the-job use.
I believe that this book can be strongly 
recommended for use by all who have any 
responsibility for the diagnosis and treat­
ment of the acute abdomen. The authors’ 
approach is clinical; they stress the in­
vestigative procedures that are practical. 
The value of such investigations is always 
considered supplementary to the history 
and examination of the patient.
T. Keith Scobie 
Department of surgery,
Ottawa Civic Hospital,
Ottawa, Ont.
ADVANCES IN SURGERY. Vol. 10.
Edited by William P. Longmire, Jr. 330
pp. Illust. Year Book Medical Publish­
ers, Inc., Chicago, 1976. Price not
stated. ISBN 0-8151-5632-4
This text has again accomplished the ob­
jective of identifying and reviewing ad­
vances in surgical knowledge.
The first chapter on electrocardiography 
is succinct and applicable to all surgical 
disciplines. The concept that the general 
surgeon should be knowledgeable in simple 
electrocardiography, signals a desirable 
change in surgical teaching. All surgeons 
who manage patients with acute disease 
should be able to recognize arrythmias, 
ischemic patterns and patterns consistent 
with pulmonary embolization; a study of 
this portion of the book would accom­
plish that purpose.
The second chapter on the endocrine 
system is excellent and should be obliga­
tory reading for residents and general 
surgeons. Included is an adequate his­
torical review and a description of the 
embryologic development of the neuro­
endocrine system. The physiology and 
pathology are described and the authors 
have included a description of the clinical 
syndromes involving the endocrine system; 
special reference is made to those related 
to the ectopic production of hormones.
The symposium on gallstones has an 
especially interesting review of etiology 
and pathogenesis. The current status of 
the systemic treatment of gallstones is re­
viewed; one can only conclude that the 
general surgeon’s workload in biliary tract 
surgery is not yet threatened. The dissolu­
tion of retained common-duct stones is of 
historical interest only but it is complete. 
The nonoperative extraction of common- 
duct stones is described in detail. This pro­
cedure is the most recent addition to 
the repertoire of the surgeon who deals 
with biliary tract problems. It is a useful 
technique that will contribute to lower 
morbidity; unfortunately it occasionally 
carries with it serious complications. The 
availability of this procedure should not 
make the surgeon complacent about leav­
ing a stone in the common bile duct.
The review of tumours of the islands of 
Langerhans is complete and detailed; much
of the material is repetitious of the chapter 
on the endocrine system. The contributions 
of the author, Dr. R.M. Jolinger, are put 
into perspective. The new glucagonoma 
syndrome and other syndromes associated 
with tumours or hyperplasia of the islands 
of Langerhans are described.
Although uncommon in most surgical 
practices, benign esophageal stricture re­
mains a serious problem and the authors 
have therefore properly included a chapter 
containing a good description of the etiol­
ogy and management. The operative tech­
niques for Collis gastroplasty, Thai patch 
and Nissen plication are adequately de­
scribed and the authors have also ex­
plained colon and gastric tube interposition 
procedures. As the numbers are small, no 
attempt is made to compare the results 
of the various techniques.
The final chapter is a brief review of 
currently available breast cancer detection 
procedures including mammography, xero­
mammography, chemography and sono­
graphy. The author describes the screening 
procedures available and attempts to put 
into perspective the logistics and feasibil­
ity of breast screening. It is clear that 
thermography and sonography are of lim­
ited use in the detection of breast cancer.
A.R. Downs 
Professor and head,
Department of surgery,
University of Manitoba,
Winnipeg, Man.
ARTHRITIS SURGERY. Leonard Mar- 
mor. 548 pp. Illust. Lea & Febiger, 
Philadelphia; The Macmillan Company 
of Canada Limited, Toronto, 1976. 
$54.30. ISBN 0-8121-0537-0
Contained within this single book is an 
excellent detailed description of practically 
every operative procedure for treating the 
arthritic patient. Each chapter describes 
the arthritic involvement of an anatomical 
region, including the gross anatomy, physi­
cal examination and methods of treatment. 
Each chapter in turn is divided into the 
problems of the patient with rheumatoid 
or osteoarthritis. Two final chapters refer 
to the specific problems of juvenile rheu­
matoid arthritis and fracture management 
in arthritic patients. The total content en­
compasses a reasonable survey of the cur­
rent status of surgery for patients with 
arthritis.
The author is a noted orthopedic sur­
geon who brings a vast personal experience 
in all aspects of arthritic surgery to this 
book. Because of his experience, the details 
described are pertinent and extensive; de­
tails include the preferred drug and the 
relative costing. The surgeon will appre­
ciate particularly the author’s detailed de­
scriptions of the pre- and postoperative 
management, techniques and pitfalls.
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The book is well illustrated; many of 
the anatomical drawings are taken from 
“Gray’s Anatomy”. An extensive reference 
list is included with each chapter.
The chapters on the knee and hip joints 
contain a brief history of the development 
of prosthetic joints. The author puts too 
much emphasis on the value of the knee 
prosthesis that he designed; this is a major 
criticism of the book. People in the field 
will be aware of the numerous prosthetic 
devices and their inherent problems. Read­
ers are also aware of the numerous efforts 
to design better artificial joints. At the 
present stage of development, however, it 
is difficult for the reader to match the 
enthusiasm of the author for the Marmor 
modular knee system.
The practising orthopedic surgeon will 
rely on texts such as this because of the 
considerable advances and changes occur­
ring in arthritis surgery during each de­
cade. The orthopedic trainee would do 
well to peruse at least the anatomical de­
scriptions and the operative techniques 
described in this book. The essential mes­
sage for us all from this author is clear. 
We are told what not to expect from 
certain reconstructive procedures.
James J. Wiley 
Orthopedic surgeon,
Ottawa General Hospital,
Ottawa, Ont.
BREAST CANCER. Edited from the Pro­
ceedings of the International Breast 
Cancer Conference held in Lucerne, 
Switzerland, July 3Ist-August 4th, 1976. 
Edited by Albert C.W. Montague, 
Geary L. Stone and Edward F. Lewison. 
549 pp. Illust. Alan R. Liss, Inc., New 
York, 1977. $38. ISBN 0-8451-0012-2
As the title suggests, this book comprises 
papers presented at the International Breast 
Cancer Conference held in Lucerne, Swit­
zerland in 1976. The chapters included are 
on epidemiology, biology, hormonal in­
fluences, clinical detection and screening, 
roentgenographic and thermographic diag­
nosis, treatment of the primary lesion, ad­
juvant therapy, treatment of metastatic 
disease, bilateral breast cancer and re­
habilitation. Each chapter consists of from 
two to nine papers with occasional 
duplication but also differing points of 
view. Most of the authors are well-known 
authorities from the United States; the 
remaining authors are chiefly Swiss, but 
a few are from other countries such as 
Great Britain and Italy, and three are 
Canadians — A.G. Fagekas, J.K. Mac- 
Farlane and L.J. Mahoney.
The treatises will be highly attractive 
to clinicians with a special interest in 
breast cancer although many of the pre­
sentations have been published earlier and 
add nothing to the original publication. 
The student will find standard textbooks 
more relevant to their needs because of 
the uneven coverage that is to be expected 
in such a symposium. Pathology, for in­
stance, is not covered.
A minor irritation is the photostatic re­
production of the submitted manuscripts. 
As a result, the type varies in kind and 
size, and hand-written corrections of some 
of the typographical errors are included.
The book presents succinctly the state of 
the art in 1976 of the topics covered.
J.E. D evitt 
Associate dean,
Continuing medical education,
University of Ottawa,
Ottawa, Ont.
CHIRURGIE PLASTIQUE CUTANEE 
DE LA MAIN ET DE LA PULPE, 2e 
ed. R. Yilain et J. Michon. 162 pp. 
Illust. Masson, Paris, 1977. $26. ISBN 
2-225-45122-2
The main emphasis 6f this text is on the 
anatomy, physiology and treatment of 
trauma as it applies to the specialized skin 
of the hand. The book is not a com­
pendium of hand surgery and there is 
little discussion of congenital anomalies, 
skeletal injury, nerve and tendon trauma, 
or complex reconstructive procedures.
The introductory chapters review basic 
concepts of wound healing, techniques of 
hand surgery, incisions and applied ana­
tomy. The book is well illustrated with 
photographs and excellent line drawings.
The authors include descriptions of 
ingenious methods by which local flaps 
may be used to resurface the hand; some 
of these were pioneered by the authors. 
In addition, the book includes several ex­
amples of the versatility of the flag flap 
and discussions on the standard distant 
flaps, the classic cross-finger, thenar and 
cross-arm flaps.
The problems involved in resurfacing 
mangling injuries of the volar and dorsal 
aspects of the hand are outlined; unfor­
tunately the detailed section on fingertip 
injuries does not include a description of 
the Kleinert flap. The most detailed and 
original material is in the chapter on 
injuries of the nail and nail bed.
The bibliography ends with 1974 refer­
ences and largely reflects pre-1974 con­
tributions. Thus, newer practical concepts 
such as the groin flap, the deltopectoral 
flap, principles of free flaps, microvascular 
surgery and finger degloving injuries are 
not reviewed in this volume.
The text is wordy. Since most of the 
material is well covered in standard Eng­
lish texts of hand surgery, it is unlikely 
that it will be translated into English.
Paul R. Benoit 
Ste. 104,
340 McLeod St.,
Ottawa, Ont.
CLINICAL MICRONEUROSURGERY. 
Edited by W. Th. Koos, F.W. Bock and 
F.R. Spetzler, 317 pp. Illust. Georg 
Thieme Yerlag Publishers, Stuttgart; 
Publishing Sciences Group, Inc., Acton, 
1976. $41.50. ISBN 3-13-523601-3
Sixteen years ago, in the pages of this 
journal, Lougheed and Tom (Can J Sur% 
4: 329, 1961) first recorded the use of 
the operating microscope in surgery of 
the nervous system. Since then, the micro­
scope has become essential to the safe 
and accurate performance of many neuro­
surgical procedures. It is now almost un­
thinkable to clip a cerebral aneurysm, re­
move an acoustic or pituitary tumour, or 
even suture a peripheral nerve, without the
clarity of exposure, magnification and il­
lumination provided by a microscope.
Contemporary neurosurgical literature 
is replete with microsurgical information 
ranging from elegant coloured microana- 
tomical displays to technical details and 
results of microneurosurgical procedures. 
Therefore, a reader should have high ex­
pectations from a book entitled “Clinical 
Microneurosurgery”, which is intended to 
“serve as a thorough reference work on 
the state of modern microsurgery.” Unfor­
tunately, the reader will probably be dis­
appointed.
The book is an update based on con­
tributions to the International Congress 
on Microsurgery, held in Vienna in Oc­
tober 1972. Most of the contributors are 
European, although a few are North 
American or Japanese. The translation into 
English is adequate. The black and white 
illustrations and photographs are, for the 
most part, quite clear.
The book provides a matrix into which 
the large experience of the University of 
Vienna neurosurgical department is woven. 
The chapter on the microanatomy of the 
cerebellopontine angle provides a clear 
review of the relations of the lower 
cranial nerves and tiny blood vessels. 
Koos, Bock and Spetzler review 60 angle 
tumours, 90% of which were of very 
large size; the mortality rate was 3% in 
patients with large tumours and 8% in 
patients with very large tumours. These 
authors describe a standard posterior fossa 
approach in well-illustrated step-by-step 
detail. They recommend, but do not de­
scribe, prior translabyrinthine removal of 
the intracanalicular portion of large tu­
mours by an otolaryngologist.
Koos and his colleagues also reported 
320 patients with sellar lesions. Most of 
the pituitary adenomas were removed by 
a transcranial subfrontal approach. Al­
though numerous black and white photo­
graphs taken through the operating micro­
scope illustrate the paper, there are no 
step-by-step descriptions of the technique 
used and no breakdown of the results. In 
their paper on 32 craniopharyngiomas, the 
authors state that even with the help of 
the operating microscope total tumour 
removal is usually impossible; two thirds 
of the patients thought to have had a total 
removal, developed late recurrences. The 
book also contains papers on the transeth- 
moidal approach, and the transfrontal 
transsphenoidal approach to the sella.
The section on microsurgery of vascular 
lesions is very brief. There are papers that 
have little connection with microsurgery. 
These include, for example, the effects of 
subarachnoid hemorrhage on cerebral 
blood flow, percutaneous trigeminal trac­
totomy and vestibular tests in acoustic 
neuromas. There is no section on instru­
mentation or technique, and the chapter 
describing microscopes is unfortunately 
quite out of date.
To those already doing microneurosur­
gery, the book offers little that is new. 
To those entering the field, the book is 
insufficient to be of much value. It is the 
sixth book on microneurosurgery in this 
reviewer’s library. A comprehensive text 
on the subject has yet to appear. One
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awaits with interest the appearance in 
December 1977 of the second edition of 
Rand’s book on microneurosurgery.
Ross F l e m i n g  
Division of neurosurgery,
Toronto Western Hospital,
Toronto, Ont.
CURRENT MANAGEMENT OF ACUTE 
GASTROINTESTINAL HEMOR­
RHAGE. Edited by Teruo Matsumoto. 
256 pp. Illust. Charles C Thomas, Pub­
lisher, Springfield, IL, 1977. $19.75. 
ISBN 0-398-03582-2
The editor has included in this book a 
wide range of clinical entities. He presents 
excellent material on pathogenesis with
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particular reference to upper gastrointes­
tinal hemorrhage. Sections on stress ulcer, 
gastritis and duodenal ulcer are also well 
done.
The very little information included 
regarding the technical aspects of surgical 
management can be considered a strength 
rather than a weakness in a book of this 
size.
Diagnostic aids are dealt with reason­
ably well. The roentgenograms are excel­
lent and demonstrate lesions clearly. The 
chapter on arteriography is not well bal­
anced. There is too much technical detail 
and no mention is made of the use of 
arteriography in the management of small 
bowel and colonic hemorrhage; this is its 
most common application in our in­
stitution.
Time spent in several chapters on the 
management of hypovolemic shock is not 
appropriate and often is inaccurate. For 
example, we disagree with the belief that 
packed cells and fresh-frozen plasma is 
preferable to whole blood in treating hem­
orrhagic shock. Space occupied by this 
material could have been devoted to a 
more detailed description of the surgical 
management of lower gastrointestinal hem­
orrhage. This section is weak.
The editor has succeeded in presenting 
for our consideration a knowledge base 
for medical students and primary care 
physicians. Most of the information is 
accurate and well presented.
J o h n  R. G u t e l i u s  
Department of surgery,
Queen’s University,
Kingston, Ont.
SPECIAL TUMORS OF OVARY AND 
TESTIS AND RELATED EXTRA- 
GONODAL LESIONS. Comparative Pa­
thology and Histological Identification. 
2nd ed. Gunnar Teilum. 513 pp. Illust. 
Munksgaard International Publishers 
Ltd.. Copenhagen; J.B. Lippincott Com­
pany of Canada, Toronto, 1976. $59.50. 
ISBN 0-397-58197-1
This is an interesting, well-illustrated and 
well-referenced text by an authority who 
has published a great deal in the fields 
he covers. The content of this book ex­
tends beyond that suggested by the title. 
In a conventional text the author might 
systematically cover all tumours of a sys­
tem or organ. In this text the author de­
scribes only certain tumours of both the 
male and female genital organs including 
those of germ cell origin and gonadal 
stroma, clear cell tumours and meso­
nephric adenocarcinomas; the various 
malignant and benign lesions associated 
with intersex are also described. Teilum 
includes a description of the embryologic 
development of ovary and testis and fol­
lows this up with an explanation of the 
comparative pathology of ovarian and 
testicular tumours. Related extragonadal 
lesions are also included in this discussion.
In the second part of the book Teilum 
concerns himself with histologic identif­
ication; for each tumour mentioned, synon­
yms are listed and a definition and his­
torical perspective are included. Where 
indicated the author describes the histo­
genesis, gross appearances, histology and 
differential diagnosis.
The book is large, but the arrangement 
is not cramped; reading it is therefore not 
a chore. The content is well organized 
and pertinent. The information is similar 
to that found in other texts of gynecologic 
pathology, but the author’s comments 
based on extensive personal experience 
give this text a special benefit. The illus­
trations are all in black and white, either 
full or half-page; the detail and the related 
text are clear and to the point. This book 
is an excellent reference text for the rou­
tine and comparative pathology of the 
particular gonadal tumours included and 
would be of interest to pathologists and 
gynecologists concerned with oncology.
H.D. S t e e l e  
Department of pathology,
Kingston General Hospital,
Kingston, Ont.
TRAITE DE TECHNIQUE CHIRURGI- 
CALE O.R.L. ET CERVICO-FACIAUE. 
Tome HI. Pharynx et Larynx. Yves 
Guerrier. 502 pp. Illust. Masson, Paris, 
1977. $121. ISBN 2-225-45420-5
Bien qu’il s’agisse avant tout d’un livre de 
technique chirurgicale, on n’a pas neglige 
pour autant les indications de chacune des 
techniques, la preparation du malade a 
l’intervention, les soins postoperatoires 
souvent tres difficiles, le traitement des 
complications eventuelles, les associations 
radiochirurgicales ainsi que les traitements 
medicaux d’appoint en cancerologie. On 
y traite aussi des temps de reconstruction 
plastique dans la chirurgie reparatrice du 
pharynx et du larynx.
Cet ouvrage est divise en 10 grand cha- 
pitres: le premier est consacre a la chirur­
gie pharyngee per-orale, le second con- 
cerne la chirurgie du fibrome naso-pharyn- 
gien et les 8 autres chapitres, la chirurgie 
majeure par voie cervicale.
Ce tome concerne exclusivement le pha­
rynx et le larynx. II fait partie d’un en­
semble de quatres tomes dont le premier 
sur l’oreille et l’os temporal, et le deuxieme 
sur le nez et la face ont ete rediges sous 
la direction du professeur Michel Port- 
mann. Les tomes 3 et 4 le sont sous celle 
du professeur Yves Guerrier. Le tome 4 
traitera de la cavite buccale et du cou.
II n’y a aucun doute que ce volume, tout 
comme les deux premiers tomes, rendra 
grand service non seulement aux etudiants 
en otorhinolaryngologic, mais a tous ceux 
qui sont interesses a la cancerologie de 
ces regions.
Le prix de ce volume peut paraitre ex- 
cessif (au-dela de $100.), mais ce cout n’en 
n’est pas moins tres justifie par la masse 
des connaissances qu’il apporte et l’abon- 
dance de ses illustrations.
Le professeur Guerrier et ses collabora- 
teurs ont depasse largement le strict point 
de vue technique, et on voit tout au long 
de la lecture de ce volume, que l’oto- 
rhinolaryngologiste doit traiter non seule­
ment une maladie mais aussi un malade.
P. F u g e r e
Directeur du departement d’ORL, 
Universite Laval,
Quebec, PQ
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